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1.

INTRODUCTION

The primary therapeutic use of norphi.c.e is to alleviate pain.
Recent evidence suggests that opiates can exert their analgesic effect
in three ways.

First, opiates can inhibit

sion in the dorsal horn of the spinal cord.

prL~ary

afferent transmis-

Cells in lamina I and V of

the spinal cord which receive noxious input are inhibited by morphine:
whether they are firing spontaneously, or induced to fire by noxious
stimuli applied to their receptive field (Kitahata, Kosaka, Taub,
Bonikos and Hoffert, 1974; Takagi, Doi a.c.d JL~aike, 1976; Duggan, Hall
and Headley, 1977b).

The response of cells in the spinal cord to non-

noxious stimuli (jet of air, light touch) are not inhibited by morphine
(Calvillo, HenrJ and Neuman, 1974).

Further support for a direct

spinal action of opiates includes the finding by Yaksh and Rudy (1976)
that morphine injected into the spinal subarachoid space of a rat (with
its spinal cord transeeted) produces antinociception.

The response was

rapid, making unlikely the possibility that diffusion of the opiate to
supraspinal structures was involved.

Second, opiates can inhibit so-

matosensory affe:::-ent t!·ansmission at the supraspinal level.

Morphine

applied directly to the periaqueductal grey (PAG) hypothalamus, nucleus
reticularis gigantocellularis and medial thalamus results in analgesia
(Herz, Albus, .Metys, Schubert and Teschemact~er, 1970; Pert and Yaksh,
1974; Takagi et al., 1976; Pert, 1978).

One important observation con-

cerning brain regions that appear to mediate opiate analgesia is that
they receive input from the anterolateral pathway of the spinal cord:
l

2

a pathway which presumably carries pain information.

Injection of

~or-

phine into certain other areas of the brain such as the cerebral cortex,
tectum and midbrain reticular formation was ineffective in producing
analgesia (Pert, 1978).

However, interpretations of these findings are

difficult in view of the possibility that morphine could have diffused
into the ventricular system.
ing inhibitory pathways.

Third, opiates can activate the descend-

Descending pathways from the raphe magnus,

periaQueductal grey and possibly the locus coeruleus inhibit the firing
of dorsal horn cells and their responses to noxious input (Oliveras,
Besson, Guilbaus and Liebeskind, 1974; Fields, Basbat,m, Clanton and
Anderson, 1977; Basbaum and Fields, 1978) .

SubseQuent studi.es have

shown that syste_mically administered mor:phine increases the spontaneous
activity of cells in the raphe magnus and PAG (Anderson, Basbaum and
Fields, 1977; Urea and Liebeskind, 1979).

Satoh and coworkers (1971)

presented additional support for the importance of descending supraspinal control by demonstrating that bradykinin induced increases in
activity of dorsal horn cells \vere inhibited by morphine (2 mg/kg) in
intact rabbits, but not in spinal rabbits.
With chronic exposure to morphine, tolerance to many of the
acute effects develop and the sudden discontinuation of the drug leads
to profound physiological and behavioral changes.
been used to establish the brain
of opiate dependence.
brain regions.

region~

'l':fo methods have

important in the development

One method involves the lesioning of discrete

Chemical or electrolytic lesions attenuate or abolish

certain signs of opiate withdrawal.

The following areas have been

lesioned in the rat and shown to be involved:

ventromedial nucleus of

3
the hypothalamus (Kerr and Pozuelo, 1971), medial forebrain bundle
(Glick and Charap, 1973), noradrenergic bundles which innervate the
thalamus or hypothalamus (Lewis, Costa and Jacobowitz, 1976), medial
thalamic nuclei (Teitelbaum, Catravas and McFarland, 1974) and caudate
nucleus (Borison, 1971).

In addition, it ha,s been demonstrated in

human addicts that prefrontal lobotomy reduces the craYing for opiates
(Mason and Hamby, 1948).
ship from such studies:

It is difficult to assess any

c~US13.1

relation--

the lesions may.owe their effects to nonspecif-

ic sequelae of the operation or to loss of integrated cerebral activity
and circuitry which are essential to the expression of the opiate withdrawal syndrome.

The second method involves the microinjection of nar-

cotic antagonists into discrete orain sites.
into a

n~~ber

?ne injection of naloxone

of brain regions precipitates abstinence in addicted rats.

The brain sites in which these withdrawal signs could oe elicited appeared to be localized in the nucleus anterior ventralis, anterior
media~is

and parafascicularis of the

~halamus

(Wei, Loh and Way, 1973).

More recently, Wei and coworkers (1975) reported that injection of naloxone into the medial hypothalamus and periaqueductal grey matter elicited an intense withdrawal reaction in morphine dependent rabbits,
and concluded that the medullary and pontine regions of tfJ.e brainstem
were important areas for the development of opiate dependence.

Al-

though there appeared to be site specificity with the microinjection
studies, it is difficult to reach

de~ite

conclusions due to incomplete

information about the spread of the injected antagonist.
sion and microinjection studies suggest a
sites as foci

fo~

addictive mechanisms;

numbe~

Both the le-

of different brain

however, both studies suffer

4
from the inherent assum~tion (which need not necessarily be correct)
that those areas which can elicit or

withdr~val

are

those areas intimately involved in the development of dependence.

In

su~press

signs of

other words, it is not possible to decide whether the site of action
was made at the primary site of withdrawal or along a complex neuronal
circuit.
The basic mechanisms underlying the acute analgesic effect of
ouiates and opiate tolerance and addiction remain
numerous efforts by investigators

usiP~

havioral and pharmacological techniques.

obscure in spite of

a variety of biochemical, beIt has been established that

opiates act directly on neurons and the result of such an interaction
are changes in the mer:tbrane properties of the neuron.

It was my in-

tention to elucidate the underlying mechanism of acute and chronic opiate action in single myenteric neurons using an electrophysiological
approach.
Electrophysiologica~

out in vivo or in vitro.
each approach.

L~al

the

There are advantages and disadvantages to

Studies in vivo are performed under physiological con-

ditions in which the
tact.

studies of neural tissue may be carried

anatomica~

and functional connections are left in-

Further advantage includes the ability to record while the anis moving and behaving normally.

i~

vivo approach.

Yet, there are

lL~itations

to

The method of drug administration is usually by

local application onto the tissue under investigation (iontophoresis,
microinjection) or by systemic injections into blood vessels.

In either

case the concentration of the drug and the exact site of drug action
is unLnown.

Advantages of the in vitro technique include the following.

5
One, the concentration of the drug at the site of its action is known.
Two, the ionic composition of the perfusate can be altered when the
ionic mechanism of action is to be studied.

Three, it can generally

be distinguished whether the observed effects are taking place directly
on the neuron

lli~der

study.

Limitations of the

tec~Dique

include main-

taining viability and stability for long periods of time and extrapolation of the data to the whole animal is difficult because anatomical
connections have been severed and the physiological mileu altered.
The isolated myenteric plexus-longitudinal muscle of the guineapig ileum is a site in the peripheral nervous system which is sensitive
to the opiates.

It is a network of neurons adherent to the longitud-

inal muscle layer of the gut wall.

The myenteric plexus affords one

the opportunity to measure electrophysiologically the activity of
single mammalian neurons which are morphine sensitive.

The tissue pro-

vides a convenient model to study the responses which directly follow
the interaction of a narcotic agonist with the opiate receptor.

The

acute actions of opiates in this preparation are to inhibit the nerve
mediated contraction of the longitudinal muscle by reducing the output
of acetylcholine from cholinergic nerves and to inhibit the spontaneous

'

firing of neurons which can be recorded with extracellular electrodes
(Paton, 1957; Schaumann, 1957; Sato, Takayanagi and Takagi, 1973; 1974;
Dingledine, Goldstein and Kendig, 1974; Dingledine and Goldstein, 1975;

1976; North and Williams, 1977).

That the action of opiates on the

myenteric plexus is mediated by opiate receptors identical to those
subserving analgesia in the central nervous system (CNS) is substantiated by the following evidence.

First, the myenteric plexus possesses

6
opiate binding sites (Pert and Snyder, 1973).

Second, the potency of

an antagonist to inhibit naloxone binding in brain homogenates correlates well with its dissociation constant for binding in the myenteric
plexus (Creese and Snyder, 1975).

Third, the opiate action is stereo-

specific and occurs at low concentrations.

Fourth, the action of o-

piates is reversed with a concentration of naloxone several fold lower
than that of the agonist (Kosterlitz et al., 1968; North and Williams,
1977).

Fifth, the relative potencies of a series of narcotic agonists

in depressing the electrically induced contractions of the myenteric
plexus-longitudinal muscle preparation are comparable to their analgesic
potency in man (Kosterlitz and Waterfield, 1975; Creese and Snyder,
1975).

Sixth, narcotics in,.'-libit the spontaneous firing of myenteric

neurons (Sato et al., 1973; Dingledine and Goldstein, 1975) which is
similar to the action of opiates on central neurons (see review by North,
1979a).

Seventh, the antagonist potency of

na~cotics

determined in

morphine-dependent monkeys correlates well with their antagonist potency
determined on the guinea-pig ileum (Kosterlitz, Waterfield and Berthoud,
1971~)

•
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1.1.

OPIATE TOLERANCE

k~ DEP&~ENCE

When morphine is acutely administered to man a number of pharmacological effects are seen.

Among the most salient acute effects are

sedation, analgesia, euphoria, constipation, respiratory depression and
cardiovascular depression.

With repeated (chronic) exposure to morphine,

tolerance to most of the acute effects develop.

1~at

is, to attain a

desired effect the dose of the narcotic must be progressively increased.
Chronic administration of morphine leads to profound physiological and
behavioral changes which readily become evident upon the sudden discontinuation of the drug.

The characteristic withdrawal syndrome >vhich

ensues has many of its clinical manifestations in directions onposite
....,,...,
'

to thos.e seen when opiates are given acutel:r (Ja,ffe, 1968}.

A more

violent yet shorter lasting withdrawal syndrome is induced when naloxone or nalorphine is administered to chronically opiate treated individuals (Jaffe, 1968).

8

1.1.1.

Definitions

Legal involvement in dealing with narcotic addiction along with
common street terminology has led to much confusion over the exact definition of the narcotic related terms.

Efforts have oeen made oy the

World Health Organization (WHO) to develop a consistent
with an exact definition.

terminolo~J

The following terms are commonly referred

to in this manuscript and their WHO definition is presented (IsoelJ.
and Cr~usciel, 1970).
Drug Dependence: A state, psychic and sometimes also physical, resulting from the interaction between a living organism and a drug,
characterized by behavioral and other responses that always include
a compulsion to take the drug on a continuous or periodic basis in
order to experience its psychic effects, and somet:i.m.es to ayoid the
discomfort of its absence.
Tolerance may or may not oe present.
A person may be dependent on more than one drug.
Psychic Dependence: A compulsion that requires periodic or continuous adr.:tinistration of a drug to produce pleasure or avoid discomfort. This compulsion is the most pow·erful factor in chronic intoxification with psychotropic drugs, and with certain types of
drugs may be the only factor involved in the perpetuation of abuse
even in the case of most intensive craving. Psychic dependence,
therefore, is the universal characteristic of drug dependence.
Operationally, it is recognized oy the fact that the dependent continues to take the drug in spite of conscious admission that it is
causing harm to his health and to his social and familial adjustment, and that he takes great risks to obtain and maintain his supply of the drug.
Physical dependence: A pathological state brought about by repeated
administration of a drug and that leads to the appearance of a
characteristic and specific group of symptoms, termed an abstinence
syndrome, when the administration of the drug is discontinued or
in the case of certain drugs -- significantly reduced. In order to
prevent the appearance of an abstinence syndrome the continuous
taking of the drug is required. Physical dependence is a powerful
factor in reinforcing psychic dependence upon continuing drug use or
in relapse to drug use after wi thdra;ral.

9

Tolerance: The state in which repetition of the same dose of a CL"Y>Ug
has progressively less effect, or in which the dose needs to be increased to obtain the 5ame degree of pharmacological effect as was
caused by the original dose.
Cross-tolerance: The state in which tolerance to one drug has the
effect of causing tolerance to another drug of the same or a different chemical type.

10

1.1.2.

Opiate Receptor Studies

The concept of receptors was originally introduced by Paul
E'nrlich who stated that "substances can only be anchored at any particular part of the organism if they fit into the molecules of the recipient complex like a piece of mosaic finds its place in a pattern"
(Ehrlich, 1960).

However, several criteria must be fulfilled before a

binding site can be classified as an opiate receptor.

'I'he drug must

have a high affinity for the binding site, there must be a difference
in the affinity with which stereoisomers bind, the number of binding
sites must be limited, and interaction of an agonist w·ith the binding
site must elicit a hiological response.
The interaction of opiates with high affinity membrane binding
sites

·(re~eptors)

results in a series of neuronal events leading to

changes in pain perception, motor behavior, mood and autonomic ·.:respons.es.
Opiate receptors have been localized to discrete brain areas; some prob-,.
ably subserve pain perception but others are not associated 1vith pain.

'Two

techni~ues

have been used to study opiate specific binding

sites (receptors) in nervous tissue.

The radioreceptor assay is an ill

vitro technique which discrimi::J.ates between opiate enantiomers (Pert
and Synder, 1973).

Radioreceptor studies have revealed that the fol-

lowing brain regions are rich in opiate stereospecific binding sites:
caudate, putamen, amygdala, periaqueductal grey, thalamus, hypothalamus
and substantia gelatinosa (Kuhar, Pert and Synder, 1973; Lamotte, Pert

ll
and Snyder, 1976).

Autoradiography is the second technique available

with which to study opiate specific bi:c.ding sites.

After parenteral

injection, 3H-diprenorphine is localized primarily in the caudate, putamen, locus coeruleus, amygdala, zona compacta of the substantia nigra,
nucleus tractus solitarius, nucleus ambiguous and the substantia
gelatinosa (Pert, Kuhar and Snyder, 1975; Atweh, Murrin and Kuhar, 1978).
There is a good correlation betvreen the regional distribution of the
specific binding sites indicated by the two techniques.

Both techniques

reveal negligible density of specific binding sites in the cerebellum and
white matter.
nique.

There are disadvantages and difficulties with each tech-

The radioreceptor technique does not localize receptors in their

physiological or functional setting and stereospecific binding has been
shown to occur at clearly non-functional sites, such as glass filters
(Snyder, Pasternak and Pert, 1975) and cerebroside sulfate (in vitro)
(Loh, Cho, Wu and Way, 1974).
autoradiographic technique.

There are also limitations with the
These include diffusion of the high affinity

ligand away from the specific binding site to other areas ;.;hich therefore sets limits to the resolution of the technique.

Furthermore, the

technique fails to differentiate between multiple high affinity binding
sites.

Also one is restricted to using high affinity compounds T..rhich are

not readily metabolized by the body.
Subcellular distribution studies reveal high densities of stereospecific binding sites in the mitochondrial and microsomal brain fractions.
These fractions are rich in synaptosomes and membrane fragments, respectively and the inference is that opiate receptors may be located on nerve

12
terminals (Pert, Snowman and Snyder, 1974).

Evidence that opiate recep-

tors are located primarily on nerve terminals and associated 1vith primary afferent fibers comes mainly from studies of deafferentation.

De-

afferentation of the vagus or enucleation of the eye resulted in a marked reduction of autoradiographically identifi.ed opiate receptors in
the respective primary sensory nuclei (Atweh et al., 1978).

In addition,

Lamotte (1976) demonstrated an approximately 50% loss of opiate specific
binding sites in the dorsal horn of monkey spinal cord following transection of the

~orsal

roots.

A study of several narcotic agonists has revealed that several
distinct clinical syndromes accompany their administration.

Martin

(1976) has postulated that these differences, most notably in subjective
effects and

tJ~es

of physical dependence, are a consequence of the drug

interacting with different types of the opiate receptor.

He suggested

that there are three types of opiate receptor located in nervous tissue and designated

them~'

ceptors are morphine
clazocine (K).

(~),

K,

and cr.

Prototypic agonists for these re-

N-allylnormetazocine (a) and ethylketocy-

More recently, Lord and colleagues (1977) have identi-

fied a fourth form of the receptor fihich has been designated 8.

These

investigators found that ·in the guinea-pig ilema, the enkephalins are as
readily antagonized by naloxone as is normorphine; however, in the mouse
vas deferens they are not.

About 10 times more naloxone was required to

reverse the inhibition produced by enkephalins than was required to reverse the inhibition caused by normorphine.

Such a difference in the pA2

values for enkephalin in the guinea-pig ileum and mouse vas deferens
strongly suggests that the receptor populations in the two in vitro models
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are heterogeneous and not identical.

In addition, these investigators

demonstrated that the inhibition of 3H-leu-enkephalin and 3H-naloxone
binding in brain homogenates of guinea-pig was not equal for opiates
and opiate peptides.

That is, both met and

leu-e~~ephalin

displaced

3H-leu-enkephalin binding whereas morphine was a much better inhibitor
of 3H-naloxone binding than of 3R-le11-e~~ephalin bindir~.

Again, such

findings strongly suggest the existence of a heterogeneous population
of opiate receptors.
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1.1. 3.

Pharme,cology of Opiates

For the most part, ne.rcotic analgesics have been classified as
belonging to one of two groups.

The classification is based on their

acute pharmacological effects as well as their dependence producing
liability.

Agonists are classified as being either morphine-like or

nalorphine-like (Martin et al. , 1976).
Mor£hine-like agonists_
The acute effects include analgesia, sedation, alteration in
mood, mental clouding, euphoria, miosis, cardiorespiratory depression,
nausea and constipation.

T:"le analgesic effect is relatively selective,

in that ~ensory modalitie$ other tP~n pain are left intact (touch, propioception, vibration).

The patient may still recognize painful stimuli but

he is not bothered or concerned over it.

Morphine is more effective in

relieving dull chronic pain rather than sharp intermittent pain.
Studies performed on absorption, distribution and metabolism
indicate that morphine and its surrogates are not readily absorbed from
the gastro-intestinal tract.

It is readily accessible to the target

site if given parenterally and is distributed in

pa.renc~vmous.

tissue.

The major metabolic pathway in h1.1.ffians is conjugation 1-rith glucuronic
acid in the liver, N-demethylation and 1..rrinary excretion of free morphine subserving minor roles (Jaffe and Martin, 1975).

Morphine does

not accumulate in tissue, and 24 hours after the last dose, tissue
concentrations are quite low.

An analgesic

dose

~f

morphine

(10 mg)

15
given subcutaneously acts within minutes and its effect typically lasts

4 to 5 hours (Jaffe and Martin, 1975).
Tolerance to and physical dependence on morphine occur with repeated use.

Studies on the suppression of withdrawal in subjects physic-

ally dependent on morphine reveal that morphine at a dose which is 1020% of a stabilization dose will markedly suppress abstinence in patients
who are near maximally dependent on morphine (Martin, 1971).

Methadone

(Dole and Nyswander, 1965), propiram, profadol (Jasinski, Martin and
Hoeldtke, 1971) and d-propoxyphene (Fraser and Isbell, 1960) will substitute for, and show cross-tolerance with, morphine in the morphinedependent subject.

Cyclazocine (Martin, Fraser, Gorodetzky and Rosen-

berg, 1965) and pentazocine (Jasinski, Martin and Hoeldtke, 1970) will
not suppress abstinence symptoms in subjects dependent on morphine; nor
will ketocyclazocine and ethylketocyclazocine suppress signs of abstinence in the morphine dependent dog (Gilbert and 'Martin, 1976).
The severity of the characteristic syndrome which occurs when an
individual abruptly discontinues chronic use of narcotic analgesics is
determined by several factors

such as, specific opiate administered,

daily dose, duration of use, and health and personality of the individual.
\Vhen morphine is abruptly

withdraw~.,the

ensuing abstinence syndrome is

characterized by an early and protracted phase.

The early phase begins

manifesting symptoms at the time of the next scheduled dose and lasts
10 days.

Early signs of opiate withdraw-al are nervousness, weakness,

muscle aches, lacrimation, abdominal cramps, anorexia, nausea, craving
for sweets, aversion to tobacco, rhinorrhea, yawning, perspiration and
restless sleep.

As the syndrome approaches its peak (2-3 days in the

4-
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case of morphine and heroin), irritability, insomnia, anorexia) yawning,
sneezing, weakness, depression, rlse in blood pressure, pulse rate,
respiratory rate and body temperature, intestinal spasm and diarrhea increase.

Administration of opiate at any point during the withdrawal

completely suppresses the syndrome.

The early phase of abstinence in a

moderately dependent individual usually subsides in 7-10 days.

However,

a much more prolonged return to preaddiction levels has been noted for
some of the signs, especially blood pressure, pulse rate, body temperature and pupillary diameter.
stinence,

p0~siological

Between the sixth and ninth week of ab-

changes begin to emerge as a result of the dis-

continuation of morphine.

This later phase, known as protracted ab-

stinence, persists for more than 30 weeks.

During this phase, blood

pressure, pulse rate, body temperature, pupillary diameter and the sensitivity of the respiratory center to C02 are below normal levels.
The level of tolerance and cross tolerance which develops depends upon the type of narcotic administered and its dose.

There have

been no thorough studies of the disappearance of tolerance following
cessation of drug treatment.

Most studies indicate that tolerance is

attenuated a few days after cessation of drug administration when compared with tpe degree of tolerance at the time of cessation.

Goldstein

and Sheehan (1969) showed that the return to normal sensitivity to the
stimulatory effect of levorphanol in mice was complete in
withdrawal.

48

hours after

In clinical studies narcotic addicts undergoing withdrawal

reported a rapid

recove~J

(within a few days) of the euphoric and de-

pressant effects of narcotis (Light, 1931).

However, tolerance to cer-

tain effects such as nausea and emesis, persists for months after termi-
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nation of chronic morphine ac~inistra~ion (rraser and Isbell, 1952).
Cochin and Kornetsky (1964) have reported that residual tolerance to
the analgesic effects of morphine can be demonstrated in rats up to

15 months after a. single injection of a. large dose of morphine.
Buprenorphine is a. strong analgesic which is some 25-40 times
more potent than morphine in rodents.

It has a rapid onset and dur-

ation of action (Cowan, Lewis and Macfarlane, 1977).

In man buprenor-

phine is capable of producing morphine-like subjective, behavioral and
analgesic effects and is 25-50 times more potent than morphine (Jasinski,
Pevnick and Griffith, 1978).

Buprenorphine has been also shown to possess

narcotic antagonist properties (Cowan et al., 1977).

In man abrupt

withdrawal of chronically administered buprenorphine results in a. mild
abstinence syndrome with the first signs appearing 2-3 days
withdrawal.

followir~

The abstinence syndrome reaches its peak intensity at 14 or

15 days after withdrawal, at which time the subjects display a drug craving behavior (Jasinski et a.l., 1978).

.tUthough buprenorphine is sj_'llilar

to morphine in certain respects (Martinet al., 1976), there are also
marked differences between these drugs.

First, in the buprenorphine

dependent subject administration of naloxone failed to precipitate an
abstinence syndrome; and second, abrupt vithdraval of buprenorphir'1e
resulted in only a very weak withdrawal syndrome (Jasinski et al., 1978).
In chronic spinal dogs buprenorphine induced a state of physical dependence and also partially suppressed morphine withdrawal.

Over 20 times

more naloxone was required to precipitate abstinence in the buprenorphine dependent dog than would have been necessary in dogs dependent
upon an equivalent amount of morphine (Martin et al., 1976).

In rats,
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mice and monkeys chronic administration of buprenorphine failed to produce overt signs of physical d;:;pendence (Cowan et al., 1971).
factory explanation is available

~s

Wo satis-

to why different results were obtained

with the monkey, rat and mouse a,s opposed to the dog e,nd human.

Perhaps,

the dependence which is observed in the dog and human is minimal or
clinically insignificant.

It is suggested that the long duration of

action and the lack o:r effect by naloxone in precipitating abstinence
are e.n indication of the high affinity of the buprenorphine-receptor
interaction, as bindibg studies indicate an extraordinarily low dissociation rate constabt (Rance and Dickens, 1978).
Nalo!_'phipe-like agoni:sts
Cyclazocine is a very potent and long acting nl".rcotic antagonist,
but when given alone has narcotic analgesic properties.

In man cycla-

zocine (0.25 - 2.0 mg) produces a state of analgesia comparable to that
seen with morphine 20 mg (Lasagna, DeKornfeld and Pearson, 1964).

Sub-

jective effects of cyQlazocine closely resemble those seen with nalorphine and consist of

~eelings

of

apatP~,

sleepiness, tiredness, irrita-

bility, racing thoughts, delusions, and hallucinations.

The majority

of subjects do not either like or dislike the drug (Fraser and Rosenberg,

1966).

In the chroniQ spinal dog cyclazocine produces nalorphine-like

effects in single

dos~s

and physical dependence with chronic administra-

tion (Gilbert and Martin, 1976).
Chronic administration of cyclazocine to man induces a state
of physical

dependenc~.

Such subjects show tolerance to all major
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pharmacological effects of cyclazocine as well as cross-tolerance to
nalorphine.

Abrupt withdrawal or administration of naloxone results in

an abstinence syndrome which closely resembles that following nalorphine
but which is clinically different to the one seen in morphine dependent
subjects (Jasinski, Martin and Sapira, 1968; Martinet al., 1965).

Af-

ter subjects have been stabilized on parenteral doses of cyclazocine
for several weeks, abrupt withdrawal results in an abstinence syndrome
which does not manifest itself until the fourth day and which does not
become maximal until the seventh day (Martin et al., 1965).

Signs of

abstinence consist of mydriasis, increased pulse rate and -body temperature, decreased body weight, lacrimation and diarrhea.

Certain signs

persist for periods as long as 6 weeks following 1-rithdrawal (Martin,
Fraser, Gorodetzky and Me Clane, 1965).
terized as being slow in onset and mild.

The syndrome has been characNo compulsion to take the

drug is apparent upon withdrawal as is common with morphine addiction.
In short, although an abstinence syndrome ensues upon abrupt vrithdrawal
of cyclazocine, the withdrawal syndrome does not produce a great desire
to continue taking the drug and,therefore,liability for abuse of cyclazocine seems slight.

Nalorphine and ketocyclazocine both suppress signs

of cyclazocine withdrawal in man and dog (Fraser and Rosenberg, 1966;
Gilbert and Martin, 1976).
Ketocyclazocine is a narcotic analgesic of the nalorphine type.
It has an analgesic activity equivalent to cyclazocine·in the rat abdominal constriction test (Michne, Pierson and Albertson, 1974) .. Chronic
administration leads to the development of tolerance and physical dependence.

Ketocyclazocine does not suppress abstinence symptoms in the
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morphine dependent rat (Michne et al.,

1974)) monkey (Swain and Seevers,

1974), or dog (Gilbert and Hartin, 1976).

Characteristics of keto-

cyclazocine withdrawal closely resemble those of cyclazocine and, there-·
fore, differ from those of morphine.
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1.1.4.

Mechanisms and Theories of Opiate Tolerance and Dependence
The question of whether opiate tolerance and dependence exists

as two separate but closely related phenomena, or as quite inseparable
phenomena with a common underlying mechanism remains unresolved.

Evi-

dence in support of the hypothesis that the two phenomena are inextricably
linked includes; 1) the finding that physical dependence seems to develop
in parallel with analgesic tolerance (Way, Loh and Shen, 1969), 2) the
greater the level of tolerance attained the harsher the withdrawal syndrome (Martin, 1971), and 3) all of the narcotics known to man cause both
phenomena (Hartin, 1971).
Several theories on the mechanism of tolerance have been proposed, but none appears to have been defined precisely and to have established its role in the development of tolerance and dependence.
Counter-Adaptive Theory of Himmelsbach
One of the earliest theories of opiate tolerance and dependence
1-ras proposed by Himmelsbach (1943).

In this theory, the effect of opi-

ates on hypothalamic centers is to disturb homeostasis.
to physiologic adaptations which

This leads

oppose the acute actions of opiates.

That is, repeated exposure to the narcotics leads to a neT,; equiliori um
in which the narcotic drug is an essential component.

wnen the narcotic

is withdrawn, it disrupts this new state of equilibrium; therefore, the
physiologic adaptations are no longer balanced by the opiate, and a c-rithdrawal syndrome is observed in which the clinical manifestations are
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usually in directions opposite to those following the acute administration of opiates.
Altered Disposition
A second theory of the mechanism of tolerance and dependence
was based on the differences i:o. biologic disposition between tolerant
and non-tolerant subjects (Light, 1931; Axelrod, 1956; Hug, 1972).

How-

ever, thorough investigations have revealed no differences in the excretion of either free or bound morphine in tolerant and non-tolerant
dogs (Cochin, Haggart, Woods and Seevers, 1954) or in the distribution
and fate of morphine in tolerant dogs, rats (Woods, 1954) or monkeys
(Mellett and Woods, 1956).
It is generally accepted that differences in absorption, distribution, metabolism and excretion of narcotic analgesics cannot possibly
account for the differences in pharmacological responses observed between tolerant and non-tolerant subjects.
Role of the Opiate Receptor
Several studies have demonstrated that naloxone,given before or
concurrently with morphine,to rats or mice, blocked the development of
tolerance to and dependence on morphine (Mushlin, Griffel and Cochin,

1975; Yano et al., 1979).

Such findings lead inv2stigators to conclude

that the opiate receptor was somehow necessary for the induction of tolerance and dependence.

Studies cvere made to determine whether changes in

receptor number or affinity parallelled the development of tolerance and
dependence.
Pert and coworkers (1973) were the first to demonstrate an in-
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crease in stereospecific binding
with morphine pellets.

Jf

3H-dihydromorphine in mice implanted

Similarly, Frederickson et al. (1974) reported an

increase in the number of opiate binding sites in rats rendered tolerant
and dependent on morphine.

Conversely, several investigators have re-

ported a decrease in the number of opiate specific binding sites with the
development of opiate tolerance and dependence.

Davis and coworkers

(1975) found that with chronic morphine therapy a decrease in receptor
affinity to morphine occurred in brainstem slices; however, these same
investigators found no difference in binding properties when binding was
measured in brainstem homogenates.

In contrast to the aforementioned

studies, the majority of investigations suggest no change in either the
affinity or number of opiate receptors.

Klee and Streaty (1974) were

the first to show no change in the stereospecific binding for either 3Hdihydromorphine or 3H-naloxone in brains from naive and opiate tolerant
rats.

Similar findings were reported by Bonnet (1976).

The reasons for

these disparities in results remain unknown; they may be related to differences in experimental technique, approach and methods used by the various investigators.
It is difficult to assess the significance of such experiments
because the binding properties which are recorded are those of a tissue
which is undergoing withdrawal from opiate rather than a tissue which
continues to be
opiate

~ust

perfor~ed.

tolerant and dependent on opiate.

This is because the

be withdrawn from the tissue for the binding studies to be
This procedure of washing the tissue (in vitro) induces a state

of opiate withdrawal and
the receptor.

~erhaps

an altered (conformational) state of

Thus, such findings may not be a reliable index of opiate

24
receptor properties during the phenomena of tolerance and dependence.
In general, it is fairly well accepted that changes in the opiate receptor, if in fact they do occur, can..'1ot adequately account for the changes
observed during opiate tolerance and dependence.

Therefore, it appears

likely that this phenomenon is somehow dependent upon events which follm.r receptor occupation.
Immune Mechanisms
A number of observations have suggested that irr®unoreactions may
be involved in opiate tolerance and dependence (Cochin, 1970).

In rab-

bits, chronic morphine administration resulted in an increased capacity
of serum proteins to bind morphine by as much as 100 fold (Herndon,
Baeder and Ringle, 1974) and there is evidence that serum proteins of
heroin addicts have a greater affinity for heroin than serum proteins
from drug naive individuals (Ryan, Parker and Williams, 1972).

Immuni-

zation of mice with a morphine immunogen (3-carboxy.m.ethyllnorphine-BSA)
resulted in the formation of an antibody to morphine.

In these mice,

the analgesia produced by a single dose of morphine was significantly
less than the analgesia produced by morphine in the adjuYant treated animals (Berkowitz and Spector, 1972).

This finding suggests that toler-

ance to the analgesic effect of morphine was accelerated by the formation of antibody.

A problem with this theory is that it does not ade-

quately explain cross-tolerance among structurally unrelated narcotics.
For instance, antibodies to morphine do not readily cross react with
methadone (Wainer, Wung, Connors and Rothbert, l979),yet methadone is
clearly less effective in florphine tolerant subjects (Dole and Nyswander,
1965).
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Cyclic Nucleotides
Administration of a phosphodiesterq.se inhibitor induces a syndrome in rats which is indistinguishable from the synd:come seen upon
cessation of chronic morphine therapy (Francis, Roy and Collier, 1975).
This behavioral pattern elicited by the pt.osphodiesterCJ.se inhibitor is
known as the qug,si-morphine abstinence syndrome ( QJvLA.S).

A fair corre-

lation has been found between the abUity of various agents to inhibit
phos:phodiesterase and the intensity of the withdrawal syndrome (Francis,
Cuthbert, Saeed, Butt a;:J.d Collier, 1978).

The q':.lasi-:rr;.orphine abstinence

syndrome is potentiated by n"1rcotic antagonists and s-uppressed by na.rcotic agonists (Collier, Francis, Henderson and Scl1neider, 1974).

In

addition, phosphodiesterase inhibitors or cyclic-M1P alone will intensify the naloxone precipitated withdrawal syndrome in morphine dependent
rats (Francis, Roy and Collier, 1975; Collier and Francis, 1975).

Con-

sistent '..ri th the premise that the cyclic nucleotides play a prominent
role in opiate tole:cance and dependence is the finding by Ho and colleagues (1973b) that administration of cyclic-AMP to mice enhanced the
development of opiate tolerance and dependence.

On the other hand,

chronic administration of t.9-tetrahydrocannabinol

(Kaymakcalan, Hak-

kiayhan and Cankattulany, 1977) or a single microinjection of

hist&~ine

in the hippocampus of the rat (Glick and Crane, 1978) and probably other
procedures can induce an opiate-like abstinence syndrome.
pounds are neither opiate-like nor do they

illi~ibit

These com-

phosphodiesterase.

Studies of neuroblastoma-glioma hybrid cells

(~TG108-15)

have

demonstrated that after an initial decrease in cyclic-:\MP levels by

26
opiates there is a compensatory increase to control levels.

That is,

cyclic-AMP levels return to normal values while the opiate is present
(acquisition of tolerance).

The hybrid cells g.lsp acquire a dependence

on opiates, in the sense abrupt ivithdrawa.l of the opiate or addition of
naloxone to the tissue results in an increase in cyclic-AMP levels well
in excess of the original level (Sharma, Kl.ee and Nirenberg, 1975),
Tolerance and dependence in NG108-15 cells are also elicited by opioid
peptides such as methionine-enkephalin (Klee, 1978).
The

experiment~

described have led to the concept of dual

regu~

lation of adenylate cyclase as a biochemical model for the acute and
chronic actions of opiates.

The inference from these studies is that

the compensatory increase in cyclic-AMP levels is responsible for symptoms associated with opiate withdrawal (see section 1.3).
Inhibitors of Tolerance and Dependence
The early findings that calcium ion antagonized the analgesic
effect

of opiates (Kakunaga, Kaneto and Hano, 1966) prompted further

studies on the role of calcium in opiate tolerance and dependence.
Kaneto (1971) reported that mice given repeated intracisternal injections
of morphine plus calcium were less tolerant to the analgesic effect of'
morphine than were the group receiving morphine alone.

Calcium was also

found to inhibit certain aspects of the naloxone precipitated withdrawal
in morphine dependent mice (Harris, Bhargava, Loh and Way, 1974).

The

mechanism by which calcium inhibits the development of tolerance and the
s~~ptoms

of withdrawal is not known.

Kowever, it may be linked to its

involYeJ..rlent with neurotransmitter release and a possible interaction
between calcium and morphine with respect to release because opiates in-
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hibit transmitter release at various sites in the nervous system
(Paton, 1957; Sanfacon and Lambreque, 1977; Henderson and Hughes,
1976).
Protein synthesis inhibitors have been shown to attenuate morphine tolerance and dependence.

Tolerance to the analgesic effect of

morphine was reduced or prevented by several drug treatments which inhibited protein synthesis.

That the effect of these agents are not due

to lethargy or debilitation of the animal or alteration in metabolic
disposition was shown by Cox and Osman (1970) and Feinberg and Cochin
(1977).

The inhibitors studies were cycloheximide, 5-fluorouracil,

mercaptopurine, actinomycin D and puromycin.

6-

The study by Cox and Os-

man (1970) was designed to reduce the complications due to systemic toxicity of the various agents.

Infusion of small doses of protein syn-

thesis inhibitors intracerebroventricularly or intravenously inhibited
the development of acute tolerance to morphine produced during a 3 to 7
hour continuous infusion.

The results support the hypothesis that pro-

tein synthesis is an integral function in the development of tolerance
to narcotics in vivo.
Neurohypophyseal peptides, as ,,,.ell as certain of their deri vatives, have oeen recently shown to alter the development of opiate tolerance and :ienendence in rodents (\'l'al ter e": al., 1973; 1979).

='he mechan-

ism of action by which these peptides exert their effect remains ooscure.
Enkenhalins and R-endornhin
The involvement of enkephalins or S-endorphin in the

mechanis~

underlying ouiate tolerance and dependence is not clearly understood.
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It is

knO'Nn

that cross-tolerance between morphine and enkephalins occurs

in the guinea-pig ileum and mouse vas deferens (Waterfield, Hughes and
Kosterlitz, 1976) and
(Pert, 1976).

~ith

respect to their analge3ic effect in the rat

Kosterlitz and Hughes (1975) have suggested. that the

development of tolerance to morphine may be associated with a decrease
in the levels and synthesis of enkephalin.

It was further suggested

that a deficiency of an endorphinergic system could explain the protracted phase of the abstinence syndrome (Goldstein, 1976) and the
high rate of recidivism after abstinence in heroin addicts (Przevlocki,
Holt, Duka, Leber, Gramsch, Haarman and Herz, 1979).
in either

~endorphin

or

er~ephalin

Hovever, no change

levels were detected in rat brains

from rats subjected to acute or chronic morphine treatment over a maximum period of 10 days (Childers et al. , 1977; Fratta et al. , 1977; Wesche
et al., 1977), although a decrease in the S-endorphin levels was observed
(in rat brain) when morphine therapy was ~~tended for periods of 30 days
(Przev1ocki et al., 1979).

Therefore, a relatively 1on,s exposure to mor-

phine appears to be necessa..7 to decrease S-·endorphin or enkephalin levels
in rat brain, and to effect the development of opiate dependence and
characteristics of withdraval.
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1.2.
1.2.1.

SINGLE NEURON STUDIES
Acute Effects of Opiates

Early electrophysiological studies on the action of opiates
were limited to those brain areas associated with pain and its transmission.

The discovery and localization of opiate receptors in dis-

crete brain regions (Pert and Snyder, 1973) redirected the studies of
single neurons toward areas enriched with these receptors.

Three cri-

teria must be fulfilled before an opiate effect may be considered receptor mediated.

First, the effect should be observed at a concentra-

tion of opiate which is pharmacologically relevant.

Second, the effect

should be stereospecific; that is, mimicked only by the (-) isomer of
enantiomeric opiates.

~nird,

naloxone should antagonize the effect.

The use of naloxone reversibility as the sole criteria for opiate specificity should be viewed with caution since naloxone has been shown to reverse the inhibitory effect of

y-aminobutyric acid (GABA) on the firing

rate of neurons located within the olfactory tubercle (Dingledine, Iverson and Breuker, 1978), the fatigue of peristalsis induced by adenine
nucleotides,haloperidol and

~Jlocaine

in the guinea-pig ileum (Van Nue-

ten, Jansen and Fontaine, 1976a; 1976b) and the antinociception produced by phenoxybenzamine in mice

(SpieP~er

and Paalzow, 1979).

However,

it remains to be determined whether these effects are mediated through
the release of enkephalin.
There is generally a good correlation between the density of
opiate binding sites and the number of cells which are responsive to
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opiates and opioid peptides (Nicoll, Siggins, Ling, Bloom and Guillemin,
1977).

Opiates administered either systemically or by iontophoresis in-

hibit the spontaneous firing of neurons in the rat sensorimotor cortex (Satoh, Zieglg~nsberger, Fries and Herz, 1974), hypothalam11s (Eidelberg and Bond, 1972), medial thalrurrus (Linse~an, 1978), parafascicular
nucleus (McClu.."lg and Dafny, 1978), locus coerulem: (Korf, Bunney and
Aghajanian, 1974; Bird and Kuhar, 1977), and caudate nucleus (Dafny et
al., 1979).
A number of studies have shown that the excitatory response of
single neurons to the stimulation of their peripheral receptive fields
are inhibited by opiates.

In the rat, morphine inhibits the neuronal

activity evoked by noxious stimulation in the mesencephalic reticular
formation (Haigler, 1976), lamina V cells of the spinal cord (Calvillo
et al., 1974; Duggan et al., l977b), thalamus (Hill and Pepper, 1978)
and locus coeruleus (Korf et al., 1974).

One area which has been ex-

tensively studied with respect to selective depression of nociceptive
activity by narcotic analgesics is the dorsal horn of the spinal cord of
cats (Kitahata et al., 1974; Duggan et al., 1977b).

Iontophoretic ap-

plication of morphine into the substania gelatinosa or systemic aruQinistration (1-2 m.g/kg i. v-.) produced a selective depression of dorsal horn
cell responses to noxious stimulation, but did not affect responses to
non-noxious stimuli.

These effects were reversed by low concentrations

of naloxone (O.l m.g/kg i.v.) (Duggan et al., 1976; l977b).
Whereas opiates usually inhibit neuronal activity, there are at
least two areas in the CNS where the predominant effect of opiates and
opioid peptides is neuronal excitation.

These are the Renshaw cells
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of cats (Davies, 1976; Davies and Dray, 1978) and the hippocampal pyramidal cells of rats (Nicoll et al., 1977).

However,

~ve

may not deal here

with a direct increase in neuronal activity, as Zieglgansberger and
colleagues (1978) have provided evidence that the opiate induced excitation of hippocampal py-ramidal cells is due to inhibition of neighboring
tonically active inhibitory neurons.

It is possible that the excitation

of Renshaw cells may have a similar explanation.
The

review of the electrophysiological study of opiates

p~ese~t

in vivo is incomplete.

The reader is referred to reviews by Bradly (1978)

and North (1979a) for a complete and detaiJ.ed description of the action
of opiates in vi-vo.
In Vitro Studies
Sato and colleagues (1973) were the f:!.:rst to demonstrate an
effect of morphine on myenteric neurons in vitro.
~w1)

phine (approximately 8.5
gle myenteric neurons.

In this study, mor-

inhibited the spontaneous activity of sin-

These same investigators later demonstrated that

morphine (approximately 3

~M)

inhibited neurons whether they were firing

spontaneously or induced to fire by 5-hydroxytryptam.ine (5-HT) or caerulein (Sato, Takayanagi and Takagi, 1974).

The concentrations of mor-

phine used in these studies were quite high, considerably greater than
the concentration

necessa~J

to inhibit the electrically induced contrac-

tion of the longitudinal muscle myenteric plexus preparation of the
guinea-pig ileum (ID50 85 ru1) (Goldstein and Schulz, 1973).

Subsequent

studies by Dingledine and Goldstein (1975; 1976) have demonstrated that
the inhibitory effect of morphine on myenteric neurons could be reproduced using a concentration of morphine comparable to those used in the
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twitch studies.

The inhibition of

firi~g

was stereospecific, that is it

was mimicked by levorphanol but not dextrorphan, and was antagonized by
low concentrations of naloxone (Dingledine, Goldstein and Kendig, 1974;
Dingledine and Goldstein~ 1975).
those by Sato's group.

Their findings confirm and extend

In addition, morphine was shown to be effective

under conditions of synaptic transmission blockade (Dingledine and Goldstein, 1976; North and Williams, 1977).

The inference from these studies

as well as those by Sato in which morphine depressed the excitations
induced by 5-HT, caerulein and nicotine vras that morphine probably acts
directly on the myenteric neuron to reduce excitability.

Similar results

were obtained with the endorphins (North and Williams, 1976; Williams
and North, l979a).

The mechanism of action of opiates on single myenteric

neurons is discussed in detail below.
Studies of dorsal root ganglia and spinal cords dissociated from
each other and allowed to make connections in culture have demonstrated
a possible presynaptic site of opiate action (Crain, Peterson, Crain and
Simon, 1977; MacDonald and Nelson, 1978).

In the study by Crain et al.

(1977), electrical stimulation of the attached dorsal root ganglion resulted in a complex negative slow vave potential which vras selectively
depressed by opiates.

The effect was seen with low concentrations of

morphine, etorphine and levorphanol, and was antagonized by naloxone.
Dextrorphan had no effect.

Naloxone alone in many cases selectively

increased the amplitude and duration of
in the dorsal horn.

t~e

sensory evoked potential

The inference was tnat these sensory networks develop

localized opioid inhibitory control

syste~s

mediated by the endorphins.

In the other study, intracellular recordings were made from spi-
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nal neurons.

Stimulation of the dorsal root ganglion gave rise to an

excitatory postsynaptic potential (e.p.s.p.) in spinal neurons.

The

e.p.s.p. was depressed by iontophoretically applied etorphine.

Since

etorphine did not have any postsynaptic effect of its own, the authors
concluded that etorphine exerted its effects by

inhibiti~~

the release

of transmitter from the primary afferent terminals (MacDonald and Nelson, 1978).
There are at least two viewpoints as to the underlying mechanism
of opiate action in single mammalian neurons.

One view holds that mor-

phine acts postsynaptically to block the inward sodium current induced
by glutamate or possibly other excitatory agents at the subsynaptic membrane.

Intracellular recordings of spinal motoneurons in vivo revealed

no significant changes in the membrane potential or input resistance to
iontophoretically applied morphine but it was found that morphine reduced
the rate of rise of the e.p.s.p. and the potential evoked by iontophoretic
application of glutamate

(Zieglg~nsberger

and Bayerl, 1976).

A second

view proposes a membrane hyperpolarizing effect of morphine as the underlying mechanism of action.

A significant proportion of myenteric neurons

recorded in vitro were hyperpolarized by opiates and opiate peptides
(North and Tonini, 1977; North, Katayama and Williams, 1979).

It has

been proposed that such a hyperpolarizing effect may explain not only the
inhibition of neuronal firing but also the inhibition of acetylcholine
release evoked by field stimulation.

Furthermore, it appears likely

that the site of opiate action in the myenteric plexus is non-somatic;
that is, morphine acts by hyperpolarizing the nerve processes.

Morphine

showed no consistent effects on the amplitude of the excitatory postsynaptic potential (North, 1979b).
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1.2.2.
T~en

Chronic Effects of Opiates

rats were chronically exposed to morphine by means of sub-

cutaneous pellet implantation or by multiple subcutaneous (or intraperitoneal) injections, no change in the pattern or frequency of the spontaneous neural firing was reported for the opiate treated animals as
compared with drug naive animals (Satoh, Zieglgansberger and Herz, 1976).
Furthermore, tolerance to the usual depressant effect of morphine on spontaneous activity or activity evoked by acetylcholine or glutamate was demonstrated on neurons in the rat sensorimotor cortex (Satoh et al., 1974),
hypothalamus (Eidelberg and Bond, 1972), parafascicular nucleus (McClung
and Dafny, 1978) and locus coeruleus (Aghajanian, 1978) (Table 1.).

Simi-

larly, tolerance to the inhibitory effect of morphine on single neuron
activity has been demonstrated in the medial thalamus, periaqueductal grey,
caudate nucleus, hippocampus and nucleus accumbens of rabbits (Peters and
Klem, 1977).
Naloxone >:o7as '.vi thout effect on the firing rate of neurons in
drug nai7e animals, whereas it induced a marked excitation of neurons in
opiate dependent animals (Table l.).
brain

si~es

sensorimo~or

In opiate dependent rats, those

in which naloxone increased neuronal activity included the
cortex (Satoh et al., 1975), hypothalamus (Eidelberg and

Bond, 1972), medial thalamus (Frederickson, Norris and Hewes, 1975) and
the locus coeruleus (Agha,j ani an, 1973).

This increase in neuronal acti v-

ity induced oy naloxone has been referred to by some investigators as a
::J.anifestation of opiate dependence.

Similar results have been renorted
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Table l.

The action of morphine and naloxone on the firing rate
of neurons of drug naiye and opiate pretreated animals.

AbbreYiations:

morph
nalox
ne
t·

+

morphine
naloxone
no effect
firing rate increased
firing rate decreased
not tested

"'
Predominant Response
Tolerant I

Naive
Animal

Region

morph

nalox

morph

Dependent
Reference

naloxone

Rat

Sensorimotor
cortex

t

ne

t

t

Rat

Hypothalamus

t

ne

t

t

Eidelberg and Bond, 1972

Rat

Medial
thalamus

t

ne

--

t

FredericksQn et e,l.' 1975
Linseman, 1978

Rat

Parafascicular
nucleus

i

--

t

--

Guinea
pig

Myenteric
ganglion

t

ne

ne

t

Rat

Locus
coeruleus

t

ne

t

t

ne

ne

ne

ne

Rat

Cerebellum
(Purkinje
cells)

ne

Rat

Mes enc eph.alic
nucleus of
the 5th nerve

Rat

Reticular
formation

ne

ne

ne

ne

Rat

Spinal
interneuron

ne

ne

ne

ne

Rat

Brainstem

t

ne

t

t

ne

ne

Satoh et al._,

1~14

McClung and Darny, 1978
North and Williams, 1971;
North and Zieglgansberger,
1978
Agha.lanian

1978.

Agha.ianian

1978

Aghajanian

1978

Agha_j an ian

1978

ne

Davies

19'76

Bramwell and Bradley, 19~

w

0\
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for peripheral mammalian neurons studied in vitro.

Extracellular re-

cordings from myenteric neurons from guinea-pigs pretreated with morphine demonstrated tolerance to the usual inhibitory effect of morphine.
A naloxone-induced excitation was also observed (North and Zieglg~ns
berger, 1978).
Changes in neuronal sensitivity occur concommitantly with the
development of tolerance.

The sensitivity to excitations by glutamate

of striatal neurons (of drug naive rats) increased during and after a
prolonged microelectrophoretic application of met-enkephalin:

at the

same time, the inhibitory effect of met-enkephalin progressively diminished.

This tachyphylaxis to the inhibitory effect of met-enkephalin

occurring concurrently with an increased sensitivity to glutamate may
or may not be related to the tolerance described (Fry, Zieglgansberger
and Herz, 1978).

The mechanism underlying the changes in neuronal sensi-

tivity has not been thoroughly investigated; however, one hypothesis
suggests a membrane depolarization as the basis for the effect (Johnson,
Westfall, Howard and Fleming, 1978).

In support of this view, is the

membrane depolarization recorded when naloxone is administered to tissue
(myenteric neurons) which has been pretreated (20 h) with a morphine
solution (Johnson and North, 1980).

It is believed that tissue exposed

in this manner is tolerant to and dependent on morphine (Hammond et al.,

1976).

38

1.3.

THE INTERACTION OF

CYCLIC~AMP IU~

1.3.1.

RELATED AGENTS WITH OPIATES

Antinociception

Recent studies on the biochemical basis of opiate analgesia
have implicated the cyclic nucleotide system(s).

It has been demonstra-

ted that cyclic adenosine-3' ,5'-monophosphate (cyclic-AMP), dibut~~yl cyclic adenosine-3' ,5'-monophosphate (dbcyclic-AMP), or theophylline administered intracerebrally or intravenously antagonizes the antinociception produced by morphine in mice (Ho, Loh and Way, 1973a).

Similarly,

prostaglandin E1 (PGE1 ) administered intraventricularly reversed the
antinociception produced by morphine in the rat (Feri, Santagostino,
Braga and Galatulas, 1974).

This effect of PGE1, which is to reverse

the antinociception produced by morphine, may be due to its ability to
elevate cyclic-AMP levels (Collier and Roy, 1974; Welman and Schawabe,
1973).

Nevertheless, the mechanism whereby these compounds reverse the

analgesic effect of morphine has not been completely elucidated.

It may

be that they are indeed exerting their effect by directly altering intracellular levels of cyclic nucleotides, or perhaps by affecting neurotransmitter release (Nathanson, 1977; Schulz and Cartwright, 1976) or
mobilizing ca++ stores (Ramwell and Shaw, 1970; Hayashi, Mori, Yamada
and Kunimoto, 1978).

The acute actions of opiates have been shown to be

related to each of these factors.
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1.3.2.

Studies on Brain Homogenates and Neuroblastoma-Glioma
Hybrid Cells
Studies by Collier and Roy (1974) provided the earliest biochem-

ical evidence linking the opiates to a.denylate cyclase activity.

These

workers found that the conversion of 3H-ATP to 3H-cyclic-AMP was stimulated approximately two fold by prostaglandin E1 .

Morphine inhibited

this stimulation but was without effect on the basal production of cyclic-AMP.

The inhibitory effect was dose related, mimicked by heroin

but not dextrorphan, and reversed by naloxone.

Similar findings in

homogenates of monkey amygdala (Wilkening, Mishra and Makman, 1976),
and in brain slice preparations (Minneman and Iverson, 1977) have confirmed the results by Collier and Roy (1974), although a number of other
laboratories have been unsuccessful in their attempts to do so (Katz and
Catravas, 1977; Van Inwegen, Strada and Robison, 1975).

Several expla-

nations· have been offered to account for these discrepancies, such as
regional heterogeneity of cell types in brain homogenates, lability of
brain enzymes under experimental conditions, inability to control factors which are known to affect adenylate cyclase activity such as ions
and neurotransmitters, and the possible variable effects of morphine on
cyclic-AMP levels in different brain regions (Bonnet, 1975).
Studies on neuroblastoma-glioma hybrid cell (NGlOB-15) have revealed an inhibitory action of morphine on basal and PGE1 stimulated
cyclic-AMP levels.

The parent cell lines, neuroblqstoma Nl8TG-2 and

glioma C6BU-l, are not significantly affected by opiates and this agrees

4o
with the finding by several investigators that they posses few if any
opiate binding sites (Klee, Sharma and Nirenberg, 1975).

The hybrid

cells on the other hand, possess opiate receptors (Klee, Sharma and
Nirenberg, 1975; Chang, Cooper, Hazum and Cuatrecasas, 1979).

Mor-

phine inhibits basal, PGE1 , and adenosine stimulated cyclic-AMP formation in these cells.

These effects are stereospecific and naloxone re-

versible (Sharma, Klee and Nirenberg, 1975).

In the continued presence

of morphine (several hours), the initial inhibition of adenylate cyclase
in these hybrid cells is followed by an increase in enzyme activity.
After a 12 hour exposure to morphine, adenylate cyclase activity has
returned to normal and the cells could be said to be tolerant.

With-

drawal of the morphine or addition of naloxone leads to a rapid increase
in cyclic-AMP formation which exceeds the original level (Sharma, Klee
and Nirenberg, 1975);

this has been interpreted as a sign of dependence.

Thus, tolerance to and dependence on morphine have been induced in neuroblastoma-glioma hybrid cells in vitro.

The effects were only partially

blocked by the protein synthesis inhibitor cycloheximide, implying perhaps, only a limited role for protein synthesis in the underlying mechanism (Sharma, Klee and Nirenberg, 1977).
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1.3.3.

Myenteric Plexus

Adenosine and the adenine nucleotides such as adenosine triphosphate (ATP), cyclic adenosine 3'-5'-monophosphate and dibutyryl cyclic adenosine 3'-5'-monophosphate depress the nerve mediated contractions of the longitudinal muscle of the guinea-pig ileum by inhibiting
the release of acetylcholine (Takagi and Takayangi, 1972; Sawynok and
Jhamandas, 1976; Hayashi, Mori, Yamada and Kunitomo, 1978).

Several

xantine derivatives including theophylline have been reported to antagonize this inhibitoryeffect (Hayashi et al., 1978; Sawynok and Jhamandas, 1976).

In addition, theophylline has been reported to reverse the

inhibition of the contractile response by morphine but not by tetrodotoxin, adrenalin and strychnine (Hayashi et al., 1978; Hammond, Schneider and Collier, 1976).

The mechanism whereby theophylline reverses the

inhibitory effects of both morphine and adenosine is not clearly understood.

It appears unlikely that a common mechanism mediates the reversal

of the effects by both drugs for the following reasons.

First, there

is evidence that the adenine nucleotides mediate their depressant effect
by activation of an extracellular adenosine receptor and that theophylline
is a competitive antagonist at this receptor (Hayashi et al., 1978).

Two,

the low concentration of theophylline necessarJ to antagonize the adeno3ine response does not itself alter the size of the nerve mediated contraction, whereas the higher concentration of theophylline necessarJ to
reverse the morphine depression, itself, increases the nerve-mediated
2ontraction.
It may be that an alteration in the intracellular calcium dis-
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position is involved in the underlying mechanism of action since the
antagonism of morphine is seen only with those phosphodiesterase inhibitors which mobilize calcium stores.

For example, the phosphodiesterase

inhibitors theophylline and xanthine antagonize morphine's inhibitory
action on the twitch response of the guinea-pig ileum, whereas Ro 201724, a non-xanthine phosphodiesterase inhibitor, does not.

Theophylline

and xanthines mobilize calcium stores whereas Ro 20174 does not (Hayashi
et al., 1978; Gintzler and Mussachio, 1975).

Therefore, it seems likely

that it is the mobilization of the neuronal calcium stores and not phosphodiesterase inhibition which is the mechanism by which theophylline reverses
opiate inhibition.
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l. 4.

THE MYENTERIC PLEXUS

l. 4 .l.

Anatomy

The "enteric nervous system" consists of two major ganglionated
plexuses of considerable complexity (Gabella,

1976).

One plexus is situ-

ated between the longitudinal and circurar muscle layers and is known as
the myenteric or Auerbach's plexus.

The second plexus is located in

the submucosa and is the submucous or Meissner's plexus.

They extend

uninterrupted from the lower part of the esophagus to the anus and send
nerve fibers to the musculature, blood vessels and mucosa.

Single gan-

glia within the plexus contain between a few to several hundred neurons.
The number of neurons depends upon the species studied as well as the
segment of the alimentary canal under investigation (Gabella, 1976).
Glial cells are numerous and in the guinea-pig outnumber neurons by a
ratio of 3:1 (Gabella, 1972).

The entire surface of the ganglia is en-

capsulated by a very thin sheet of collagen (Taxi, 1965).
In the myenteric plexus of the guinea-pig ileum, the ganglia
are arranged in a regularly spaced manner with many interconnecting
strands located between them.
varies between 20 to 200.
in length.

The number of neurons 1vithin each ganglia

The neurons range in size from 15 to 45

~m

With respect to histological organization, the presence of

a dense neuropil, absence of an extracellular space, compactness of
structure, arrangement of blood vessels and connective tissue make the
cells of the myenteric plexus more like CNS tissue than autonomic ganglia (Gabella, 1972).
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Studies of myenteric neurons by light microscopists have demonstrated the presence of three types of neurons.

This cl8ssification was

based primarily on morphology (see Schofield, 1968).

However, classi-

fication of myenteric neurons on the basis of ultrastructural characteristics has revealed the presence of nine distinct types of ganglion cells
(Cook and Burnstock, 1976).

The classification is based on neuronal

size, distribution of organelles and their location and relationship to
satellite cells.

Similarly, eight different types of axon profiles were

identified according to vesicular size, shape and content (Cook and Burnstock, 1976).

Still other studies have utilized intracellular

staining

techniques to identify and describe myenteric neurons (Nishi and North,
1973a).

These studies have demonstrated that most neurons are multi-

polar and have from one to seven processes.

The processes usually arise

from the poles of the oval soma and are varicose; however, some are
smooth.
The enteric nervous system of vertebrates contains a multiplicity
of neurotransmitters.

Cholinergic innervation of the gastrointestinal

tract of the cat, guinea-pig and monkey has been studied using the histochemical method for acetylcholinesterase or choline acetylase (Jacobowitz, 1965; Feldberg and Lin, 1950).

From these and other studies

(Koelle, Koelle and Friedenwald, 1950) it was established that the intramural plexuses consist of cholinergic neurons whose postganglionic
fibers innervate the intestinal musculature.

Adrenergic cell bodies do

not exist in the myenteric plexus of the guinea-pig ileum but there is
an adrenergic innervation from the prevertebral ganglia (Gabella, 1976).
Norberg (1964) and Jacobowitz (1965) using fluorescence microscopy

demonstrated the presence of
in the myenteric plexus.

nQ~erous

adrenergic nerve fibers terminating

Denervation of the sympathetic nerves led to a

marked reduction of noradrenaline fluorescense in the gut (Furness, 1969).
The presence of 5-HT in nerve terminals and its uptake and synthesis in
cultured myenteric neurons suggests that 5-HT may function as a neurotransmitter in the gut (Dreyfus, Sherman and Gershon, 1977; Dreyfus,
Bornstein and Gershon, 1977).
firmation.

However, these results await further con-

Finally, immunohistochemical studies have demonstrated the

localization of enkephalin (Elde, Hokfelt, Johansson and Terenius, 1976),
substance P (Nilsson, Larsson, Hakansson, Brodin, Pernow and Sundler,
1975), vasoactive intestinal polypeptide (VIP) (Larsson et al., 1976) and
somatostatin (Costa, Patel, Furness and Arimura, 1977) in nerve fibers
and/or cell bodies in the myenteric plexus of the guinea-pig.
Electrophysiological studies have demonstrated a clear functional
role for acetylcholine in the myenteric plexus (see below) (Nishi and
North, 1973a).

The action of noradrenaline in the myenteric plexus is to

inhibit the presynaptic release of neurotransmitter (Nishi-and North,
1973b; Hirst and McKirdy, 1974); and the fULDctional role of substance P
(Katayama and North, 1978) or 5-HT (Wood and Mayer, 1978) may deal with
slow excitatory synaptic transmission.

Extracellular recordings of

my-

enteric neurons in vitro have demonstrated excitatory effects of substance P (Williams and North, l978a)

and VIP (Williams and North, l979b),

and inhibitory effects of enkephalin (North and Williams, 1976) and
somatostatin (Williams and North, 1978b).
detail in sections 1.4.2. and 1.4.3.

These are discussed in greater

46

1.4.2.

Electrophysiology

Extracellular Recordings.

The first to report on extracellular recorded

action potentials from single myenteric neurons in vitro was Yokayama in
1966.

Subsequent studies by Wood (1970) and Ohkawa (1972) further demon-

strated three types of myenteric neurons.

This classification was based

on the pattern and frequency of spike discharge.

These studies were per-

formed on myenteric neurons from cat jejunum and employed similar experimental methods.
gators were

The three types of neurons described by these investi-

1) single spike

2) burst and

3) mechanosensitive.

Single

spike type cells continuously fired action potentials at low frequencies
(0.1 - 1 Hz) and with no consistent pattern of discharge.

Burst type

cells fired action potentials at very high frequencies (2 - 34 Hz) but
only intermittently (intervals between bursts of 0.5- 40 sec).

Mechano-

sensitive cells responded to mechanical distortion with an increased rate
of discharge; for example, pressure applied to the ganglion by the recording electrode served to activate these neurons.

Several subclasses

for each of the types have been reported by Wood (1970).
On the other hand, electrophysiological studies by Dingledine
(1974; 1975) and Sato (1973) demonstrated only two types of myenteric
neurons in the guinea-pig.

They classified the cells as being of the

single spike or burst type.

The majority of neurons recorded were of

the single spike type whereas Wood (1970) and Ohkawa (1972) found that
the majority of cells were of the burst type.

The difference in the

47
number of cell types and the type most frequently recorded can be explained as due to a difference in the experimental techniques used by
the two groups.

For instance, the studies by Wood (1970) and Ohkawa

(1972) utilized metal electrodes for recording while those of Dingledine and Sato utilized glass suction electrodes.

It is possible that

a particular type of electrode may preferentially select a distinct
neuronal type.
Typically, action potentials of myenteric neurons were biphasic,
ranging in amplitude from 50 to 300 ~V and in duration from 2 - 4 ms.
The spikes were abolished by tetrodotoxin and local anesthetics (Wood,
1970; Sato et al., 1973; Dingledine et al., 1974; North and Williams,
1977).

Mechanosensitive and burst type neurons were relatively insen-

sitive to most drugs, whereas single spike units were sensitive to a
variety of agents.

Single spike neurons were excited by 5-HT, acetyl-

choline, nicotine, pentagastrin, caerulin (Sato et al., 1973), substance
P (Williams and North, 1978a), neurotensin (Williams, Katayama and North,
1979), and VIP (Williams and North, 1979b).

The firing of these neurons

was inhibited by morphine, noradrenaline (Sato et al., 1973), somatostatin (Williams and North, 1978b) and enkephalin (North and Williams,
1976; Williams and North, 1979a).
Intracellular Recordings
Studies using intracellular recording techniques have revealed
two types of myenteric neurons.

This classification was based on the

electrical and membrane properties of the neurons (Nishi and North,
1973a; Sirst, Holman and Spence, 1974).

One type (Type lor S cell)

receives a synaptic input (cholinergic), has a relatively
resistance, and a low membrane potential.

~igh

input

The second type (Type II or
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or AH cell) does not receive a fast synaptic input, has a higher resting
potential and lower input resistance, and is less excitable than the S
cell.

An excitatory post synaptic potential is observed in the Type 1

cell as a result of electrical stimulation of the preparation (Nishi
and North, 1973a; Hirst, Holman and Spence, 1974) or by distension of
the ileum by an intraluminal balloon (Hirst, Holman and Spence, 1974).
The e.p.s.p. is abolished by 5-HT and noradrenaline; these substances
do not affect depolarizations of a time course similar to that of the
e.p.s.p. produced by iontophoresis of acetylcholine.

This finding sug-

gests a presynaptic site of drug action for 5-HT and noradrenaline
(Nishi and North, 1973b; Henderson and North, 1975).

The second type

of neuron is characterized by a prolonged hyperpolarizing afterpotential.

The afterhyperpolarization persists for 10 - 20 seconds, requires

calcium ions and is produced by an increase in potassium conductance
(North, 1973; Nishi and North, 1973a).
The main difference between

the results obtained with intra-

cellular and extracellular recording techniques in the guinea-pig myenteric plexus was the lack of spontaneous activity recorded with the
intracellular electrodes.

Wood as early as 1975 explained this apparent

discrepancy as a differential selectivity of each method for a particular
type of neuron and/or for specific parts of the same neuron.
explanation was proposed by North and \Hlliams in 1977.
that large extracellular electrodes

mec~anically

Another

'They suggested

deforms the cell mem-

brane causing the membrane potential to reach threshold and discharge
action potentials.

1.4.3.

Actions of Opiates on the Guinea-Pig Myenteric Plexus
Electrical stimulation of the isolated guinea-pig ileum, or its

myenteric plexus longitudinal muscle preparation, induces the release
of acetylcholine from intramural nerves and this results in a contraction of the longitudinal muscle (Paton, 1957).

Narcotic analgesics in-

hibit this nerve mediated contraction by inhibiting the release of
acetylcholine (Paton, 1957; Schauman, 1957).

This action is stereo-

specific, concentration dependent, and reversed by naloxone in a competitive manner (Kosterlitz and Watt, 1968; Kosterlitz and Waterfield,
1975b).

A number of narcotic analgesics have been shown to depress the

electrically induced contraction; these include morphine, normorphine,
buprenorphine, levorphanol, ketocyclazocine and cyclazocine (discussed
below).

The myenteric plexus of the rabbit (Greenberg, Kosterlitz and

Waterfield, 1970) and cat (ErNin, Nonchoji and Wood, 1978) are not
opiate sensitive.
The concentration of a drug which inhibits the nerve mediated
contraction of the guinea-pig ileum by 50% is known as the

rc 50

rc 50 .

The

for morphine, normorphine, levorphanol, ketocyclazocine, cyclazo-

cine and buprenorphine in this preparation was 68, 73, 9.2, 2, 3.6 and

4 nM respectively (Kosterli tz et al., 1972; Kosterli tz et al. , 1974;
Schulz and Herz, 1976b).

2ecovery from the depressant effect of high

concentrations of normorphine was complete within 90 seconds of washout
and a constant depression was observed with repeated exposures at 5 minute interYals (Kosterli tz, =:..ord and r,ratt, 1972).

The half-time of re-
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covery from the inhibition produced by morphine, ketocyclazocine and
levorphanol in the guinea-pig ileum was 32, 130 and 268 s respectively
(Kosterlitz, Leslie and Waterfield, 1975; Schulz ~~d Herz, 1976b).

The

half-time of recovery from the inhibition produced by buprenorphine was
so very long that it could not be determined with accuracy (Schulz and
Herz, 1976b).

In general, the more lipophilic

the compound the longer

its half-time of onset of action and half-time of recovery in the guineapig ileum (Kosterlitz, Leslie and Waterfield, 1975).

It appears that

important differences between the actions of normorphine and morphine in
the guinea-pig ileum is the rapid recovery of the twitch after inhibition
by normorphine and the reduced tendency of normorphine to develop tachyphylaxis (Kosterlitz, Lord and Watt, 1972).
Naloxone antagonized the inhibitory effect produced by morphine
and the other agonists.

However, naloxone was much less effective in

antagonizing the inhibition of the twitch produced by cyclazocine,
ketocyclazocine and buprenorphine than the

illi~ibitions

produced by

normorphine and morphine (Kosterlitz et al., 1972; Kosterlitz and Watt,
1968; Hutchinson et al., 1975; Schulz and Herz, 1976b).
The action of opiates on the firing rate and membrane properties
of single myenteric neurons has been described in section 1.2.1.
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1.4.4.

Opiate Receptor Studies

Opiate receptors of myenteric neurons appear identical to those
receptors subserving analgesia in the cer-tral nervous system.
statement is supported by the following evidence.

This

First, the myenteric

plexus possesses high affinity opiate binding sites (Gyang and Kosterlitz, 1966; Pert and Snyder, 1973).

Second, the potency of an antagonist

to inhibit naloxone binding in brain homogenates (Pert and Snyder, 1973)
correlates well with its dissociation constant determined pharmacologically
in the myenteric plexus (Kosterlitz and Watt, 1968; Kosterlitz, Lord and
\iatt, 1972).

Third, the relative potencies of a series of opiates in de-

pressing the electrically induced contractions of the guinea-pig myenteric
plexus longitudinal muscle preparation is comparable to the analgesic potency in man (Kosterlitz and Waterfield, l975a; Creese and Snyder, 1975).
Fourth, the depressant ,effect of narcotic agonists on the firing rate of
myenteric neurons is similar to the action of opiates on central neurons
(North, l979a).

Fifth, the inhibitory action of opiates in the myenteric
/

plexus is stereospecific and occurs at low concentrations (Kosterlitz and
Waterfield, 1975b; North and Williams, 1977; Dingledine and Goldstein,
1975).

Sixth, the action of opiates is reversed with a concentration of

naloxone several fold lower than that of the narcotic agonist (Kosterlitz
et al., 1972; North and Williams, 1977).

Seventh, the antagonist potency

of narcotic analgesic drugs determined in morphine-dependent monkeys correlated well with the antagonist potency determined on the guinea-pig
ileum (Kosterlitz, Waterfield and Berthoud, 1974).

Finally, tolerance
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and cross tolerance to the action of narcotic analgesics and the endogenous
opioid peptides develops in the guinea-pig ileum (Goldstein and Schulz, 1973;
Waterfield, Hughes and Kosterlitz, 1976), as it does in the central neryous
system {Pert, 1976).

'
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1.4.5.

Opiate Tolerance and Dependence

The first demonstration of tachyphylaxis to opiates in the
guinea-pig ileum was made by Paton in 1957.

In his experiments he de-

scribed that the action of morphine to inhibit the electrically induced
contraction of the longitudinal muscle was diminished with repeated large
concentrations or with lesser concentrations repeated at shorter intervals
(less than 15 minutes).

This finding was later confirmed by Kosterlitz

and Waterfield in 1975 using very high concentrations of morphine (66 300 ~M).

They showed that this effect of opiates was related to their

anticholinesterase action and was not an opiate receptor mediated event.
A second demonstration of tachyphylaxis to morphine in the guinea-pig
ileum was made by Shoham and Weinstock in 1974.

In their experiments a

lower concentration of morphine (50 - 100 nM) was used, and the morphine
was allowed to remain in contact with the tissue for 90 minutes.
this time,

the inhibitory response to morphine

During

slowly diminished, al-

though the output of ACh remained constant. The authors concluded that
the tachyphylaxis observed was due to a supersensitivity of the muscle
to ACh much like the denervation supersensitivity observed at other
neuromyal junctions (Thesleff, 1960; Fleming, 1976).
Studies on the opiate binding sites during the development of
opiate tolerance and dependence revealed no detectable changes in either
affinity or number of sites.

That is, direct measurement of 3H-etorphine

binding indicated no difference in receptor
teric plexus strius from

morphi~e

nw~ber

or affinity in myen-

dependent guinea-pigs (Cox and Padhya,
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1977).

However, it is difficult to interpret the results obtained from

this type of experiment (see section 1.1.4.}.

Two techniques of exposure haye been used to induce opiate
erance and dependence in the guinea-pig ileum.
~exposure

tol~

The first technique, in

to opiates, was achieved by implanting morphine pellets

subcutaneously in guinea-pigs (Schulz and Goldstein, 1973).

The second

technique, in vitro exposure, was made by incubating segments of guineapig ileum with a physiological solution containing morphine for periods
of 18 - 22 h (Ha.nunond et al. , 1976).
In Vivo Exposure
Ileum removed from opiate pretreated animals which is then maintained in an opiate containing Krebs solution (normorphine 200 nM) shows
a reduced sensitivity to subsequent applications of morphine.

That is,

tolerance to the inhibitory effect of morphine on the nerve mediated
contraction had developed (Schulz and Herz, 1976a).

Cross-tolerance to

the inhibitory action of pentazocine, ketocyclazocine (Schulz and Herz,
1976b), and enkephalin (Waterfield et al., 1976) also developed.

Ex-

posure to naloxone resulted in a contracture of the longitudinal muscle
(Schulz and Herz, 1976a).

The contracture was greater when a larger

dose of naloxone was used and was the result of a relatively synchronous
release of ACh from the myenteric neurons which innervate the longitudinal muscle (Frederickson, Hewes and Aiken, 1976).

This contracture has

been taken by some investigators to be a manifestation of opiate dependence.

A good correlation has been found between the ability of a series

of opiates to maintain a state in which naloxone can induce a contracture
and their drug dependence liability (Schulz and Herz, 1976b).

For exam-
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ple, buprenorphine produces a very low level of physical dependence in
man (Jasinski et al., 1978) and does not substitute for morphine in
maintaining a state giving a naloxone contracture.

Likewise, ketocyclaz-

ocine and pentazocine only poorly maintain a state in which naloxone produces a contracture (Schulz and Herz, 1976b).
Changes in neuronal sensitivity accompany the development of
opiate tolerance and dependence.

These experiment3 were performed with

the isolated tissue placed in a Krebs solution free·of opiate or with the
tissue placed in a solution containing morphine.

In the first instance,

it was found that the tissues were supersensitive to agents which excite
neurons or release ACh, such as 5-HT, potassium chloride, nicotine and
PGE1 (Johnson et al., 1978; Schulz and Herz, 1976a) but subsensitive to
agents which inhibit the release of acetylcholine, such as adrenaline,
dopamine, noradrenaline and clonidine (Schulz, Cartwright and Goldstein,
1974; Ward and Takemori, 1976; Hughes, Kosterlitz, Robison and Waterfield, 1978).

Similar, but less dramatic results have been found with

tissue maintained in a morphine containing Krebs solution (Schulz and
Herz, 1976a).

The mechanism whereby the supersensitivity and -subsensitiv-

ity to a number of agents was achieved has not been elucidated.

It appears

that these changes are relatively non-specific and that the continued
(chronic) presence of the opiate may lead to a slight depolarization of
the cell membrane.

This explanation would account for the apparent in-

crease in sensitivity to excitatory agents and a decrease in sensitivity
to inhibitory agents.

Compatible with such an explanation was the

find~

ing by Cox (1978a) that the tension produced by a given electrical stimulus was greater in ileal tissue removed from morphine pretreated guinea-
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pigs than in drug naive guinea-pigs.
Extracellular recordings have been made from myenteric neurons
removed from morphine pretreated guinea-pigs.

The ileum was excised and

placed in a physiological solution either with or without morphine.
the latter condition

In

neurons fired at a higher frequency than neurons

from drug naive guinea-pigs, and they were also 10 times more sensitive
to the excitatory effects of 5-HT (Takayanagi, Sato and Takagi, 1974).
Recordings from neurons which were maintained in a morphine containing
Krebs solution yeilded somewhat different results.

No obvious change in

the pattern of spontaneous activity was noted but the frequency of the
spontaneous activity was less than those of neurons from drug naive animals (North and

Zieglg~nsberger,

1978).

Myenteric neurons treated in

this manner responded to the application ot naloxone by greatly increas!
ing their spontaneous rate of discharge. The frequency which was often
attained was rarely seen in control situations (North and

Zieglg~nsber-

ger, 1978).
In Vitro Exposure
Hammond et al. (1976) found that incubation of ileal segments with
morphine (0.35- 17.5 ~M) for approximately 20 hours, induced a state of
tolerance and dependence.

Tolerance was measured as a reduced ability of

morphine to inhibit the contractile response and the degree of tolerance
was dependent upon the concentration of morphine in the incubation media.
Tolerance was induced by levorphanol but not dextrorphan;

control in-

cubations were without effect on the sensitiyity of the tissue to opiates.
Tissue incubated with morphine responded to naloxone with a contracture.
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These long term effects of opiates were observed whether incubations
were made at 4°C or 37°C, and were similar to those seen in tissues re.'

moved from opiate dependent animals (Hammond et al., :1976; Schulz and
Herz, 1976a).
Several agents have been shown to modify this development of
opiate tolerance and dependence.

Concomitant incubation of ileal seg-

ments with morphine and cycloheximide (1.9 ~M) attenuated the degree-of
tolerance to moprhine.

Similar findings were obtained when segments of

ileum were incubated with morphine and PGE 2 , or morphine and dbcyclicAMP (Hammond et al., 1976).

Agents which were found to enhance the

development of opiate tolerance included caffeine and 8-bromocyclic-3',
5'-guanosine monophosphate sodium (Hammond et al., 1976).

If the action

of caffeine is mediated through an adenylate cyclase-cyclic-AMP mechanism then we would expect dbcyclic-AMP to have an action similar to that
of

caffeine~

because caffeine inhibits the enzyme phosphodiesterase which

would result in an increase in the intracellular levels of cyclic-AMP.
A further inconsistency includes the results obtained from whole animal
studies where it was demonstrated that cyclic-AMP and related agents
enhanced the development of opiate tolerance (Ho et a1.,· 1973b).
Similarily, the involvement of protein synthesis in the development of opiate tolerance and dependence is somewhat ambiguous.

Hammond

(1976) reports that cycloheximide (1.9 ~M), a protein synthesis inhibitor, reduces tolerance formation in the guinea-pig ileum, yet states
that an equieffective level of tolerance was induced at 4°C and 37oc.
It is doubtful whether any protein synthesis is being carried out at
4°C (Gutfreund, 1966) and

furthermore, other investigators have re-
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ported that concentration of cycloheximide necessary to inhibit protein
synthesis in this preparation to be 100

~M

(McKnight, Sosa, Hughes and

Kosterlitz, 1978).
Time Courses of the Recovery of Opiate Sensitivity After Chronic Exposure
A biphasic

recove~J

from opiate tolerance has been demonstrated

in subjects made physically dependent on opiates (see section 1.1.3).
A similar biphasic pattern of recovery has been demonstrated in the
guinea-pig ileum (Cox, 1978b).

Cox has reported that ileum removed

from morphine-dependent guinea-pigs and maintained in an opiate containing Krebs solution were highly tolerant to the inhibitory actions
of morphine.

However, when the opiate was washed from the tissue, tol-

erance rapidly declined (within 2 hours) until a stable state had been
attained.

A.second protracted phase of tolerance then ensued which

persisted 10 hours or more (Cox, 197&; Johnson, personal communication).
Cox referred to the tolerance associated with the first (rapid) and
second (protracted) phases of recovery as type 1 and type 2 respectively.

Type l tolerance has been likened to a state of receptor de-

sensitization and it is in this state that naloxone proyokes a withdrawal reaction (a contracture).

Within 1 hour of switching to a so-

lution free of normorphine it was found that naloxone had lost its propensity to induce a contracture.

Narcotic antagonists do not provoke

a withdrawal reaction during type 2 tolerance unless an opiate agonist
is previously readministered (Schulz and Herz, l976a).
The isolated vas deferens from morphine pretreated mice is an
example of a tissue which rapidly returns to normal sensitivity when
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it is washed with a solution lacking opiate.

However, if the yasa are

maintained in an opiate containing solution after their removal from the
animal, and then tested to a higher dose of normorphine, a
ance is exhibited.

4 fold toler-

In other words, this is an example of a tissue which

develops only type 1 tolerance (Cox, 1978b).
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1.5.

SPECIFIC AIMS

The first aim of the present study was to investigate the underlying mechanism of acute opiate action in the guinea pig myenteric plexus.

Extracellular recording techniques were used to determine the in-

volvement of the cyclic nucleotides in the depression of neuronal activity by morphine.

This part of the study included elevating intracell-

ular cyclic-AMP levels and subsequently testing the preparation for
opiate sensitivity.
The second aim of this study was to examine the phenomena of
opiate tolerance and dependence at the single neuron level.
of the study included:

This part

(a) an electrophysiological investigation of

the effects of long term exposure of myenteric neurons to opiates in
vitro or in vivo in order to determine whether tolerance and dependence could be demonstrated; (b) an examination of the effects of drugs
which

c~n

serve~

modify the development of any tolerance and dependence ob-

and (c) an investigation of the time course of events

recovery from any opiate tolerance and dependence observed.

2.
2.1.

METHODS
THE TISSUE

Male guinea-pigs (250 - 500 g) were stunned and bled from the
neck.

A section of ileum 10 - 15 em in length, excluding the portion

·10 em oral to the ilea-caecal junction, was rapidly removed and placed
in Krebs solution.

The ltiminal content was then gently flushed out.

A

2 - 3 em piece of ileum was cut and gently slipped onto a glass rod
(diameter 4- 6 mm).

The diameter of the rod was slightly greater than

that of the relaxed ileum.

Under the dissecting microscope (lOX) the

longitudinal muscle with the attached myenteric plexus was carefully
stripped away from the circular muscle by gently stroking it with damp
cotton wool.

The myenteric plexus-longitudinal muscle preparation was

gripped by forceps and gently pulled from the remainder of the ileum
and placed in a shallow tissue bath.
The method of dissection was originally described by Ambache
(1954) , and modified later for electr~phy::tiological x-eco,:rdin~s- by- Nis.hi
and North (1973a).
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2.2.
The longitudinal
with

ple~~s

uppermost.

IMMOBILIZATION

ntuscle was pinned with

slight stretch and

Ganglia were visualized under a dissecting micro-

scope (10- 60X) and viewed by transmitted light.

Electrophysiological

recordings from ganglia which contained large swollen cells or those
which were concealed by a thick sheet of circular muscle often proved
unsuccessful.

An area surrounding several suitable ganglia (free of

circular muscle and with no swollen cells) was immobilized with several
pins (tungsten wire 25

~min

diameter and 1- 2 mm in length).

maining tissue was cut and discarded.

There-
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2. 3.

PERFUSION AND DRUG APPLICATION

Krebs solution of the following composition (roM):

NaCl 117,

KCl 4.7, CaC1 2 2.5, MgCl2 1.2, NaHC0 3 25, Glucose 11.5, gassed with 95%

o2 - 5% C02, was continuously pumped over the tissue at a rate of 1 - 3
ml/min.

The Krebs solution was warmed in a heating jacket such that

the final bath temperature was maintained at 35 - 37°C.

Drugs were

applied to the tissue by changing the perfusing solution to one which
differed only in its content of the drug,
Drugs were prepared fresh daily from stock solutions (1 mM in
distilled water) except cyclic-AMP and dbcyclic-AMP which were prepared
daily from the solid.

Stock solutions of ketocyclazocine and cyclazo-

cine were acidified to pH 5.0 and all stock solutions were kept frozen
when not in use.

Prostaglandin E2 was dissolved in ethyl alcohol be-

fore addition of the Krebs solution.

There was a "dead time" of about

45 - 90 seconds between the time the tap was turned and the arrival of
the drug at the bath.

In the figures presented in this manuscript, the

times indicated are those at which the tap was turned.
The drugs

use~

were:

normorphine hydrochloride (Dr. E.L. May),

normorphine sulphamate (Dr. E.L. May), normorphine base (Dr. E.L. May),
(-)-naloxone hydrochloride (Endo Laboratories), hexamethonium bromide
(Sigma), morphine sulphate (Mallinckrodt), dextrorphan tartrate (Roche),
levorphanol tartrate (Roche), cycloheximide (Sigma), ketocyclazocine
(Dr. R. Schuster), cyclazocine (Dr. R. Schuster), buprenorphine (Reckitt and Colman), PGE2 (Dr. S. Ehrenpreis), lidocaine (ICN- K&K Labs),
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theophylline (1,3-dimethylxanthine) (Sigma), 3-isobutyl-1-methylxanthine
(Aldrich), adenosine 3' ,5'-cyclic monophosphoric acid (Sigma), N6, 02dibutyryl adenosine 3' ,5'-cyclic monophosphoric acid (sodium salt)
(Sigma), hyoscine { (-) scopolamine HCl} (Sigma)", · (+)-naloxone hydrochloride (Dr. A. Jacobson), (+) and(-) 5,9-diethyl-2-(3-furyl methyl)2'-hydroxy-6,7 benzomorphan hydrochloride (Mr 2266/7) (Boehringer Ingelheim).

Morphine antibody was a gift from Dr. B. Wainer.
None of the drugs used significantly altered the pH of the Krebs

solution.

Concentrations of drugs refer to the final bath concentrations

of the compounds listed above.

2. 4.

THE TISSUE BATH

The tissue bath was similar to the one described by Nishi and
North (1973a).
of a piece of

A rectangular hole (20 x 40 mm) was cut from the center
plexiglass (50 x 80 x 1 mm).

A coverslip (23 x 50 mm)

was then glued over the hole and the trough filled with a thin layer
(1 mm) of silicone rubber (Sylgard,#l84; Dow Corning Corp.).
This clear resin can be transilluminated and is soft enough to
allow penetration by fine tungsten pins (for fixing the tissue).

A rim

of bathtub caulk (5 mm) along the edge of the trough was used to prevent overflowing of solutions and to secure the perfusing tubes and the
indifferent electrode.
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2.5.

ELECTROPHYSIOLOGICAL RECORDINGS

A glass suction electrode of tip diameter 40 - 90 ~M was used
to record extracellular action potentials.

The recording electrode

was prepared by breaking longer electrodes with a smaller tip diameter.
The electrodes were then examined microscopically and those with smooth,
flat tips of appropriate size were used.
tip diameter greater than 90

~m

The use of electrodes with a

often resulted in simultaneous recording

from more than one neuron, whereas attempts to record with electrodes
with tip sizes less than 30

~m

were usually unsuccessful.

The indif-

ferent electrode was similar but had a tip diameter of 90 - 150
was placed near the site of recording.
resistance of 300 - 1000 !ill.

~n;

±t

The recording electrode had a

It was attached by a piece of rubber

tubing to a syringe (5 ml) and suction was applied by withdrawing the
plunger.
glia.

The electrode was gently lowered onto the surface of the gan-

The suction was sufficient to cause the ganglion to adhere to

the electrode tip when the electrode was raised 10 - 20

~m.

A third

electrode (chlorided silverwire) was placed at a distant site and served
to ground the bath.
The recording and indifferent electrodes were filled with Krebs
solution,; chle>rided silver wires

led to an AC..,..ce>upled prea.mJPlifier

(Tetronix 122, coupling time constant of 2 ms).

The signal was ampli-

fied and displayed on an oscilloscope (Tetronix 502A).
Spike activity was gated by amplitude (Mentor Spike Analyzer)
and the output was used to determine the number of spikes in a given
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time period.

This was done either directly from a chart recorder or

from a rate analyzer (Fredrick-Haer).

Histograms of firing rate were

plotted (with respect to time) either by hand from the chart recorder
or automatically from the output of the rate analyzer.
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2.6.

24 HOUR INCUBATIONS - IN VITRO

Pieces of ileum several centimeters in length from newly killed
guinea pigs were incubated for approximately 24 hours in either normal
Krebs or Krebs solution containing an opiate.

Conditions of the in-

cubation were such that the Krebs solution was changed every 4- 6 hours,
gassed with 95% 02- 5% C02 to maintain a pH of 7.4, and the temperature
was kept at approximately 21- 24°C.

In the first of two situations,

the ileum was incubated in a normal Krebs solution.

Individual myenteric

neurons from the incubated preparation were observed with regard to their
pattern and frequency of firing, and the acute action of agonists and
antagonists on their firing rate.

These results were compared with the

data obtained from non-incubated preparations.

In the second situation

ileum was incubated in a Krebs solution which differed only in its content of a narcotic.

This Krebs solution was also perfused over the tis-

sue throughout the period of extracellular recording to maintain a constant narcotic environment.

Individual myenteric neurons from this in-

cubated preparation were observed with regard to their pattern and frequency of firing, and the effect of agonists and antagonists on their
firing rate.
In cases where the ileum was concomitantly incubated with a narcotic and another agent, control incubations were also performed with
the other agent alone.

A summary list of all incubation solutions used

is in Table 3.
Tolerance was tested in two ways.

First, the concentration

of the narcotic in the incubation solution was sufficient to inhibit

completely the spontaneous actiyity of non-incubated cells or of cells
incubated in normal Krebs solution.

Therefore) any neuronal activity

recorded after 24 hour exposure to an opiate should reflect tolerance.
Second, the ability of eyen higher concentrations of narcotics to inhibit neuronal firing of cells incubated for 24 hours was tested.

The

effective concentrations of the narcotics were compared with concentrations which were effective in control incubated tissues.
Signs of dependence were sought in two ways.

The firing rate

of the myenteric neuron was recorded whilst changing the perfusing
solution either to a solution which did not contain morphine, or to a
solution which contained both morphine and a narcotic antagonist.
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2 • 7.

MORPHINE PELLET L\fPLANTED OR INJECTED ANLV1ALS - IN VrTO

Guinea pigs were injected subcutaneously (cervical area) '1-Ti th
morphine sulphate 3 times daily for two days.

The following regimen of

fixed doses and times was employed:

4 p.m.;

night; 40 mg/kg, 8 a.m.; 80 mg/kg,
kg, 8 a.m.

10 mg/kg,

4 p.m.;

20 mg/kg, mid-

100 mg/kg, mi~~ight; 100 mg/

Two hours after the last dose the animal was stunned and

exsanguinated.
Guinea pigs were also ·subcutaneously implanted with 4 morphine
base pellets (2 x 75 mg pellets on each flank).

The animals were then

sacrificed on the third day after implantation.

The ileum from both

groups of animals was removed as previously described and placed in a
Krebs solution which contained morphine (200 - 500 Th\1).

This concen-

tration was chosen because it approximates that in plasma on the third
day after pellet implantation (Schulz and Goldstein, 1973).
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2.8.

PLASMA LEVELS OF MORPHINE

Trunk blood was collected from guinea-pigs at the time of death
and morphine levels assayed immunologically (courtesy of Dr. Bruce
Wainer).
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2.9.

DE~INITIONS

The following terms are commonly referred to in this text.
inhibition

- is defined as a reduction in the spontaneous firing
rate of a neuron to a rate which is less than

75%

of the control rate.
excitation

- is defined as an increase in the firing of a neuron
to a rate which is at least double the control rate.

slight excitation

- an excitation during which the firing rate rises
to less than 3 times the original rate.

marked excitation

- an excitation during which the firing rate rises
to more than 3 times the original rate.

slight inhibition

- an inhibition during which the firing rate falls
to not less than

marked inhibition

75% of the original firing rate.

- an inhibition during which the firing rate falls
to a level which is less than

75% of the original

firing rate.
majority

- a number greater than 1/2 the total number.

passed off

- is an example of a response which does not remain
constant at its

rapid

maximal level.

a drug effect was described as rapid in onset if
the observed response occurred within 40 s on
arrival of the drug to the tissue bath.

unit

- neuron.
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2.10

ANALYSIS OF DATA

The percentage change in cell firing (HZ) in response to a drug
treatment was determj.ned as follows.

After a control period o:t at least

five minutes, the tissue was perfused with drug and the change in the
rate of discharge recorded.
frequencies less than 10 Hz.

The rate interval analyzer was limited to
Therefore it was necessary, for the purpose

of calculating the actual firing in cases of marked excitation, to ascribe
a numerical value of 15 Hz to any frequency greater than 10 Hz.

The

justification for selecting this value was provided by visual observation
of the interspike interval meter.

A drug effect was not accepted tmless

a reversal of the effect occurred upon washout of the drug solution.
Results were analyzed by calculation of the mean, standard deviation and standard error of the mean, for the percentage change from control frequencies of firing.

The Student's t test was used to compare the

means of two groups which received different experimental treatments.

3.

RESULTS

The present results are based on extracellular recordings made
from 540 neurons in ganglia removed from 162 animals.
3.1.

EXTRACELLULAR RECORDING

Two types of electrical potentials were recorded from the myenteric plexus.

They were distinguished from one another on the basis of

their duration, amplitude, spike waveform (Fig. 1) and sensitivity to
tetrodotoxin and lidocaine.

Electrical activity was considered to be

of neuronal origin if it lasted 1-3 ms in duration, ranged in amplitude
from 50 to 400

~V

and was reversibly abolished by tetrodotoxin and

lidocaine (Sato et al., 1973; Dingledine et al., 1974; 1975; North
and Williams, 1977).

Neuronal action potentials had a biphasic wave-

form with a fast component followed by a slower one of opposite polarity(-/+) (Fig. 2).

Neuronal action potentials were recorded when the

extracellular recording electrode was placed on the surface of a ganglion and suction was applied.

It was not possible to record spon-

taneous neuronal activity without the use of suction; nor were recordings successful with electrodes of tip diameter less than 30

~m

or when

the electrode tip was placed on interconnecting strands between the
ganglia or on the muscle itself.

Occasionally, when larger tip elec-

trodes (90 ~m) were used, multi-unit recordings were ~ade possible with
one electrode in a single position.
ti~ls

Individual neuronal action

~oten

were distinguished on the basis of their spike waveform and ampli-
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tude (Fig. 2).

The precise origin of this spontaneous neuronal activity

has not been thoroughly investigated;

howeve~,

it may be attributed to

a mechanical deformation of the neuronal membrane caused by the suction
electrode (North and Williams, 1277} .

The second type of electrical

activity recorded originated from -muscle.

The spike waveform r,.ras typi-

cally biphasic, greater than 20 ms in duration, the amplitude ranged from
400

~V

to 2 mV; this activity could be recorded only if the electrode were

placed on the muscle.

These action potentials were resistant to the action

of lidocaine and tetrodotoxin (Sato et al., 1973; Dingledine et al., 1974).
The marked difference in spike duration allowed neuronal action potentials
to be easily distinguished from muscle action potentials (Fig. 1).
Two types of neurons were distinguished on the basis of their
frequency of firing, pattern of discharge, spike waveform and sensitivity to drugs (Sato et al., 1973; 1974; North and Williams, 1977).

The

most common type encountered fired at a rate. of 3.0 + 0.2 Hz (mean +
S.E.M., n=79) and the pattern of discharge was quite variable.

In most

cases the firing rate declined throughout the period of extracellular
recording.

Only those units having a stable baseline for at least .15

minutes were included in this study.
50

~V

to 300

~V

and spike duration was 2-3 ms.

usually biphasic.

amplitu~e

ranged from

The spike waveform was

The second type of neurons (15% of cells) had a higher

spike amplitude (150 to 400
(0.1- 1Hz).

The spike

~V)

and fired regularly with low frequency

These findings confirm previously published reports (Dingle-

dine et al., 1974; North and Williams, 1977).

Fig;ure l.

Comparison of neuronal ar:.d s:uooth !lluscle action potentials ',
recorded with an extracellular suction electrode.

Figure

illustrates one sweep of the trace across the oscilloscope,
The first potential change is a smooth muscle action

poten~

tial; the later hro arise from tv':l different neurons.

In

this and

~11

subsequent oscilloscope photographs, an up-

ward deflection indicates negativity of the recording electrade.

Calibration:

Horizontal 20 ms.

Vertical 200 1-1V.

The time constant of the prea:nplifier •.vas 1 second.
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Figure 2.

Spike waveforms recorded with a single extracellular electrode in one position.
the electrode is
neurona.

~~e

two distinct waveforrns indicate

sL~ultaneously

Calibration:

recording activity from two

Horizontal 5 ms.

Vertical 100

Coupling time constant of the preamplifier was 2 ms.
the typical biphasic waveforms.

~V.

Note
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3.2.

THE ACTION OF OPIATES
3.2.1.

Morphine (10 nM - l
86% of the neurons tested (n

~M)

Morphine
inhibited the neuronal firing rate in

= 42;

12 animals).

Of ll cells tested with

morphine (300 nM), one was unaffected and the degree of inhibition of
the remaining cells was 90% + 3

(mean~

S.E.M.).

In a given cell the

degree of inhibition was related to the concentration applied.

The

inhibition reached its maximum within 30 s of the application of the
drug, lasted throughout the period of application (2 - 60 min) and was

relatively slow to washout.

After a 3 min exposure to morphine (300

~~),

6 - 9 min was usually required for the neuronal firing to return to its
original rate (Fig. 8a).

Tachyphyl~~is

applications of morphine (100 nM - l

~M)

was not observed with repeated
for 3 min periods at intervals

of 12 min.

3.2.2.

Normorphine

Nonnorphine had an action similar to that of morphine on the
neuronal firing rate.

Normorphine (l nM - 1

firing rate in 85% of the neurons tested (n

~M)

inhibited the neuronal

= lll;

41 animals).

The

inhibition was rapid in onset, usually lasted throughout the period of
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Figure 3.

The inhibition of neuronal firing by morphine and the reversal of inhibition by an antibody to morphine.
spike freQuency (bin width- 10 s).

Abscissa:

Ordinate:
time.

Dur-

·ing the·periods indicated by the solid and open bars, the
solution which perfused the tissue contained morphine (300
nM) and morphine antibody (morph-Ab), respectively.

Mor-

phine produced an inhibition in firing which was immediately reversed by the concurrent presence of morph-Ab.

If

3.3 times more antibody was added to the bathing solution
than was necessary to completely bind all the morphine,
then a more rapid reversal was observed.

The morph-Ab

alone did not cause any effect on the firing rate.

The

action of morphine on this cell was unusual in that the
period of inhibition of cell firing did long exceed the
period of application.
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application (2- 60 min) and was readily reversed on washing (Fig.

4).

Following exposure (2 min) to normorphine (300 nM), 2-3 min were required for the neuronal firing to return to its control rate.

Tachy-

phylaxis to the inhibitory effect of normorphine on the neuronal firing
rate was sometimes observed (section 3.5.1.).

Those cells which were

inhibited by morphine were also inhibited by normorphine;
pounds appeared to be approximately equipotent.

the com-

The inhibition of

firing caused by normorphine was related to the concentration applied:
at 30 nM, 2 cells were unaffected and the mean inhibition of

4

other

cells was 58%; at 100 nM, 4 cells were unaffected and the inhibition
of 19 other cells was 80% + 4 (mean

.i S.E.M.); at 300 nM, 4 cells were

unaffected and the inhibition of 22 other cells was 82% 1. 3;

at l

~M,

l cell was unaffected and 6 other cells were inhibited by 93% + 2.

3.2.3.
Levorphanol (30 ru~ -

4

in 84% of the neurons tested (n

Levorphanol
~M)

inhibited the neuronal firing rate

= 18;

5 animals).

The inhibition was

rapid in onset, persisted throughout the period of exposure (2- 45 min),
and washed out with a time course similar to that of morphine.

Neurons

which were inhibited by morphine were also inhibited by levorphanol
(Fig. 5).

Levorphanol (100 nM) inhibited the spontaneous firing of

cells by 91% + 2 (n

= 7):

this was approximately the same degree of

84
Figure

4.

Concentration dependent inhibition in firing produced by
normorphine.

During the periods indicated by the solid

bars, the perfusing solution •H"as changed to one vrhich containe~

normorphine

(~T.M).

The numbers above the bars indi-

cate the concentrations (nM).
(bin widih- 10 s).

Abscissa:

Ordinate:
time.

spike frequency

Normorphine caused

an inhibition in firing which was related to the
tion in the bath.

concentr~

During the prolonged exposure to a

tively low concentration of normorphine (50 nM) the
tory response 'passed off' with time.
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Figure 5-

The effect of morphine, levorphanol, dextrorphan and naloxone on a single myenteric neuron.
quency (bin width- 10 s).

Ordinate:

Abscissa:

time.

spike freThe solid bam

·indicate the periods during which the bathing solution contained either morphine, levorphanol or dextrorphan and the
hatched bat indicates the period during which naloxone was
added to the perfusing solution.

The numbers above the bam

indicate the concentration (ni1).

Morphine and levorphanol

caused a marked decrease in the firing rate which was rapid
in onset.

Dextrorphan and naloxone were without effect.
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inhibition as that observed with normorphine (1 ~M).

3. 2. 4.
Dextrorphan (100

ru~

Dextrorphan

- 3

~M)

had no effect on the spontaneous

firing rate of 9 cells from 3 animals (Fig. 5; Table 2).

These ob-

servations confirm those previously reported by Dingledine and Goldstein (1975) and North and Williams (1977).

3.2.5.

Cyclazocine

Cyclazocine (3 - 300 nM) inhibited the neuronal firing rate of
53% of the neurons tested (n

~

19; 6 animals).

The inhibition was

Tapid in onset, persisted throughout the period of application (2 - 8
min) and washed out slowly.

The inhibition produced by a 3 min ex-

posure to cyclazocine (100 ru1) often outlasted the period of exposure
by about 3 - 6 min.
by normorphine (n

Neurons inhibited by cyclazocine were also inhibited

= 6)

and met-enkephalin (n

unaffected by cyclazocine (10 nM).

= 2).

Cyclazocine (30

Three cells were
nM) was without

effect on 3 cells, excited 1 cell and inhibited 6 cells by 80%

~5.
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Table 2.

The number of neurons in which firing was inhibited by
various narcotic analgesics.

Inhibition indicates that

the firing rate fell to at least 75% of the control rate.

Drug

Excited

Inhibited

Normorphine
(1 nM - 1 )JM)

2

94

15

Morphine
(10 nM - 1 )JM)

0

36

6

Levorphanol
(30 nM - 1 IJM)

0

15

3

Dextrorphan
(30 nl-1 - 1 )JM)

0

0

9

Keto cyclazocine
(30 nM -l)JM)

1

8

1

Cyclazocine
(3 - 300 nM)

2

10

7

Buprenorphine
(10 - 100 nM)

5

4

8

No Effect

I

\0

0
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A concentration of 100

ru~

cyclazocine was without effect on 7 cells,

and the inhibition of firing of 8 other cells was 83% + 4.

In 2 out

of 3 cells in which cyclazocine (30 and 100 nM) had no effect on neuronal
firing, its presence prevented the inhibition of firing caused by normorphine.

That is to say, it acted as a narcotic antagonist.

3.2.6.

Ketocyclazocine

Ketocyclazocine (30 nM - 1

~)

rate in 80% of the neurons tested (n

~

inhibited the neuronal firing
10; 4 animals).

The inhibition

was rapid in onset but did not readily reverse upon washing (Fig. 6).
In a given cell, higher concentrations of ketocyclazocine caused
greater degrees of irillibition.

Neurons inhibited by ketocyclazocine

were also inhibited by normorphine.

Ketocyclazocine (100 nM) had no

effect of 3 cells, and inhibited the

fi~ing

of 6 other cells by 81% + 5

(mean+ S.E.M.).

3.2.7.

Buprenorphine

The effect of buprenorphine (10 - 100 nM) on the firing rate was
variable (n ~ 17; 5 animals).

Neurons were excited (30%), inhibited

(23%) or not affected (47%) (Table 2).

Ti?O cells initially showed a
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a biphasic response, excitation followed by inhibition, but with the
second application of buprenorphine to the same cell only an excitation
was observed (Fig. 7).

The excitations recorded were slight, occurred

within seconds on entry of the drug to the tissue bath and lasted
throughout the period of exposure.

No particular tendency was noted

for higher concentrations to cause an inhibition or vice-versa.

In

those cells whose firing was inhibited by buprenorphine, the inhibition
was slight, slow in onset (3 - 20 min) and never fully recovered to
control levels upon washout of the drug.

Prior exposure of the tissue

to buprenorphine much reduced the sensitivity of the neurons to the
inhibition by normorphine (Fig. 7).

3.2.8.

Narcotic Antagonists

In only one of 9 cells did naloxone (1 ~M) increase the firing

rate to two times its original value.

This confirms previously published

findings in which naloxone had no effect on 85% of myenteric neurons
tested (n

= 30)

(Williams and North, l979a) (see also Fig. 5).

Both

enantiomers of 5,9-diethyl-2-(3-furylmethyl)-2'-hydroxy-6,7-benzomorphan
excited a similar proportion of cells (n

= 8).

The excitation with any

antagonist was always slight (less than three fold increase in rate) and
rarely lasted throughout the period of application (3- 9 min).

The

lack of stereospecificity of this effects suggests that the excitation
was not a conseQuence of the occupation of the opiate receptor by the
antagonist.
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Figure 6.

A comparison of the effects produced by normorphine and
ketocyclazocine on a single myenteric neuron.
spike frequency (bin width- 10 s).

Abscissa:

Ordinate:
time.

Dur-

lng the periods indicated by the solid and hatched bars,
the perfusing solution was switched to one which contained
normorphine and ketocyclazocine respectively.

Normocphine

(300 nlvi) produced a marked irL.'1.ibition in the firing rate
which rapidly reversed upon washout.

~ne

inhibition of

firing by ketocyclazocine (180 nM) was also rapid in onset,
and slower to washout.
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Figure.7.

A comparison of the effects produced oy normorphine and
buprenorphine on a single myenteric neuron.
spike frequency (bin width- 10 s).

Ordinate:

Abscissa:

time.

Dur-

.

ing the periods indicated by the solid and open bars, the
perfusing solution •,ras switched to one which contained normorphine and buprenorphine respectively.

Normorphine (300

nM) caused a marked inhibition of the firing rate.

The

first application of buprenorphine produced a biphasic response, excitation followed by inhibition; the subsequent
application caused only a slight excitation.

Exposure of

the tissue to buprenorphine prevented the response of the

I,

j

j

neuron to normorphine.
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Naloxone (30 - 300 nM) prevented or reversed the inhibition of
firing rate by morphine (100 r~- 1 ~M) (18 of 18 cells) (Fig. Sa);
normorphine (100 nM- l~M) (9 of 9 cells); levorphanol (100- 300 nM)
(10 of 10 cells) (Fig. 8b); cyclazocine (30 -100 nM) (2 of 3 cells)

and ketocyclazocine

(100 nM) (once in one cell).

The inhibition of

firing by buprenorphine (10 - 100 nM) was not reversed by naloxone
(100 nM- 1 ~M) (3 of 3 cells).

The inhibition of firing produced by· morphine was prevented
or reversed by an antibody to morphine (Fig. 3) (n
alone had no effect on the spike firing rate.

~

4).

The antibody

98

-

.

/

Figure 8,

Inhibitions of firing produced by morphine and levorphanol and the reversal of these inhibitions by naloxone.
Ordinate:
time.

spike fre~uency (bin width- 10 s).

Abscissa:

The solid bars indicate the periods during which

the bathing solution contained either morphine or levorphanol in the concentrations indicated, and the hatched bars
indicate the period during which naloxone was added (200 300 nM) to the perfusing solution.
firing produced by morphine (1

~M)

(a)

The inhibition of

was marked and long

lasting and did not 'pass off' with a prolonged exposure
(60 min).

The addition of naloxone (200 nM) caused an im-

mediate reversal of the firing rate to control levels.
Legend continued on the following page.
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Figure 8b.

Levornhanol (100 nM) produced an inhibition in the firing
rate and this effect was immediately reversed by the addition of naloxone (300 nM).

There was a "rebound" increase

in the firing rate during the naloxone reversal which was
not observed with morphine reversals.
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3. 3.

THE ACTION OF THE CYCLIC NUCLEOTIDES AND RELATED
COMPOUNDS ON S:INGLE UNI.T ACTIVITY
3.3.1.

Cyclic-AMP

Cyclic-AMP caused an inhibition of neuronal firing in 80% of
the neurons tested; 20% were not affected (n

= 20).

The inhibition

was rapid in onset and decline, lasted throughout the period of application (2 - 10 min) and was readily reversed on washout.

Increasing

the concentration of cyclic-AMP (5 11M - 1 mM) caused greater degx·ees
of inhibition.

The inhibition of firing was prevented or reversed by

the administration of theophylline (50-

4oo

llM) (Fig.

9).

Theophyl-

line alone produced a weak excitation (1.5 - 3x) in the majority of
cells tested (n

= 17).

Naloxone (1 llM) failed to affect the inhibition

'produced by cyclic-AMP in the three cells tested.

3.3.2.

Dibutyryl Cyclic-AM?

The effects of dbcyclic AMP were more variable than those of
cyclic-AMP.

Eighteen % of the neurons were excited, 25% of the neurons

were inhibited and 57% were unaffected (n

= 28).

No particular tend-

ency was noted for higher concentrations to cause excitation and lower
concentrations to cause inhibition, or vice-versa.

The inhibition of

firing was rapid in onset and decline, lasted throughout the period of
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application (2- 10 min), and readily reversed on washout,

The inhi-

bitory effect was concentration dependent (Fig. 10) and when inhibition
occurred the effect could be induced repeatedly by repeated applications
of the same concentration of dbcyclic-AMP at intervals of 6 minutes.
The inhibition of neuronal firing was prevented or reversed by theophylline (50-

4oo

~M)(n

= 3).

3.3.3.

Prostaglandin E2

PGE2 (10 - 30 nM) increased the firing rate in 80% of the
neurons tested (n

= 26).

It was difficult to perform experiments with

concentrations greater than 30 nM because muscle contractions occurred
which sometimes dislodged the recording electrode.

The increase in

firing caused by PGE 2 was rapid in onset; however, it often did not persist throughout the period of exposure (5- 15 min).
occurred in the presence of hexamethonium (300

~M)

The excitations

and hyoscine (1

and are,therefore,unlikely to be the consequence of the release of
acetylcholine.

~M)
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Figure 9.

The inhibition of firing rate by cyclic adenosine 3' ,5'monophosphate (c-A}P) and the reversal of inhibition by
theophylline.
s).

Abscissa:

Ordinate:
time.

spike frequency (bin width - 10

During the periods indicated by the

open and solid bars the perfusing solution was changed to
one which contained c-AMP and theophylline,respectively.
The mnnbers along side the bars indicate the concentration
(~M).

c-AMP caused an inhibition of firing which was rapid

in onset and offset, and which persisted throughout the
period of exposure.
versed the

i~~ibitory

Theophylline (50 - 300 ~M) rapidly reaction of

e-ft~~.

The rapidity and

degree of reversal was dependent upon the concentration of
theophylline.
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Figure 10.

Concentration dependent inhibition of neuronal firing by
dibutyryl cyclic adenosine-3' ,5'-monophosphate (dbcyclicA~).

scissa:

Ordinate:
time.

spike frequency (bin width- 10 s).

Ab~

During the periods indicated by open and

solid bars, the perfusing solution contained dbcyclic-AMP
(concentrations indicated) and normorphine (NM) (300 nM)
respectively.

The firing of this neuron was inhibited in

a dose dependent manner by dbcyclic-AMP.
hibited by normorphine.

It was also in-,!
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3.3.4.

rsobutylmethylxanthine

IBMX ( 6 - 50 ~M) did not affect the firing rate of 78% of the
myenteric neurons;

22% of the neurons tested were excited (n

= 28).

In these neurons the excitation was slight (2 - 3 x: the control firing
rate), rapid in onset and did not persist throughout the period of
application.
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3. 4.

LACK OF EFFECT OF CYCLIC NUCLEOTIDES ON THE INHIBITION
OF NEURONAL FIRING BY OPIATES

3.4.1.

Cyclic-AMP

In those neurons in which morphine inhibited firing, the inhibition was not changed when the perfusion solution contained cyclic
At~

(5

~M

- 1 mM) for 6 min prior to and during the presence of the

morphine (n = 12).

This lack of effect of

cyclic-~W

was observed

both in cells in which cyclic-AMP itself inhibited firing and in those
in which cyclic-AMP had no effect.

When the firing was inhibited by

morphine, changing to a solution which contained both morphine and
cyclic-AMP did not reverse the effects of the morphine (n =5).

3. 4. 2.

Dibutyr:yl Cyclic-At"lP

Results obtained using dbcyclic-AMP were similar to those reported for cyclic AMP (n

= 11)

(Figs. 11 and 13).

110

Figure 11.

Lack of effect of dibutyryl cyclic adenosine 3' ,5 1 -monophosphate (dbcyclic-AMP) on the inhibition of firing caused
by normorphine in a single m;yenteric neuron.
spike freq~ency (bin width- 10 s).

Abscissa:

Ordinate:
time.

Dur-

ing the periods indicated by the solid and open bars, the
bathing solution contained dbcyclic-M1P (500 ~M) and normorphine (concentration indicated in nM), respectively.

The

neuronal firing rate was depressed by normorphine before,
during and after the exposure to dbcyclic-AMP.

The sensi-

tivity to normorphine was not reduced during concurrent
application of

dbcyclic-fu~.
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3.4.3.

Prostaglandin E2

Tissues were exposed to PGE 2 (10 - 30 nM) both prior to (6 - 10
min) and during the application of morphine (300 DP!- 1 pM).

A given

concentration of morphine caused the same degree of inhibition of cell
firing in the presence and absence of PGE 2 (n

= 8)

(Fig. 12).

When

cell firing was depressed by normorphine, changing to a solution which
contained both normorphine and ?GE2 did not reverse the inhibition
(n

= 5)

(Fig. 13).

3.4.4.

Isobutylmethylxanthine

Tissues were exposed to I~~ (50 ~M) prior to (6 - 60 min) and
during the application of morphine.

A given concentration of morphine

produced the same degree of inhibition whether in the presence or absence of IBMX (n

= 12)

(Fig. 14a).

Likewise, morphine was eq~ieffective

in inhibiting neuronal firing even after prolonged exposure (24 h) of
the tissue to IBMX (50

~M).

Also the narcotic antagonist naloxone was

without effect on neurons exposed to IBMX (Fig. l4b).
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Figure 12.

Interaction between prostaglandin E2 and normorphine on a
single myenteric new:·on.
width- 10 s).

Abscissa:

Ordinate:
time.

spike frequency (bin

During the periods in-

dicated by the solid and open bars, the bathing solution
contained normorphine (NM) and prostaglandin E2 (PGE 2 ) respectively.
(300 nM).

Neuronal firing was inhibited by normorphine
PGE 2 (30 nM) caused an excitation of the neuron

but this did not persist throughout the eXJ?osure.

Normor-

phine was equally effective in inhibiting neuronal firing
in the presence of PGE2.
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Figure 13.

Interaction between normorphine, prostaglandin E2 and dicut~lcyclic-fu~.

10 s).

Abscissa:

Ordinate:
time.

spike frequency (bin width_

During the periods indicated by

the solid, open and hatched bars, the perfusing solution
was changed to one which contained normorphine (NM), prostaglandin E2 (PGE 2 ), and dibutyrylcyclic adenosine 3' ,5 1 -monophosphate (dbcyclic-AMP) respectively.

Normorphine (300

ru1) inhibited the firing of this neuron, and the irillibition

remained throughout the 30 min period of application.

PGE2

(10 nM) did not excite the cell during the inhibition by
normorphine although it did excite the neuron when morphine
was not present (not shown); dbcyclic-fu~ (400 ~M) was also
without effect.
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1

Figure 14.

Lack of effect of

isooutyLmethylxanth~ne

(IBMX) on the in-

hibition of netrronal firing by'

~or~hine.

Ordinate:

frequency (oin width- 10 s).

Abscissa:

time.

spike

(a)

The

. neuromd firing rate was depressed oy morphine (1 pH) before, during and after ex~osure to IBM:X: (50 pM).

The sen...

sitivity to morphine did not appear altered during the
current application of

IR~.

con~

118

IBM X 50!-Jtvl
II MOR 1!-JM

N'
I
...._.,

5

0

30

60
Time(min)

119
Figure 14o. Prior to this experiment, the isolated

ileu~

had oeen incu-

oated in a Kreos solution containing IBMX (50

~M)

for

24 h·,

the IBMX was present throughout the period of extracellular
·recording with the exception of the period indicated oy the
open oar.

During the periods indicated oy the crosshatched

and solid bars, the oathing solution also contain2d naloxone (1

~M)

and morphine (300 nM), respectively.

Naloxone

was without effect, and morphine was as effective as usual
in causing an inhioition of firing.
did not change the firing rate.

Washing out the IBMX
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3.5.
3.5.1.

EFFECTS OF PROLONGED

Prolonged Exposures

EXPOSL~E

(~h)

TO OPIATES

whilst Recording from a

Single Neuron
Tachyphylaxis ('acute tolerance') to the inhibitory effect of
normorphine on neuronal firing was sometimes observed (n

= 7).

Low

concentrations (10 - 50 nM) of normorphine applied for long periods

(8 - 60 min) resulted in an inhibition which was not maintained at its
maximal level throughout the drug exposure.

That is to say, the inhi-

bition of firing 'passed off' during the presence of the normorphine
(Fig. 4).

The other circumstance in which tachyphylaxis was apparent

was following prolonged exposures (30 - 60 min) to a high concentration
of normorphine (l

~)

(n

= 6).

Following this exposure, the sensitivity

of the neuron to previously administered concentrations of normorphine
was reduced (Fig. 15).

3.5.2.

Prolonged Exposures

(~24

h) to Opiates Prior to and

During the Recording from a

3.5.2.1.

Q~ngle

Neuron

Normal Krebs Solution (control incubations)

Extracellular recordings of myenteric neurons were made from

122

··'

Figure 15.

Inhibition of firing of a myenteric neuron by normorphine.
Before the beginning of this recording (time zero), this
neuron had been incubated in normal Krebs solution for 24 h.
Grdinate:
time.

spike frequency (bin width- 30 s).

Abscissa:

During the periods indicated by the solid bars, the

solution contained normorphine (NM) in the concentrations
indicated (nM).

This neuron was one of the most sensitive

to the inhibition by morphine which was obserred.

Following

the prolonged exposure (30 min) to a high concentration (1
~M),

the neuron became somewhat less sensitive to the sub-

sequent effect of the lower concentrations.
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tissue which had been incubated 24 h in a normal Krebs solution (n
12 animals).

The firing rate was 2.9

~

= 30;

0.4 Hz (mean+ S.E.M.) and this

value did not differ from those of fresh tissue (3.0 ~ 0.2 Hz).

The

spike waveform and pattern of firing of these neurons did not appear
to be different from those tissues which were not incubated.

Morphine

or normorphine (1 - 300 nM) inhibited neuronal firing in a dose-dependent
manner.

Normorphine ( 30 nM) inhibited 12 of 14 cells to •t1hich it was

applied and the degree of inhibition was 56%~ 8; at 100 nM, 2 cells
were unaffected and the inhibition of 10 other cells was 81% + 6; at
300 nM, one cell was unaffected and the inhibition of 11 other cells
was 89% ~ 5.

The time course of the inhibition was the same as that

described above (see sections 3.2.1. and 3.2.2. ).
Naloxone (100
ons tested (n

= 13);

ru\1 -

1 f.lM) was without effect on 77% of the neur-

23% were excited (Table 3).

by naloxone (200 nM) was 248% (n

= 3),

the period of application (3- 9 min).

The mean excitation

and did not persist throughout
The excitation was mimicked by

both the (+) and (-) isomers of the benzomorphan antagonist (Mr 2267
and Mr 2266 respectively) ( n
~icroscopic

= 3).

examination of ganglia from tissue which had been

incubated for 24 h in Krebs solution (pH 7.4; 22- 26°C) revealed no
gross differences 'tlhen compared •t1i th ganglia from freshly removed tissue.
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Table 3.

The effect of narcotic agonists and antagonists on the firing
rate of myenteric neurons incubated 24 h in a normal Krebs
solution or in a Krebs solution containing opiate.
crease in the firing rate

(a~citation)

firing rate at least doubled.

.An in-

indicates that the

An inhibition indicates that

the firing rate fell to at least 75% of the control rate.
The proportion of units inhibited by opiates and excited by
narcotic antagonists changed

w~en

the tissue was subjected

to prolonged exposures to morphine, levorphanol, bu.prenor:phine
and ketocyclazocine.

For the concentration of opiate used

please refer to the text.

Abbreviations:

c6

-hexamethonium

hyos

-hyoscine

lido

-lidocaine

cyclohex -cycloheximide
Db c-AMP

-dibutyrjl cyclic-ili\1P

IBMX

-isobutybnethylxanthine

levorph

-levorphanol

dextror

-dextrorphan

buprenor -buprenorphine
ketocyc

-ketocyclazocine

Percent of
neurons inhibited by narcotics
(1

nM -

1 11M)

FRESH
TISSUE
Control

Control

86

85

n=ll4

0

0

0

0

0

n=55

n=20

n=l9

n=20

n=21

22

10

23

11

18

n=27

n=lO

n=l3

n=9

n=ll

23

79

81

85

60

50

86

n=l3

n=38

n=l6

n=l3

n=l5

n=l8

n=l6 n=4

n=l3 n=lO

62

66

75

50

100

18

n=21

n=3

n=4

n=2

n=20

Percent of
neurons inhibited by narcotics
(2 - 30 11M)

-

Percent of
neurons excited by narcotic an tagonists

15*

(50 nM- 6 11M)

n=30

Percent of
neurons excited by the
perfusion of
an opiate free
Krebs ..solution

-

-

INCUBATED TISSUE (24
36 h)
Morphine
ILevor}lh
Dextror
DbcAc"!P
1
C6 &
Cyclo&
100
100 1
Alone llyos Lido
hex
IBMX nN
11M
nM 11M

-

-

*Williams

C~nd

-

North 1 19'19a.

lll
n=JJ

8o

-

89

n=l5 n=9

13

- n=8

100

75

n=2 n=4

Buprenor Ketocyc

-

-

15

40

-

-

8

55

n=l3

6
n=l6

80

n=ll n=lO

n=20

65
n=26

100

-

n=2
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3.5.2.2.

Morphine

Extracellular recordings from myenteric neurons were made from
tissue which had been incubated 24 h in a morphine (1 ~M) containing
Krebs solution (n =55; animals= 18).

The tissue was also continuously

exposed to morphine (1 ~M) throughout the subsequent period of extracellular recording.
(mean~

The firing rate of these neurons was 1.5

~

0.2 Hz

S.E.M.) and this rate of discharge was significantly different

than in those cells which had been incubated without the morphine (2.9
~

0.4 Hz)

(control incubation)

(p < 0.05, t-test, df = 44).

The

firing pattern was generally more erratic with distinct bursts of
spiking.

The spike waveform was not altered.

concentration to 10 or 30
21 of 27 neurons;
16).

~M

Increasing the morphine

was without effect on the firing rate of

6 cells were inhibited by 73%

~

6

(mean~ S.E.M.)

(Fig.

Levorphanol (l - 10 llM) ( n = 7) and met-enkephalin ( 3 & 10 llM)

(n = 3) had no inhibitory effect on neuronal firing.

That is, tolerance

and cross-tolerance were apparent.
iN:hen the solution was changed to one which differed only in its
lack of morphine, the firing rate increased in 13 of 21 neurons.

'The

firing rate increased by 464% ~ 65 and this excitation often did not
persist during the entire period of 9erfusion with a morphine free
solution (up to 60 min).

When the perfusing

sol,~tion

was changed to

one which contained both mor9hine (l llM) and naloxone (10 nM - l ~M) a
marked increase in the firing rate was observed (Fig. 16; Table 3).

The

excitation by naloxone oegan immediately ( '·ri thin 40 s) of the arrival of
:1aloxone at the tissue.

Tb.e naloxone excitation occurred in 30 ouc.

e:~'

128
of 38 neurons, its amplitude was dependent on the concentration (10 nM1

~M),

and it sometimes outlasted the period of application (Fig. 16).

Naloxone (100 nM) excited 5 cells by an average of 636% + 191; at 200
ffi~

the average degree of excitation in 8 cells was 729% ~ 145, and at

1 ~M the average degree of excitation in 11 cells was 868% ~ 150.

The

firing rate of neurons excited by naloxone often reached frequencies
which were never observed in control situations (usually more than 10
Hz).

The excitation was mimicked by the benzomorphan antagonist Mr 2266

(100 nM- 1 ~M) but not its (+) -enantiomer Mr 2267 (100 ru~- 1 ~).
(+) -naloxone did not affect the firing rate (n

= 3).

The excitation

was reproducible in 73% of the cells when short exposures (3 min) to
naloxone were used.

However, 27% of the neurons tested showed progres-

sively declining excitations upon the second and third applications.
When naloxone was applied for a prolonged period of time (120 min) the
excitation 'passed off' during the presence of naloxone.

3.5.2.3.

Levorphanol

Extracellular recordings were made from myenteric neurons in
tissues which had been incubated 24 h in a Krebs solution containing
levorphanol (100 nM or l

~M).

With the lower concentration, results

are based on recordings made from 20 units taken from 9 animals.
neurons were continuously exposed to levorphanol (100

ru~)

The

throughout

the period of incubation and the subsequent period of extracellular re-
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Figure 16.

The effect on a myenteric neuron of prolonged exposure to
.morphine.

Before beginning the recording (time zero), this

neuron had been exposed continuously to a solution contain:tng morpfine (1 pH) ar..d this solution continued to perfuse

the tissue throughout the period of recording.

During the

periods indicated by the solid and hatched oars, the perfusing solution was switched to one which contained morphine and naloxone respectively.
(bin width-60s).

Abscissa:

Ordinate:
time.

spike frequency

Tolerance to the in-

hioitory effect of morphine had developed--that is, increasing the morphine concentration to 30 11H 'tTas without effect
on the firing rate.

Naloxone (100 nlvi) caused an increase

in spike frequency.

When a high concentration of naloxone

(l 11M) was used the frequency of firing exceeded 10 Hz,
(period within the dotted lines) and this excitation persisted beyond the period of exposure.

As a consequence of

the naloxone (l 11M) application the longitudinal muscle
was observed to undergo strong contractions which_led t0
the dislodgement of the recording electrode from the ganglion at time 64 min.
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The mean firing rate of these neurons was 1.3 + 0.2 Hz (n

cording.

= 18)

and this rate was significantly different from that observed in control
incubations (2.9 ~ 0.4 Hz) (mean~ S.E.M.; p < 0.05, t-test, df

= 39)

and the firing pattern was generally more erratic with distinct bursts
of firing.

Nine out of eleven units tested were not affected by increas-

ing the levorphanol concentration to 300 nM or 1 ~ (Fig. 17).

When the

levorphanol was removed from the perfusing solution during the period
of extracellular recording, the firing rate of 2 of 2 neurons increased
(Table 3).

Similarly, an excitation was observed in 14 of 16 neurons

when the perfusing solution was changed to one which contained either
naloxone (100 nM - 1
levorphanol (100 nM).
794% ~ 167.

~)

or Mr 2266 (100 nM - 1

~M)

in addition to

Naloxone (200 nM) excited 1 of 10 neurons by

The excitation occurred almost immediately when the drug

reached the tissue, persisted throughout the period of application (3 10 min), and rapidly declined when the solution was changed back to one
containing only levorphanol (100

nM).

The excitation was repeatable

Mr 2267 (100 nM - 1

with subsequent applications of naloxone.

~M)

and

(+) -naloxone were without effect on the firing rate.

Tissues were also incubated in solutions containing levorphanol
(l ~M) (4 animals}.

The mean firing rate (1.7 ~ 0.3 Hz) (n = 11) and

pattern of firing were similar to those of neurons incubated in levorphanol 100 nM.

Seven of 8

n~uxons

tested were not inhibited by increas-

ing the levorphanol concentration to 2 - 10
was without effect on the firing rate (n
tolerance had developed.

~.

= 5);

Normorphine (1 - 10

~M)

that is to say, cross-

When the levorphanol was removed from the per-

fusing solution during the period of extracellular recording, the firing
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rate of 3 of

4 neurons increased by 775% (Table 3).

When naloxone or

Mr 2266 was added to the perfusing solution an excitation was observed
similar to that described above for neurons incubated in levorphanol
(100 nM) (Table 3).
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3.5.2.4.

Dextrorphan

These results are based on extracellular recordings from myenteric neurons in tissue which had been incubated in dextrorphan (100 nM
or 1

~M).

The firing rate (2.3

~

0.4 Hz) (n = 24), spike waveform and

firing pattern of these neurons did not differ-markedly from those of
control incubated tissue (p > 0.05, t-test, df

= 45).

Neurons treated

in this manner were still sensitive to the inhibitory action of normorphine (30- 300 nM).

Normorphine (300 nM) inhibited 12 of 15 cells in-

cubated in dextrorphan (100 nM), and the degree of inhibition was 83%

3.
(1

~

Normorphine (300 nM) inhibited 8 of 9 cells incubated in dextrorphan
~M)

by 84%

~

5.

The inhibition was rapid in onset and offset, persisted

throughout the period of application, and these findings were not distinguishable from the effect of normorphine on control incubated tissue.
In the case of dextrorphan (100 nM), changing to a dextrorphan
free solution resulted in an excitation in 2 out of 11 cells.

The ex-

citation was slight (approximately doubling of firing rate).

The effect

was observed of changing to a solution which contained dextrorphan (100

nM) and one or other of the isomers of benzomorphan.

The (-) isomer,

(Mr 2266) (100 nM - 1 ~M) caused a small excitation in 2 of 13 cells.

The (+) isomer (Mr 2267) (100 nM
rate of 4 cells (Fig. 17).

1

~M)

had no effect on the firing

(+)Naloxone (100

ru~-

1

~M)

also had no

effect on firing when added to the dextrorphan containing solution.
However, tissues incubated with the higher concentration of dextrorphan
(1 ~M) responded differently.

Removing the de~~rorphan from the per-

I

~4
·-l'l

134

J

Figure 17.

'::'he eff2ct of the narcotic o.ntagonist Mr 2266 on myenteric
neurons exposed to levorphanol or dextrorphan for 24 h.
Before beginning the recording. (time zero), this neuron
had been exposed continuously either to a solution containing levorphanol (100 ru1) or to one containing dextrorphan (100,&1) for 24 h;

these solutions continued

to

perfuse the tissue throughout the period of ::-ecording.
During the periods indicated by the solid and hatched bars,
the perfusing solution was changed to one which contained
levorphanol and either Mr 2266 or Mr 2267.

The

above the bars indicate the concentration (lli\1).
spike frequency (bin width- 10 s).

Abscissa:

n~~bers

Ordinate:
time.

(a)

A neuron which had been incubated in levorphanol (100 Ih\1).

The firing rate was not inhibited by the application of a
high concentration of levorphanol (300 nN).

The inactive

isomer of the benzomorphan antagonist Nr 2267 (100 ru\1),
(Mr (+)),was without effect on the firing rate whereas Mr
2266 (100 nM), (Mr (-)), caused an excitation.

Even after

the -.rashout of the antagonist the firing rate rose and fell
for several min.

(b)

Mr (+) and Mr (-) were without

effect on neurons previously incubated in dextrorphan (100
&1) for 24 h.
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fusing solution resulted in an increas.e in the firing rate in 8 of 10
neurons.

Naloxone (100 nM - 1

~M)

and Mr 2266 (100 nM - 1

~M)

excited

4 of 10 neurons (Table 3) which were incubated with dextrorphan (l ~M).

The mean excitation produced by naloxone (200 ru~) was '545% (n

= 4),

and

this value was not significantly different from the value (692% + 107)
obtained with levorphanol (1 JlM) incubations (p > 0.05, t-test, df = 11).
The excitation was rapid in onset and persisted throughout the period of
application (3- 6 min).

An excitation was not observed with either (+)

-naloxone (100 n.M - 1 ~M) or Mr 2267 (100 nM - 1 ]1M) (n

= 5).

These

results suggest that the higher concentration of dextrorphan was producing
changes analogous to those caused by morphine or levorphanol.

3.5.2.5.

Buprenorphine

The results are based on extracellular

recordiP~s

from 22 neur-

ons (6 animals) from tissue which had been incubated for 24 h in Krebs
solution containing buprenorphine (30 nM).

The neurons were contin-

uously·exposed to buprenorphine (30 nM) throughout the subsequent
period of extracellular recording.
(n

= 12)

The firing rate of these neurons

was 2.9 ~ 0.5 Hz, and this value did not differ from that

observed in tissue which had been incubated without buprenorphine (p >
0.05, t-test, df

= 33).

Increasing the concentration of buprenorphine

to 100 nM was without effect on the firing rate.

Morphine (2 - 30 ]1M)

had no effect on firing of 12 of 13 neurons (Fig. 18; Table 3).

It is
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possible that this represents cross-tolerance to morphine.

However,

in the naive tissue (see section 3.2.7.), buprenorphine inhibited the
firing of only about one-quarter of cells, yet acted as a morphine
antagonist in every case (n

= 5).

The blockade of morphine inhibition

after prolonged presence of buprenorphine may, therefore, be an expression of buprenorphine's antagonist properties -to which tachyphylaxis
has not developed.
When the perfusing solution was changed to one which contained
both buprenorphine (30 nM) and naloxone (100 nM - 1
(30 nM) and Mr 2266 (100 nM- 1

~M),

~M)

or buprenorphine

the firing rate was not affected in

15 of 16 cells (Fig. 18); one neuron was excited (Table 3).

3.5.2.6.

Ketocyclazocine

The results are based on recordings made from 39 neurons from

9 animals.

Tissue was kept in Krebs solution containing ketocyclazocine

(300 nM & 1 ~M) for 24 h and perfused with the same solution during the
period of extracellular recording.
+ S.E.M.) (n

= 26)

The firing rate was 1.9 + 0.2 Hz (mean

and this value was not different than the value (2.9 ~

0.4 Hz) obtained from tissue incubated in a similar solution except that
it lacked ketocyclazocine (p> 0.05, t-test, df
concentration of ketocyclazocine to 5

~M

= 47).

Increasing the

was without effect on the firing

rate (Fig. 19), whereas in control incubations this concentration inhib-
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ited spike discharge.

Morphine (2

~M)

or decreased it by less than 50% (n

had no effect on the firing rate

= 8).

of morphine (or normorphine) up to 6

~M

Increasing the concentration

resulted in an inhibition (77%

5) of neuronal firing in ll of 20 neurons (Fig. 19):

~

this contrasts with

the effect of normorphine on tissue incubated with levorphanol or morphine, in which neuronal firing was rarely inhibited by normorphine (5

~M).

Neuronal excitations were observed when the perfusing solution was changed
to one which contained naloxone (n = 16), cyclazocine (n
(n

= 8),

in addition to ketocyclazocine (Table 3).

= 2),

or Mr 2266

The excitation by

naloxone (200 ru~- 2 ~M), or ~rr 2266 (200 nM- 2 ~M) was marked (3- 10
fold) (Fig. 19) and similar to that caused by naloxone in morphine-incubated tissue.

It began immediately upon arrival of the antagonist at

the tissue, was concentration dependent and often repeatable on the same
cell.

The excitation produced by naloxone (200 nM) was 484% + 166 (n

Larger concentrations of naloxone (1 and 2
162 (n

= 7)

~M)

= 5).

gave excitations of 636% +

and 742% + 194 (n = 5), respectively; these excitations were

comparable to those caused by naloxone in tissues incubated with levorphanol (100 1~) (794% + 167) and morphine (1 ~M) (729% + 145) (mean +

S.E.M.).
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Figure 18.

The effect on a myenteric neuron of prolonged exposure to
buprenorphine.

Before beginning the recording (time zero)

this neuron had been expo0ed continuously to a solution
. containing buprenorphine (30 nM) for 24 h and this solution continued to perfuse the tissue throughout the period
of recordlng.

During the periods indicated by the open,

solid and hatched bars, the perfusing solution was changed
to one which contained cyclic-AMP ( 250 f.!M), normorphine ( 3 &

30 f.!H) and naloxo::1e (200 nM), respectively.
spike frequency (bin width- 10 s).

Ordinate:

Abscissa:

.....
'"'lme.

Cyclic-ANP (250 }1M) caused an inhibition in firing rate
which was maintained throughout the period during which
the cyclic-l'u\1P. was in the bath.

(3 & 30 llM) or naloxone (200
affect the firing rate.

ru~)

Application of normorphine
did not significantly
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Figure 19.

The effect on a myenteric neuron of prolonged exposure to
ketocyclazocine.
clazocine (1

~M)

~ne

tissue had been exposed to ketocy-

for 24 h and was continuously bathed with

.the same solution throughout the subsequent period of recording except for the time indicated by the open bar.

The

solid, diagonally hatched, vertically hatched, and horizontally hatched bars indicate the periods during which the
perfusing solution was changed to normorphine (3 - 6

~M),

ketocyclazocine (5 ~M), naloxone (200 nM & 1 ~M) and cyclazocine (1 & 3 ]lM), respectively.
quency (bin width- 10 s).
phine (3 & 6

~M)

Ordinate:

Abscissa:

time.

spike fre(a)

Normor-

produced an inhibition in firing re.te

which was dose-dependent.

However, such concentrations of

normorphine would completely inhibit cell firing in control incubated cells (see Fig. 15); that is to say, some
cross-tolerance tc normorphine had developed.
cine (5 ]lM) was without effect.

Ketocyclazo-

Naloxone (200 nM- 1 ~M)

produced a concentration dependent excitation.

!ncubated in Ketocycla zocine
Nalox (uM)
Ketocyc (uM)

9r
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Figure 19b. Same neuron as in (a).

Perfusing the tissue with cyclazo-

cine (1 - 3 ~M) or a ketocyclazocine free Krebs solution
also produced an excitation, however, the excitations pro. duced were not as marked as those caused by naloxone.
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Prolonged Exposures In Vivo (3 days)

3.5.3.

---

Samples of blood were collected from guinea-pigs subcutaneously
injected (n

= 11)

with morphine sulfate or implanted (n

phine pellets (see Methods).

= 6)

was 12.7

~M.

with mor-

The average serum concentration of morphine

from pellet implanted animals (n
animals (n

= 8)

= 4)

was 4.7

~M

while that of the injected

Samples of blood were collected 2 h after the

last dose was given to the injected group and on the third day following
implantation.

The average weight loss for the injected and implanted

animals was 25 and 28 g, respectively.

The ileum was removed and pre-

pared for electrophysiological recording.

Either morphine or normorphine

(200 - 500 nM) were present in the Krebs solution throughout the electrophysiological studies.

The firing rate (2.3

~

0.3 Hz) (n

= 40),

spike

waveform and pattern of discharge of these neurons did not markedly differ
from those observed in neurons taken from animals not pretreated with morphine (3.0 -+ 0.2 Hz) (mean+
- S.E.M.; p > 0.05, t-test, df

= 119).

Increasing the concentration of morphine or normorphine up to
10 11M was usually without effect on the firing rate (n
the development of tolerance (Fig. 20).

At 3

~M,

= 47),

indicating

morphine inhibited 6 of

21 cells tested, the mean degree of inhibition of these cells being 53%
11.

At 5

~M,

morphine inhibited 3 of 12 cells tested by 56%

11M morphine was without inhibitory effect on
Levorphanol (1- 3

~M)

~

16.

~

At 10

4 cells to which it was applied.

did not inhibit firing (n

= 8).

When the perfusing

solution was changed to one which differed only in its lack of morphine, a
clear increase in firing was observed in 22 of 30 neurons (Table

4).

Typi-

146
cally, the excitation was moderate (2 -

4

fold increase in firing rate)

and lasted throughout the period of perfusion with the morphine-free
solution (6- 60 min).
Neuronal firing rates increased markedly when the perfusing
solution was changed to one which contained both naloxone (10 ru~ - 1 ~M)
and morphine (200 nM) (Fig. 20).

Naloxone (200 nM) excited 12 of 17

neurons by 802% ~ 84, and this value agrees well with that obtained from
morphine incubated tissue (729% ~ 145).

The excitation was rapid in on-

set, often reached frequencies of 10- 20Hz and usually persisted
out the duration of the exposure (3- 12 min).

throu&~

Excitations of equal mag-

nitude could usually (65% of experiments) be produced by repeated applications of the same concentrations of naloxone to a single cell; however,
in about one-third of cells such excitations became progressively less
(Fig. 21).

With longer periods of exposure, the excitations progressively

declined during the presence of naloxone.

The excitatory effect was

stereospecific; that is, it was shared by Mr 2266 (100 nM- 300 nM) but
not Mr 2267 (100 nM- 1 ~M) or (+) -naloxone (100 nM- 1 ~M).

1

' i':.

. ·~

Table 4.

A comparison of the effects of narcotic agonists and. antag-

,,,

onists on myenteric neurons which have been incubated. (-24 h).
·in Krebs solutions containing morphine and. those removed. from.''
·morphine pretreated. guinea-pigs.
the firing rate at least cloublecl.

An excitation inclicates

tha.11

An inhibition inclicates

th~t the firing rate fell to at least

75%

of the control rate~

Myenteric Neurons

I

morphine incubated tissues
(24 - 36 h)

RESPONSE

tissue removed from morphine*
pretreated animals (1 - 10 h)

0
n=55

0
n=lO

22
n=27

25
n=47

Percent of neurons
excited by narcotic
(10 nM - 1 ]1M) antagonists

79
n=38

70
n=46

Percent of neurons excited by perfusing with
an opiate free Krebs
solution

62
n=21

73
n=30

Percent of neurons

1

inhibited by opiates

2-30 ]1M

<;

J.IM

I

*Ileum removed from morphine pretreated animals was placed in a Krebs solution containing
morphine or norrnorphine (200- 500 nM).

Figure 20.

The effect of normorphine and naloxone on myenteric neurons
removed from morphine pretreated guinea-pigs.

The tissue

was perfused throughout the period of recording in a Fxebs
solution-containing morphine or normorphine (200 nM), except for the periods indicated by the open bars.
the

period~

During

indicated by the solid and hatched bars the

solution which perfused the tissue contained normorphine
and naloxone,respectively.
width- 10 s).

Abscissa:

Ordinate:
time.

(a)

spike freq_uency (bin
The neuronal firing

rate was slightly decreased by no:rrwrphine (NM) ( 3 J..lM) but
was markedly increased (indicated by the area within the
dotted lines) by the (-) isomer of naloxone (100 nM).
excitatory effect was not shared by the (+) isomer of
naloxone (100 nM).

Legend continued on next page.
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Figure 20b. A different cell from that in (a) .

The firing rate was in-

creased by removing the morphine from the perfusing solution; and an excitation was also observed when naloxone
.(100 nM). was added to the bathing solut1on.

The increase

in firing produced by naloxone vas rapid in onset and
ed off'

dur~ng

the exposure.

(bin width-60s).

Abscissa:

Ordinate:
time.

1

pass-

spike frequency
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Figure 21.

The effect of naloxone on a myenteric
a morphine pretreated guinea-pig.

ne~ron

removed from

The tissue was perfused

throughout the period of extracellular recording in a Krebs
~o1ution.containing

frequency.
by'the

Abscissa:

30li~

contained

morphine (500
time.

nM).

Ordinate:

spike

During the period indicated

bexs the solution which perfused the tissue

~aloxone

(100

nM).

The excitatory response to

the same concentration of naloxone (100
repeated applications.

w~)

diminished with
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3.6.

TIME COURSE 0~ RECOVERY FROM OPIATE TOLERANCE
A~ID

'DEPENDENCE'

A study was undertaken to determine the time course of
from opiate tolerance and dependence.

recove~J

Tissue from morphine pellet im-

planted guinea-pigs, morphine injected guinea-pigs and from drug naive
guinea-pigs which had been incubated in Krebs solution containing morphine (1

~M)

for 24 h were studied.

In these experiments, morphine was

withdrawn from the Krebs solution which perfused the neurons, and at
various known intervals thereafter the degree of tolerance, and naloxone
induced-excitations (manifestation of dependence; see Methods) was tested.
A neuron was described as tolerant if 300 nM morphine (or normorphine) did
not inhibit the neuronal firing rate by at least 50%.
EXPeriments on tissue incubated in morphine for 24 h.
effect of a 2 - 3 min application of normorphine (300

The inhibitor]
~~)

was tested at

different time intervals after the first exposure of the tissue to a
morphine-free solution.

A partial return to normal sensitivity (de-

fined as a 50% reduction in firing rate by normorphine 300 ~~) occurred
rapidly during the first 2 h of morphine withdrawal; 53% of neurons had
normal sensitivity at 2 h.

However, the proportion of neurons Nitb nor-

mal sensitivity rose more slowly thereafter and by 6 - 10 h after morphine removal the percent of cells (70%) which were sensitive was still
less than in control conditions (85%) (Fig. 22; Table 5).
~ithdrawal

of morphine from the bathing solution resulted in an

excitation (see section 3.5.2.2.).

Following the withdrawal of

mor~hine

Table 5.

Time course of the recovery from opiate tolerance in single
myenteric neurons.

.~

inhibition indicates that the firing

fell to at least 50% of the control rate.

Abbreviations:

MFK- morphine-free Kcebs solution
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RECOVERY FROM TOLERANCE

MORPHINE TREATED ANU1A.LS (IN VIVO)

No. of units
tested

Percent

2

8

25

3

10

30

5

10

50

5

8

62

2

3

67

0

1

0

Number of units which have returned
to within normal sensitivity*

II

Hours in
MFK

PROLONGED INCUBATIONS IN MORPHINE (IN VITRO)

Number of units which have returned
to within normal sensitivity*

No. of units
tested

Percent

0-1/2

0

4

0

1/2-1

1

6

17

1-2

9

17

53

2-3

5

9

56

3-4

2

3

67

4-6

4

6

67

6-10

T

10

TO

*Normal sensitivity was considered to be a 50% inhibition of neuronal
firing by normorphine (or morphine) 300 ru~.

I
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Figure 22.

The effect of morphine (or normorphine) on myenteric neurons undergoing opiate withdrawal.
quency (bin width - 10 s).

Ordinate:

Abscissa:

time.

spike freDuring the

period indicated by the solid bo.rs, morphine (or normorphine) was added to the perfusing solution.

(a)

This neu-

ron had been incubated in morphine (l ~M) for 24 h and
prior to the start of this recording (time zero) had been
exposed to a morphine free Krebs (MFK) solution for 8 h. M:r.,.
phine (0.3- 3

~M)inhibited

the neuronal firing rate in a

concentration dependent manner, but

~he

inhibition of fir-

ing caused was not so large as in non-incubated tissue (see
Figs.. 3 & 8).

That is, tolerance to morphine's effect was

present even after 8 h in MFK.

(b)

This neuron had been

incubated in morphine (1 ~M) for 24 h and at the arrow, the
perfusing solution was changed to one which was free of
morphine.

Application of normorphine ( 300 n_M) at intervals

of 15 min resulted in a progressively increasing
of firing during the next l h.

i~hibition

However, even after 1 h,

300 nM normorphine did not cause maximal inhibition of fir- ·
ing.

(c)

Tissue was removed from a morphine pretreated

guinea-pig and exposed to a Krebs solution containing morphine (200 ~1).

Thirty min prior to the begi~~ing of the

recording (time zero) the solution was changed to one free
of morphine.

Morphine (400

ted the firing rate, -w-hereas

ru~

- 4

~M)

only weakly

i~~ibi-

in control tissue a complete
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sue removed from morphine treated animals or ileum exposed 24 h to morphine (1 ~M).

160

sue removed from morphine treated animals or ileum exposed 24 h to morphine (1 ~M).
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from the perfusing solution, the neurons rapidly lost their propensity
to be excited by naloxone.

In these experiments naloxone was applied

only once (3 min duration) to any neuron, the time of this application
being 15, 30, 45 or 60 min after withdrawal of opiate.
neurons (n

= 2)

At 15 min all

were excited by naloxone; (+) -naloxone was ineffective.

The proportion of neurons excited by naloxone fell during the first hour
in a morphine-free solution (Table 6) until it was not different from
that in tissue from naive animals never exposed to morphine (23%).
Experiments on tissue from morphine pretreated guinea-Pigs.

Within 2 h

of changing to a morphine-free Krebs solution, half of the neurons
tested had returned to normal opiate sensitivity (Table 5).

In those

cells which had recovered their normal sensitivity after withdrawal of
morphine, the effect of subsequent prolonged exposure (30 - 60 min) to
normorphine was studied.

Normorphine (300 nM- 1

~M)

inhibited the

neuronal firing by more than 75%, but in 4 of 7 cells tested this inhibition passed off during the presence of the normorphine (Fig. 23).
In 2 of these

4 cells, a marked increase in neuronal firing (frequencies

> 20 Hz) was observed upon the washout of the normorphine.

Such a de-

cline in the inhibitory effect of normorphine (300 ru~ or 1 ~~),or
excitations upon r.vashout of normorphine were never observed during experiments on naive tissue.

These limited observations suggest that the

signs of tolerance and excitations on withdrawal of agonist can be readily reinduced in tissue which had previously had prolonged exposure to
opiates.
'::'issues '..rere tested vith naloxone (100 - 200 nM) at different
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periods from the time of morphine withdrawal.
posed to naloxone only once.

A single tissue was ex-

The degree of excitation caused by naloxone

(100 - 200 nM) became less as the time from withdrawal of morphine increased (Fig. 24).

The excitations themselves were rapid in onset and

offset but rarely lasted throughout the period of exposure (3-

6 min).

The excitation was not mimicked by (+) -naloxone (100- 200 nM).

The

proportion of neurons excited by naloxJne also declined progressively
(Table 6).

Sixty-six percent of the neurons were excited by naloxone

at 15 min whereas only 25% were excited after 45 min of morphine removal.
This latter value is not different from the proportion excited by naloxone in naive tissue and control incubated tissue (see sections 3.2.8.
and 3.5.2.1.).
These findings reveal no major differences in the action of
opiate agonists and antagonists on guinea-pig myenteric neurons exposed
to opiates in vitro or in vivo (Tables 4, 5 & 6).

Table

6.

The effect of naloxone on myenteric neurons undergoing withdrawal from morphine.

The number of myenteric neurons which

showed a naloxone induced excitation decreased with increasing
periods of exposure in morphine free Krebs

(~WK)

solution.

An excitation indicates at least a doubling of the firing

rate.

After 45 min in a MFK solution naloxone failed to pro-

duce a significant number of excitations (25%) when compared
with control tissues (15-23%).

164

TIME COURSE HI THE LOSS OF NALOXONE INDUCED EXCITATIONS
MORPHINE TREATED Jll1IMALS (IN VIVO)

.

I
Minutes in
MFK

Humber of units excited (>2x)
by naloxone (100-200 nM)

No. of units
tested

Percent

0-15

2

3

66

15-30

2

3

66

30-45

2

4

50

45-60

1

4

25

60-75

0

1

0

PROLONGED INCUBATIONS IN MORPHINE (IN VITRO)
II

Minutes in
MFK

Number of units excited (>2x)
by naloxvne (100-200 nM)

No. of units
tested

Percent

0-15

2

2

100

15-30

3

4

75

30-45

1

4

25

45-60

1

4

25

60-75

0

1

0

75

1

5

20

-

Figure 23.

The effect of

nor~orphine

on myenteric neurons removed

from a morphine pretreated guinea-pig, and subsequently
perfused in a morphine free Krebs solution.
~he begi~ning

(a)

Before

of this recording (time zero) the neuron had

been exposed to a morphine free Krebs (MFK) solution for
105 min.
Abscissa:

Ordinate:
time.

spike frequency (bin width- 10 s).

The solid bar indicates the period dur-

ing which the bathing solution was changed to one containing normorphine (NM).

Exposure to normorphine (l ~M) re-

sulted in an inhibition of neuronal firing which 'passed
off' during the presence of the normorphine (contrast this
with Figs. 8 & 15).

Washout of the normorphine produced

an excitation. Legend continues on the following page.
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Figure 23b. At time zero, the neuron had been exposed to !<1FK for 70
min.

Normornhine (300 ru\1) inhibited the firing rate, and

with the prolonged exposure to the narcotic 'tachyphylaxis'
~o

the iphibitory effect was observed.

Upon washout of the

normorphine, no marked increase in neuronal activity was
observed.

,In tissue taken from drug naive

posure to normorphine (300
60 min

~aused

cl~ -

1

~M)

5~inea-pigs,

for periods of up to

an inhibition of firing which persisted

throughout the period of application.

ex-
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Figure 24.

T'ne effect of naloxone on the firing rate of a myenteric
neuron removed from a morphine pretreated guinea-pig.

Be-

fore the beginning of the recording the tissue had been
perfuse~

Ordinate:
time.

in a Krebs solution containing morphine (200
spike frequency (bin width- 10 s).

nM).

Abscissa:

The. solid bar indicates the period during which the

bathing solution was changed to one conte.ining either the
(+) or (-) isomers of naloxone.

At the arrow, the perfus-

ing solution was svitched to a Krebs solution which was ·
free of morphine (l'!FK).

The excitatory effect of naloxone

(-) diminished v:i.th each application vrhile naloxone ( +)
was without effect.

The data from this Figure was not in-

cluded in the resuJ_ts since the tissue was given naloxone
more than once.
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3. 7.

THE

EFFEC~

OF SEVEH.AL AGENTS ON THE DEVELOPHENT OF OPIATE

TOLERANCE AND 'DEPENDENCE 1 AT THE SI.NGLE NEl.i1\0N LEVEL
3.7.1.

Synaptic Transmission Blockade

3.7.1.1.

Hexamethonium and Hyoscine

Incubations in hyoscine and hexamethonium.
bated for 24 h in a solution containing hyoscine
(300

~M).

Tissues were incu-

(1~)

and hexamethonium

The same solution perfused the tissue during the electro-

physiological experiments.

The frequency and pattern of neuronal

firing was not different from that observed in control incubated tissues.
Morphine (300 nM) inhibited the firing of all 6 cells to which it was
applied.
(n

= 5).

Naloxone (100 n..\1 - 1

~M)

had no effect on neuronal firing

The concentration of hyoscine and hexamethonium used has been

shown to block completely cholinergic transmission in the myenteric
plexus-longitudinal muscle preparation (Kosterlitz and Lydon, 1971) and
to block the fast excitatory postsynaptic potentials recorded from myenteric neurons (Nishi and North, 1973a}.
Incubations in mornhine, hyoscine and hexamethonium.

The effects

of opiate agonists and antagonists on tissue incubated for 24 h in a
solution containing hexamethonilun (300
(1 ~M) were studied.

~M),

hyoscine (1

~M)

and morphine

The results are based on 20 cells from 7 animals.

The tissue was continuously exposed to this solution throughout the
period of extracellular recording.

The basal firing rate of these cells

was 1.5 + 0.3 Hz and this was not different from the firing rate of
tissues incube.ted in morphine alone (1.5

.:!:._

0.2 Hz)

(mean~

S.E.M.).
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Increasing the morphine concentration to 10

~M

was without ef-

fect on the firing rate, indicating that tolerance to the inhibitory
effect of morphine had developed (Fig. 25a).
had no effect on neuronal firing (n

= 3).

Levorphanol (1- 10 ~M)

r~en

the perfusing solution

was changed to one which was free of morphine an increase (411%) in
neuronal firing was observed in 2 of 3 cells.

Similar but more marked

excitations were observed when the solution was changed to one which
contained naloxone (in addition to morphine, hyoscine and hexamethonium)
(n

= 16).

The excitation produced by naloxone (100 nM)

(683% ~ 102)

occurred in 11 of 13 neurons and was not distinguishable from the excitation by naloxone
alone.

(636% ~191)

The excitation was mimicked by Mr 2266 (100 nM - 1 ~M) (n

but not Mr 2267 (100 nM- 1 ~M) (n
(n

= 2)

in tissue incubated with morphine

= 3)

= 3)

or (+) -naloxone (100 nM- 1 ~M)

(Fig. 25a; Table 3).
The results described did not differ from those described for

tissues incubated in morphine alone (1 pM) (see section 3.5.2.2. ).

3.7.1.2.

Lidocaine

Incubations with lidocaine alone.

Tissues were incubated for

24 h in a solution containing lidocaine (1 w~).

No neuronal activity

could be recorded from tissue which continued to be perfused with such
a solution.

Within 3 - 10 min of changing to a lidocaine-free Krebs

solution, neuronal activity could be readily recorded.

Extracellular
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recordings made in these circumstances were not distinguishable from
those made from control incubated tissue; firing rates were unaffected
by naloxone (100 nM - 1
(Fig. 26).

~)

(n

= 7)

and inhibited by morphine (300 nM)

Morphine (300 nM) inhibited 5 of 5 cells and the degree of

inhibition was 86% + 4) (mean~ S.E.M.).
Incubations in mornhine and lidocaine.

The effects of opiate

agonists and antagonists on tissue incubated in morphine (1
lidocaine (1 mM) were tested on 19 units from 5 animals.

~)

and

After the

period of incubation, and during the subsequent period of extracellular
recording, the Krebs solution contained only morphine (1

~).

The results obtained did not differ from those described above
for tissue incubated in morphine alone (see section 3.5.2.2.).

Mor-

phine (5 J.lM) inhibited neuronal firing by 87% + 8 in 3 of 13 cells
tested; 10 cells were unaffected or excited.
or Mr 2266 (200 nM) (n

= 3)

Naloxone (200 nM) (n

= 11)

produced an immediate and large increase in

firing rate (829 ~ 116); a less marked excitation (457%) was also observed
by changing to a morphine-free solution (3 of 4 cells}(Fig. 25b).

The

characteristics of the excitation were closely similar to those observed
for tissue incubated in morphine alone.
-naloxone (100 nM - 1
3).

~M)

Mr 2267 (100 nM - 1 w1) and (+)

were without effect on the firing rate (Table

1[4

Figure 25.

Effect on a myenteric neuron of prolonged exposure to morphine in conditions of synaptic transmission blockade.
·Ordinate:
·time.

spike frequency (bin width- 10 s).

Abscissa:

During the periods indicated by the solid, diago-

nally hatched, vertically hatched and horizontally hatched
ba~s,

the perfusing solution was switched to one which con-

tained morphine, naloxone, Mr (+) and Mr (-),respectively.
Note that Mr (-) and

I~ (+)

refer to the enantiomeric isomers

of a benzomorphan (see Methods), Mr 2266 and Mr 2267, respectively.

(a)

Before beginning the recording (time zero), this

neuron had been exposed continuously to a solution containing
morphine (1 ~M), hyoscine (1 ~M), and hexamethonium (300 ~M)
for 24 h.

This solution continued to perfuse the tissue

throughout the period of recording except for the time indicated by the open bar, when it contained only hyoscine
and hexamethonium.

Tolerance to the inhibitory action of

morphine was evident in that a very high concentration of
morphine (10
rate.

~M)

no longer depressed the neuronal firing

Naloxone (100

ru~)

caused a pronounced increase in

the firing (in excess of 10 Hz), ;,rr 2266 also caused a marked
excitation, whereas its (+) isomer, Mr 2267 had no clear
effect on the firing rate.

Removing the morphine from the

perfusing solution resulted in an increase in firing.
continued on the following page.

Legend
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Figure 25b. This neuron had been exposed continuously to a solution containing morphine (1 ~M)

and lidocaine (l ~~) for 24 h.

Five min prior to the beginning of this recording (time
.zero), the perfusing solution was changed to one which differed only in its lack of lidocaine and this solution continued to perfuse the tissue throughout the period of recording except for the time indicated by the open bar.

Tol-

erance to the inhibitory effect of morphine had developed,
in that morphine (5

~M)

did not inhibit the firing rate.

Naloxone (200 nM) and Mr (-) (200 rM) caused a marked increase in firing (in excess of 10 Hz as indicated by the
area within the broken lines), but Mr (+)was without
effect.

Changing the bathing solution to one which was

free of morphine (indicated by open bar) also caused an increase in firing.

This increase did not persist throughout

the period of exposure.
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Figure 26.

The effect on a myenteric neuron of a prolonged exposure to
lidocaine.

This neuron had been exposed continuously to a

solution containing lidocaine (l mM) for 24 h.
~rior

Ten minutes

to·the beginning of the recording (time zero), the

bathing solution was switched to one which was free of lidocaine (normal Krehs solution).

Ordinate:

(bin width- 10 s).

time.

Abscissa:

spike frequency

During the periods

indicated by the solid, open, and hatched bars, the perfusing solution was changed to one which contained normorphine, naloxone and lidocaine respectively.

Normorphine

(300 ill~ - l ~M) caused a dose depe~dent inhibition of neuronal firing.
firing rate.

Naloxone (200 ruv1) was without effect on the
Lidocaine (l mM) depressed neuronal firing

in a reversible manner.

Compared with control treated tis-

sue, no change in neuronal sensitivity to the agents listed
above was observed.
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3.7.2.

Protein Synthesis Inhibitors

Incubations with cycloheximide alone.

Tissues were incubated

for 24 h in a solution containing cycloheximide ( 100 11M).

The concen-

tration of cycloheximide used was similar to the concentration necessa~J

to block the synthesis of enkenhalin in the myenteric plexus

Knight et al., 1978).

(~c

This solution perfused the tissue throughout the

electrophysiological experiments.

The rate of discharge

and

pat-

tern of neuronal firing were not different from those observed in control incubated tissue (see section 3.5.2.1.).
had no effect on neuronal firing (n

= 6)

Naloxone (100 nM- 1 uM)

and morphine (300 nM) inhibited

(87% + 3) the firing of 7 of 7 cells.
Incubations with morphine and cycloheximide.

The effects of

opiate agonists and antagonists on tissue incubated in a solution containing morphine (1 uM) and cycloheximide (100 uM) were tested on 20
cells from

6 animals.

The same solution perfused the tissue during the

electrophysiological recording.

= ll)

Neuronal firing rates ( l . 4 !. 0. 2 Hz) ( n

<..rere not different from those observed in tissue incubated in mor-

phine alone (1.5!. 0.2 Hz).

In only one of ll cells, was the firing rate

inhibited by morphine (5 uM) (Table 3).

That is, tolerance existed

which was similar to that caused by incubations with morphine alone.
Sixty percent of neurons were excited by changing to a solution vhich
contained naloxone (100
heximide (Table 3).

ru~

- 200 nM)

i~

addition to morphine and cyclo-

The excitation caused by naloxone ( 200 nM) '.vas

463% !. 126 ( 5 c:f 8 cells '..rere excited; 3 -..rere not affected) and "':'::lis

181
is not different than that observed with tissue incubated in morphine
alone (729% ~ 145) (mean+ S.E.M.) (p

3.7.3.
3.7.3.1.

>

0.05, t-test, df

= 11).

Cyclic Nucleotides

IBMX and Dibutyryl Cyclic-AMP

Incubations with IBMX and dbc-AMP.

Tissues were incubated for

24 h in a solution containing IBMX ( 500 1JM) and db c-AMP ( 200 lJM); and
this solution also perfused the tissue during the electrophysiological
experiments,

The frequency of neuronal firing (1.7 ~ 0.5 Hz) was re-

duced when compared with control incubated tissues (2.9 ~ 0.4 Hz).
Morphine (300 Q~) (or normorphine) inhibited the firing of 7 cells to
which it was applied (88%
neuronal firing (n

~

2).

Naloxone (200 nM) had no effect on

= 6).

Incubations with morphine, IBMX and dbc-AMP.

The effects were

studied of opiate agonists and antagonists on tissue incubated for 24 h
in a solution containing morphine (l 1JM),

(200 uM).

IBMX (500 uM) and dbc-fu~P

This same solution perfused the preparation throughout the

subsequent period of extracellular recording.

The following results

are based on extracellular recordings from 21 neurons from 5 animals.
~Teuronal

firing rates (1.6

~

0.3 Hz) were not different from those ob-

served in tissues incubated in morphine alone (1.5 ~ 0.2 Hz) or in
I3MX and dbc-AJ.'v!P (1.7 ~0.5 Hz) (p > 0.05, t-test).

~~Iorphine (3-

10 uM) failed to inhibit the firing of 9 of 11 neurons tested; two
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neurons were inhibited.

Naloxone (200 nM) produced an immediate increase

in the firing rate in 9 of 18 neurons (557% ~ 73).

The excitation caused

by naloxone persisted throughout the period of application (3 min).
2267 (200 nM) (n = 3) and (+) -naloxone (200 nM) (n
effect on the firing rate (Table 3).

= 3)

were without

Mr

4.
4 .1.

DISCUSSION

ACUTE ACTIONS OF OPIATES ON THE SPONTANEOUS
ACTIVITY OF' SINGLE fifYENTERIC NEURONS

Morphine has been shown to inhibit the spontaneous activity of
single myenteric neurons recorded extracellularly (Sato et al., 1973;

1974; Dingledine et al., 1974; 1975; 1976; North and Williams, 1977).
The inhibition was stereospecific,occurred with low concentrations of
morphine and was antagonized by naloxone.

The present investigation

confirmed these findings with respect to the actions of morphine on
spontaneously firing myenteric neurons and was extended to include
the study of the acute actions of ketocyclazocine, cyclazocine and
buprenorphine.
The inhibition of firing produced by ketocyclazocine and
cyclazocine was marked, concentration-dependent, slow in offset and
poorly antagonized by naloxone.

The effective concentration range of

ketocyclazocine and cyclazocine used in the studies of nerve-mediated
contractile responses differed from that effective in the extracellular
studies.

The concentration of ketocyclazocine or cyclazocine required

to inhibit the

ner~e

mediated contractile response-of the guinea-pig

ileum by 50% was less than 4 nM (see section 1.4.3.) whereas the concentration necessary to inhibit the spontaneous activity of single
myenteric neurons by

So%

was at least

8

fold higher.

It is possible

that ketocyclazocine (or cyclazocine) may act on receptors different
to those affected by morphine (or normorphine) in mediating the inhi-
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bition of the contractile response and the inhibition of neuronal firing.
Against this possibility is the finding that both actions are blocked
by naloxone:

however, it is not possible to say on the basis of the

present findings whether the same concentration of naloxone (pA 2 ) is
effective against both these agonist effects.
Another possibility is that inhibition of the contractile response is a more sensitive measure of receptor occupancy and that the
inhibition of neuronal firing requires a relatively higher occupancy
before its effects are apparent with the present experimental techniques.
Against this possibility is the finding that the IC50's for morphine,
normorphine and enkephalin in inhibiting the contractile response of
the guinea-pig ileum (Waterfield, Smokcum, Hughes, Kosterlitz and Henderson, 1977) agree well with the concentration of these agonists required
to inhibit cell firing by approximately 50% (present results; also
North and Williams, 1977; Williams and North, 1979a).
The effect of buprenorphine on the spontaneous firing rate of
single myenteric neurons was quite variable (30% of the neurons tested
were excited, 23% were inhibited and 47% were not affected).

The fact

that buprenorphine was without inhibitory effect on 77% of neurons
studied was somewhat surprising since all other narcotics tested inhibited 70-80% of the myenteric neurons to which they were applied.

Bupren-

orphine is a highly lipophilic narcotic analgesic with an extremely slow
rate of onset and offset (several hours) in the isolated guinea-pig
ileum (KosteYlitz et al., 1975: Schulz and Herz, 1976b).

Because of

the spontaneous changes in firing yate of individual neurons with time
and because successful recordings from neurons usually lasted only 1-2 n,
drug effec"Ss
addition,

~.vhich

c,,~i th

are of slow onset would be difficult to detect.

the Dresent technique it iS difficult to ascribe any

In
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action to a drug if it cannot be reversed by washing.

On the basis of

previous studies (Schulz and Herz, 1976b), it would not be expected
that buprenorphine's effect on spontaneously firing neUTons would rapidly washout.

The basis of the exci-'catory action of buprenorphine was

not fully investigated:
reversible on washing.

it differed from the inhibitory effect in being
This argues against the possibility that the

small proportion of neurons inhibited by buprenorphine was the result
of a concomitant excitation mediated through a different mechanism.
Analysis of the binding prope.rtie s of buprenorphine in rat
brain homogenates has revealed the presence of saturable binding sites
similar to those demonstrated by other workers for a series of
(Hambrook and Rance, 1976).

o~iates

In this binding assay, buprenorphine had

a 'sodium-shift' typical of narcotic antagonists.

In the present elec-

trophysiological experiments, myenteric neurons were no longer sensitive
to the inhibitory effects of normorphine at any time following the administration of buprenorphine.

That is, buprenorphine acted in a manner which

was similar to naloxone (see section 4.3.2.).

This is the first demon-

stration of antagonist properties of buprenorphine at the single neuron
level (Fig. 7).
Do multiple forms of the opiate receptor exist on single neurons
of the myenteric plexus?

One purpose of studying the effects of mor-

phine, ketocyclazocine and cyclazocine on spontaneously firing myenteric
neurons was to test the hypothesis that some neurons would respond to
only one of these prototypic receptor subtype agonists.

The firing rate

of single myenteric neurons was inhibited by morphine (~ & K agonist),
cyclazocine (cr & ~.agonist), ketocyclazocine (K-agonist) and enkephalin
(o-agonist).

In many experiments, several of these agonists were were
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effective on the same neuron.

This implies that if these agonists are

really selective for the proposed receptor subtypes (Hartin et al., 1976)
then all subtypes exist on each neuron.

The restriction of the range of

concentrations of cyclazocine and ketocyclazocine which were tested in
the present study imposes some limits on the interpretation of the
findings with respect to any such receptor subtype selectivity; however,
the present findings, and previous ones with enkephalin, suggest that
neurons do not bear only one receptor subtype.

187

4. 2.

THE INVOLVEHENT OF CYCLIC AMP IN THE ACUTE INHIBITORY
ACTION OF OPIATES ON NEURONAL FIRING

Morphine has two actions in the nyenteric plexus of the guineapig ileum; namely, inhibition of neuronal firing (Sato et al., 1973) and
inhibition of neurotransmitter release (Paton, 1957).

The principal aim

of the present experiment was to test the hypothesis that inhibition of
adenylate cyclase (and the resultant fall in cyclic-AMP levels) is an
intermediate step between occupation of the opiate receptor by the narcotic agonist and the inhibition of neuronal firing which it produces.
The evidence for this hypothesis has been given in section 1. 3.

4.2.1.

Inhibition of Netrronal Firing

The fact that both cyclic-ANP and morphine have similar effects
on myenteric neurons has led to certain difficulties for theories suggesting an inhibition of adenylate cyclase activity as the underlying
mechanism of opiate action.
tion of neuronal firing by

Furthermore, the finding that the inhibicyclic-~~

was antagonized by theophylline

does not support the intracellular site of action for this compound
which would be expected if cyclic nucleotides were to mediate the acute
actions of opiates.

Similar findings at other sites have led investi-
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gators to conclude that the inhibition caused by the adenine nucleotides
is mediated through activation of an extracellular receptor (Nathanson,
1977; Hiyashi et al., 1978).
drl~

Compatible

~~than

extracellular site of

action for these compounds was the finding thBt

cyclic-fu~

was more

effective in inhibiting neuronal activity than its dibutyrylderivative,
which supposedly penetrates through cell m~nbranes more easily (Sawynok
Jhamandas, 1976).
If we assume that morphine inhibits cyclic-AMP formation in the
myenteric plexus of the guinea-pig, and that this is responsible for the
inhibition of neuronal firing which morphine produces, then attenuation
of the effect on cell firing might be expected in conditions where levels of cyclic-AMP are elevated.

However, no difference in the effective-

ness of morphine was found under such conditions.

Prior or concurrent

administration of dibutyrylcyclic-AMP (or cyclic-AMP) did not reduce the
sensitivity of the tissue to the opiates (Fig. 11).

The adenine nucleo-

tides appear to inhibit cell firing themselves by acting on the outer
surface of the cell membrane; if a substantial

amo~~t

enters the cell,

as is likely in the case of dbcyclic-AMP, then this is ineffective in
modulating opiate action.
The results obtained with prostaglandin E2 and IBMX likewise do
not support the hypothesis that inhibition of adenylate cyclase is an
intermediate step in the acute action of opiates.

The sensitivity of

the tissue to the opiates was not altered by pretreatment with PGE2 or
IBMX.

Prostaglandin E2 (10 - 30 nM) alone often had a transient ex-

citatory effect on neuronal firing,and higher concentrations led to
marked excitations of neurons and a direct excitation of the longitudinal
muscle.

The concentration of PGE2 necessary to cause a 2.7 fold increase
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in cyclic-At\fP levels in rat brain homogenates was 90 pM (Collier and
Roy, 1974),and the concentration required to stimulate adenylate cyclase
in cultured neuroblastoma-glioma was 10
1975).

The possibility

~M

(Sharma, Klee and Nirenberg,

exists,therefor~that

a 1000 fold increase in

prostaglandin E2 may have revealed an antagonism of the neuronal inhibitory action of morphine.
experiments with IBMX.

A similar criticism does not apply to the
In this case a concentration of 50

~M

was used

which is 10 times the Ic 50 for inhibition of cyclic-AMP phosphodiesterase
in isolated fat cells (Beavo, Rogers, Croffard, Hardman, Sutherland and
Newman, 1970) and 2 times the IC50 for phosphodiesterase inhibition in
rat brain homogenate (Francis, Cuthberg, Saeed, Butt and CQlli.er ~ 12.78}.
The present results are in general
1

agre~~ent

with those reported

by Duggan and Griersmith (1979) for cat spinal neurons.

These investi-

gators did not observe an effect of electrophoretically applied cyclic-

M4P, its butyrylderivatives or IBMX on the nociceptive responses of
neurons located within

la~ina

IV and V of the spinal cord nor did these

substances alter the ability of electrophoretically applied morphine to
depress the response to noxious

4.2.2.

stimulation.

Inhibition or Acetylcholine Release

Adenosine and related nucleotides depress the nerve mediated
contractile response of the longitudinal muscle of the guinea-pig ileum
by inhibiting the relea.se of acetylcholine (Takagi and Takayanagi, 1972;
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Gintzler and Mussachio, 1975;
al., 1978).

Sa~7Uok

and Jhamandas, 1976; Hayashi et

This action is similar to that reported for morphine on

the guinea-pig isolated ileum (Paton, 1957).

However, the mechanism

of action whereby these compounds are able to depress the release of
acetylcholine from the cholinergic motoneurons appears to be different
(see section 1.3.4.).
Inhibition of the electrically induced contraction of the isolated guinea-pig ileum by morphine is antagonized by prostaglandin E1
or E2 (Schulz and Cartwright, 1976; Ehrenpreis, Greenberg and Belman,

1973).

It is important to stress that this antagonism is not specific

for opiate agonists since the

inhibito~;

action of non-opiates, such

as, tetrodotoxin and adrenaline were also effectively antagonized by
PGE1 (Schulz and Cartwright, 1976).

This action of PGE does not appear

to be related to its ability to stimulate adenylate cyclase but rather
to sensitize the smooth muscle to acetylcholine and in part to increase
the release of acetylcholine from the myenteric plexus (Schulz and Cartwright, 1976).

4.2.3.

Conclusion

The present results do not support the hypothesis that the inhibition of adenylate cyclase is relevant to the acute inhibitory action
of morphine on single mammalian neurons.

However, it is possible that

activation of only the a-receptor subtype might be linked to the inhibi-
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tion of adenylate cyclase activity, because the cultured neuroblastoma
cells posses only a-receptors (Chang et a1.. , 1979).

The studies on

neuroblastoma-glioma hybrid cells provide by far the strongest evidence
for an involvement between opiates (or opioid peptides) and cyclic
nucleotides.

However, North and Vitek (1980) were unable to demon-

strate any interaction between either a specific a-receptor agonist or
~-receptor

agonist and the cyclic nucleotides when they studied the

ability of their agents to depress the excitatory junction potential
recorded intracellularly from the mouse vas deferens.

rc 50 's

That is, the

for D-Ala 2 -D-Leu5-enkephalin (DADL) (a-receptor agonist) and

normorphine (~-receptor agonist) were unchanged in the presence of
dbcyclic-AMP and IBMX:.
It has not been demonstrated that opiates inhibit adenylate
cyclase activity in the myenteric plexus of the guinea-pig.

It

they do, then this is probably not an intermediate step in the acute
inhibition of neuronal firing which they produce.
sible that

cyclic-P-~

However, it is pos-

involvement may distinguish the acute from the

long term actions of opiates in the guinea-pig myenteric plexus (see
below) (Collier, 1980).
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4.3.

PROLONGED EXPOSURE TO OPIATES IN VIVO OR IN VITRO
Extracellular recordings were made from myenteric neurons either

removed from morphine pretreated guinea-pigs, or incubated in opiate
containing Krebs solution.

The effect of opiate agonist and antagonists

on these neurons were compared with their effect on myenteric neurons
from drug naive guinea-pigs.

The present results have extended previous

findings on tolerance and 'dependence' demonstrated in whole ileum
or myenteric plexus longitudinal muscle (~WLM) preparations to the
level of the single neuron.
The four major questions addressed by the present study are as
follows.

First, is the reduced inhibitory effect of morphine on neuronal

firing and the marked excitation of neurons caused by naloxone indicative of opiate tolerance and dependence?

Second, does the recovery

from opiate tolerance and 'dependence' in single neurons parallel the
time course of recoverJ in MPLM preparations or even whole animals?
Third, is the tolerance and 'dependence' demonstrated in myenteric
neurons following in vivo exposure to morphine similar to that produced by in vitro exposure to morphine?

Fourth, can drugs incubated

concomitantly with morphine modify any development of tolerance and
'dependence' which is produced?
order.

These Doints will be discussed in

193

4.3.1.

Tolerance to the Effect of Morphine

Prolonged exposures to morphine in vivo or in vitro diminished
the effectiveness of subsequent applications of morphine in inhibiting
the spontaneous firing rate of myenteric neurons.
cate the development of tolerance to opiates.

Three findings indi-

First, spontaneous

firing of neurons could be readily recorded even when the bathing
solution contained morphine at a concentration which normally inhibited completely the firing rate of all opiate sensitive neurons.
ond, increasing the concentration of morphine to 5 or 10

~M

Sec-

was with-

out any inhibitory effect on approximately 80% of the neurons.

Third,

levorphanol and met-enkephalin had no effect on the firing rate of
cells pretreated with morphine:

on the other hand, cyclic-AMP had the

same inhibitory effect on morphine pretreated neurons as on untreated
cells.
Opiate tolerance induced in single myenteric neurons in vitro
may not have been complete after 24-36 h of incubation.

The mean firing

rate of neurons incubated with morphine was lower (1.5 + 0.2 Hz) (mean
~

S.E.M.) than that of control incubated tissue (2.9 + 0.4 Hz); there

was a significant difference between the mean firing rates of the two
groups (p

<

0.05, t-test, df

= 44).

With such a large variability of

firing rates within each group, any difference in frequency would have
to be large, or a much larger
it to be detected.

s&~ple

would be required, in order for

The mean basal firing rate of neurons from ileum

removed from morphine pretreated guinea-pigs (2.4 ~ 0.2 Hz) (mean~
S.E.~.)

was not different from ~hat of freshly removed tissue (3.0 +
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0.2 Hz) thus indicating that tolerance to morphine exposure in vivo was
probably complete (p > 0.05, Student's t-test, df ~ 19).

4.3.2.

Manifestation of 'Dependence' -- Effect of Naloxone

Addition of naloxone to tissue chronically exposed to morphine
either in vitro or in vivo resulted in an increase in neuronal activity.
This excitation almost certainly reflects at the cellular level the
sustained contracture seen in the twitch studies (Schulz and Herz~. 1976a).
Naloxone caused an excitation in 79% of the myenteric neurons exposed
to morphine in vitro and 70% of the neurons exposed to morphine in vivo.
This neuronal excitation was not simply a reversal of inhibition due to
the morphine present in the bathing solution for the following reasons.
First, the frequency of firing produced by naloxone often exceeded 1020 Hz, a discharge rarely attained in normal tissue.

Second, repeated

exposures to naloxone resulten in progressively smaller excitations.

It

is possible that with repeated applications of naloxone the tissue has
become less dependent on morphine and,thus,exhibits weaker excitations
(signs of dependence) to subsequent naloxone challenges.

An excitatory

effect of naloxone due· to a reversal of the inhibitory action of morphine present in the bathing solution would be expected to be constant
with each application.

Third, prolonged exposures (greater than

60

minutes) to naloxone resulted in the neuronal excitation 'passing off'
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during the presence of naloxone.

This finding could also be explained

by a progressively reduced dependence on morphine.
mimicked by the benzomorphan antagonist
(+)-isomer

(~rr

c~~

The excitation was

2266) but not its inactive

2267) or the (+)-isomer of naloxone.

This stereospeci-

ficity indicates that the excitation is probably mediated through an
action on the opiate receptor.

A less intense excitation was observed

by changing the bathing solution from one which contained opiate to one
which was free of opiate.
Is it possible that it was the morphine present in the bathing
solution, (which was added to maintain any changes induced by the prolonged in vivo or in vitro exposure to morphine) and not the long term
exposure to morphine itself which was responsible for the changes in
sensitivity to opiate agonists and antagonists that were observed?
Some evidence has been presented already against the possibility that
it is an ongoing inhibitory action of the morphine which is responsible
for

the~e

changes; for example, the finding that repeated applications

of naloxone do not cause repeated neuronal excitations (see above).
Furthermore, application of normorphine (1 ~M) to naive tissue for
periods of

60 min caused an inhibition of firing which persisted through-

out this period, and naloxone did not cause excitations (other than
simple reversal of morphine depression) when applied after
posure to normorphine (or morphine).
the presence of morphine in

t~e

60 min ex-

Therefore, the possibility that

bathing solution causes a rapid desensi-

tization of the tissue is unlikely on the basis of these two findings
and because high concentrations of morphine still produced an inhibition of firing.
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Tolerance and 'Dependence'
Tolerance and 'dependence' was induced by prolonged exposures
to levorphanol or ketocyclazocine but not by prolonged exposures to
dextrorphan.

Levorphanol incubations induced tolerance to the effects

of both morphine and levorphanol whereas dextrorphan incubations induced tolerance to neither.

Ketocyclazocine incubations induced tol-

erance to the effect of ketocyclazocine but demonstrated poor crosstolerance to the effects of morphine or normorphine (Fig. 19).

Nalox-

one appeared to be less effective in precipitating a withdrawal reaction (excitation) in tissues incubated with ketocyclazocine as compared to tissues incubated with morphine or levorphanol.
Morphine failed to inhibit the firing rate of myenteric neurons
incubated in buprenorphine, but
excite these same neurons.

more importantly, naloxone failed to

It is not clear whether failure of morphine

to inhibit the firing rate of these neurons represents the development
of cross-tolerance which exists amongst opiates or simply an ongoing
antagonist action of buprenorphine (see section 4.1.).

In support of

the latter possibility was the finding that buprenorphine antagonized
the antinociceptive actions of morphine in the mouse and rat tail flick
tests, precipitated signs of abstinence in morphine dependent mice
(actions which are analogous to those seen with narcotic antagonists)
(Cowan et al., 1977)

and antagonized the inhibitory effect of morphine

on the spontaneous activity of single myenteric neurons (present study).
Even if buprenorphine induces the underlying changes of toler-

ance and dependence, naloxone may be unable to excite these cells because of the high affinity of the opiate receptor for buprenorphine
(which exceeds that for naloxone) and/or the high lipid solubility
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of buprenorphine (Hambrook and Rance, 1976; Rance and Dickens, 1978).
The present findings on the long term effects of buprenorphine are in
agreement with those established for the guinea-pig isolated ileum
(Schulz and Herz, l976b), monkey
ski et al. , 1978).

(Cow~~

et al., 1977) and human (Jasin-

The conclusion which is reached from these studies

is that buprenorphine is an opiate agonist with a lov capacity to induce drug dependence.
These effects of opiate agonists and antagonists on myenteric
neurons incubated in opiate containing Krebs solution are in many ways
analogous to the behavioral effects observed in humans or animals subjected to long term administration of morphine, levorphanol, buprenorphine or ketocyclazocine (see section 1.1.3.).
The phenomena of opiate tolerance and dependence have long been
.considered inseparable.

However, the present findings with long term

dextrorphan incubations support a possible dissociation of these two
events.

Tissues incubated in dextrorphan (l

~M)

were still sensitive

to the inhibitory action of morphine (absence of cross-tolerance) but
when naloxone was added to the perfusing solution or when dextrorphan
was removed a marked excitation occurred which was similar·to that observed with morphine incubations (manifestation of 'dependence').

This

action of naloxone was not observed with incubations at the lower concentration of dextrorphan (100 nM).

It is possible that dextrorphan acts

as a weak opiate agonist at the higher concentration (Kosterlitz and
Waterfield, 1975b) and incubation of tissue with this drug induces aspects of opiate dependence without evidence of tolerance.

A dissociation

of tolerance from physical dependence has been previously reported for
alcohol (Ritzmann and Tabakoff, 1976), LSD (Jaffe, 1975) and caffeine
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(Ritchie, 1975).

An alternative explanation is that the two phenomena

are inextricably linked but have different time courses in their development.

That is, the development of opiate tolerance requires a longer

period of time than the development of opiate dependence.

If the con-

ditions of the incubation could be modified so as to maintain viability
of the preparation for several days in vitro -- then the effects of
opiate agonists and antagonists on myenteric neurons exposed to dextrorphan for different lengths of time could be studied.

In this way it

might be possible to determine whether the two events are separable or
just have different time courses in development.

4.3.3.

Time Course of the Recovery from Opiate Tolerance and
'Dependence'
Extracellular recording from single myenteric neurons from

ileum chronically exposed to morphine in vitro or in vivo were made.
Within 2 h of switching the bathing solution from one which contained
morphine to one which was similar but lacked morphine, one-half of the
neurons tested had returned to normal opiate sensitivity (in vitro
incubations 53%; in vivo incubations 50%).

A second much slower com-

ponent of the recovery process followed (Table 5).

The absence of any

inhibition by morphine (300 nM) or an inhibition which reduced the
firing rate to not less than 50% of the control rate were the criteria
used to establish a cell as tolerant.

The question which might then
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be asked is whether a 50% fall in the firing rate produced by morphine
(300 nM) or normorphine (300 ru1) is really any indication of opiate
tolerance in these cells?

In tissue which has been incubated in nor-

mal Krebs solution, morphine (300 nM) reduced cell firing to less
than 25% of the control level in 9 of 11 opiate sensitive cells.
Therefore, failure of morphine to inhibit cell firing by at least 50%
surely indicates development of tolerance.

If the morphine was allowed

to remain in the perfusing solution for periods exceeding 15 min, the
inhibition was often seen to 'pass off' during the presence of the morphine.

This was never observed with similar concentrations of mor-

phine in control situations (Fig. 8).

This finding may indicate that

although the cells were sensitive to morphine as measured by short
applications, there was evidence for a persisting underlying change.
The loss of sensitivity to naloxone during the first h after
removal of morphine was apparently monotonic (Table 6).

Within 60 min

of switching the bathing solution from one which contained morphine to
one which was free of drug, application of naloxone had only the same
effect on the firing rate as on the control cells never exposed to morphine.

The time course over which single myenteric neurons recover

from opiate tolerance and lose the ability to be excited by naloxone
closely follows the time course of analogous events demonstrated in
the isolated guinea-pig ileum.

Cox (1978b), while studying the nerve

mediated contractile response, demonstrated two distinct phases in the
recovery from opiate tolerance in the isolated guinea-pig ileum.

One

phase decayed rapidly after drug withdrawal while the second phase long
outlasted the removal of the opiate from the bathing solution.

Admini-

stration of naloxone in the first or rapidly decaying phase of toler-
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ance induced a sustained contracture of the ileum but was unable to induce a contracture if administered

during the second phase of tolerance

(unless the tissue was again temporarily exposed to an opiate).

The

inference from this study was that within the myenteric plexus of the
guinea-pig there is a homogenous population of opiate sensitive neurons
and that each neuron exhibits two distinct phases in the recovery process.
The present investigation suggests another possible explanation.
That is, the biphasic pattern in the recovery process observed by Cox
may be due to the existence of two types of myenteric neurons.
rapidly regained sensitivity (eg. Fig.

One type

23) whilst the second type re-

mained tolerant to morphine for a much longer time (eg. Fig. 22).

Cox

would have been unable to distingtlish such neuronal types in his experiments on the ileum.
There are similarities in the time course of recovery from
opiate tolerance in vivo and in isolated tissues.

That is, the biphasic

character of this process in myenteric neurons resembles the biphasic
pattern characteristic of humans undergoing withdrawal (see section
1.1.3.).

However, the duration of the phases of loss of tolerance in

humans are measured in days and weeks rather than hours.

4.3.4.

In Vitro and In Vivo Exposures to Morphine -A Comparison of Effects

The results from tissues which have been incubated in an opiate
containing Krebs solution for

24-36 h did not differ noticeably from those
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of tissues which had been removed from morphine pretreated guinea-pigs

(and maintained in morphine containing Krebs solution).
(2 - 30

~M)

r1orphine

failed to inhibit the firing rate in 78% of the neurons

exposed to morphine in vitro and 75% of the neurons exposed to morphine
in vivo.

Naloxone increased the firing rate in 79% of the neurons

exposed to morphine in vitro and 70% of the neurons exposed to morphine
in vivo.

Thus, both methods of exposure are equivalent.

The time

course of recovery from opiate tolerance and 'dependence' induced by
the two methods of exposure are also similar.

A biphasic recovery

pattern for opiate tolerance and a monophasic pattern for opiate
'depen~ence'
~e

was found with each method of exposure (Tables 5 and 6).

only apparent difference between the results from the tissues sub-

jected to morphine in vitro or in vivo was the lower mean basal firing
rate displayed by the tissues incubated in vitro.
already been discussed (see section 4.3.1. ).

This finding has

The present results are

in agreement with those reported by Opmeer and van Ree (1978).

These

authors reported that opiate tolerance and 'dependence' induced in the
isolated guinea-pig ileum in vitro was similar in many ways to that induced with in vivo exposure.

In addition, these authors reported that

the degree of opiate tolerance induced with in vitro exposure was dependent on the concentration of opiate in the incubation media (0.8 So ~M).

The mean plasma concentration of morphine in guinea-pigs implanted with morphine pellets was 4.7

~Mat

the time of death.

The

concentration of morphine in the solution used to bath the myenteric
plexus from these same animals was 200 - 500 nt\1.

It is likely that

perfusing the tissue with a concentration of morphine 'N"hich is 10%
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that of plasma levels may have affected the level of toleraLce and the
time course of recovery, although it has been reported that a dose of
morphine in human subjects which is 20% that of the normal maintenance
dose is ·sufficient to prevent any overt signs of opiate withdrawal
(Martin, 1971).

This concentration of morphine (200- 500 nM) was

used because it has been previously shown to correspond to the concentration of morphine in guinea-pig plasma at the time of tissue removal
(Schulz and Herz, 1976a; Schulz and Goldstein, 1973).

It is possible

that the high value of the present determination was spurious due to
inflammation at the site of implantation (of the pellets) which resulted in an increased rate of absorption, in turn yielding a higher
plasma level.
Plasma levels of morphine from animals which were injected 3
times daily with morphine sulfate were considered artificially high
because these samples of blood were taken only 2 h after the last injection.

A more appropriate collection interval would have been 8 h

post-injection.

4.3.5.

Opiate Tolerance and Dependence in other
In Vitro Systems

Neuroblastoma x glioma hybrid cells
Opiates inhibit adenylate cyclase activity in cultured neuroblastoma x glioma hybrid cells (NG108-15) (Sharma et al., 1975).

When
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these hybrid cells are cultured for many h in the presence of opiate
the cells acquire tolerance to the

~~g.

That is, cyclic-AMP levels

which were originally depressed have now returned to normal values.
Dependence on the opiate is demonstrated by the marked increase in
cyclic-AMP levels produced by these cells when the opiate is rapidly
withdrawn or naloxone is administered.

The findings from cultured cells

as well as those from whole animals studies (QMWS) (see section 1.1.4.)
provide support for the involvement of the cyclic nucleotides in opiate
tolerance and dependence.

However,these studies suffer from certain

difficulties with respect to their application; those concerning whole
animal investigation already having been discussed (see section 1 .1. 4)
Extrapolation of the results obtained from cultured hybrid cells to
the level of the intact animal poses a certain difficulty; namely, how
can results obtained from malignant tumor cells in vitro in any way
apply to the intact,well differentiated and organized central nervous
system of the adult mammal?

This question has not been answered.

Cultured spinal cord-dorsal root ganglia
It was recently reported that opiates depressed the dorsal horn
response in fetal mouse spinal cord-dorsaJ. root ganglia (DRG) explants
(Crain et al. , 1977) .

When such cord-DRG cultures were incubated (at

35°C) in morphine (2. JlM) for 2-3 days the acute depressant action of
morphine on sensory evoked dorsal horn responses gradually disappeared
and increasing the concentration of morphine to 100 JlM was without
effect.

Thus, tolerance to the acute effect of morphine was demon-

strated (as was cross-tolerance to met-enkephalin) (Crain, Crain,
Finnigan and Simon, 1979).

Development of dependence was also·suggested
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by the enhanced dorsal horn responses in tolerant cultures.

The tol-

erance induced with in vitro exposure was long lasting (several days)
after removal of the morphine but could not be induced with incubations
at 20°C.
These findings from eord-DRG explants confirm the present study
on the myenteric plexus; that is, in vitro development of opiate
tolerance and dependence in nervous tissue.

However, the temperature-

dependence of the opiate tolerance mechanism (which suggests metabolic
requirements) and the long duration of tolerance seen in the cord-DRG
explants is in contrast to the opiate tolerance which develops in
myenteric neurons (present study).

Such differences may be due in part

to differences in the processes involved in the development of opiate
tolerance in central vs. peripheral neurons as well as differences in
the stage of maturity of the neurons (differentiated vs. undifferentiated).
Indeed, one significant advantage the myenteric plexus has over
the fetal spinal cord-DRG explant or neuroblastoma x glioma hybrid cells
as a model to study the acute and chronic action of opiates is its full
differentiation.

With respect to this concept, results obtained from

myenteric neurons may more closely resemble the actual opiate response
in the adult CNS.

·-~05

4.3.6. Alteration of the Development of Opiate Tolerance and
'Dependence' -- Concomitant Incubations with other Drugs
Segments of ileum were incubated concomitantly with morphine in
addition to agents believed to affect either protein synthesis, synaptic
transmission or cyclic nucleotide metabolism.

The purpose of these

experiments was to determine whether the induction of opiate tolerance
and 'dependence' in single neurons was somehow dependent on one or more
of these factors.
Protein synthesis inhibitors have been previously shown to suppress the development of opiate tolerance and dependence in whole animals and to partially suppress this development in isolated tissues
(Sharma et al., 1975; Hammond et al., 1976).

In the present study it

was found that incubation of ileum in solutions containing cycloheximide and morphine did not prevent the development of opiate tolerance.
That is, there was no difference in opiate sensitivity between tissue
incubated in solutions containing morphine alone and morphine plus
cycloheximide. , However, the response to naloxone was affecteq by the
presence of cycloheximide in the incubation medium.

Fewer neurons were

excited by naloxone and this excitation was of a smaller magnitude when
tissue was incubated with both morphine and cycloheximide as opposed to
morphine alone.

Two explanations for these findings are offered.

in the isolated guinea-pig ileum,

~rotein

First,

synthesis inhibitors (i.e.

cycloheximide) affect the development of opiate 'dependence' without
affecting the development of opiate tolerance.

Second, protein synthesis

inhibitors exert their modulatory effect by inhibiting the expression
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of dependence (neuronal excitation) and not by interfering with the
underlying mechanism.

This action may be secondary due to uncoupling

of oxidative phosphorylation (Robbins, 1974), fall in intracellular
pH (Robbins, 1974) or changes in the synthesis of opiate receptors.
On the other hand, it seems likely that the development of opiate
tolerance and 'dependence' in single myenteric neurons (as distinct
from the expression) does not require protein synthesis.

Evidence

for this was the finding that opiate tolerance and 'dependence' could
be induced in isolated ileum at 4°C (Hammond et al., 1976), a temperature at which a minimal amount of protein synthesis might be expected
to be taking place (see section 1.4.5.).
Agents affecting synaptic transmission were similarly tested
as to their ability to modify the induction of opiate tolerance and
'dependence'.

Tissues were incubated in solutions containing mor-

phine and lidocaine; or morphine, hexamethonium and hyoscine.

Lido-

caine prevented all neuronal activity throughout the 24 h period (see
section 3.7.1.2.):

and hexamethonium and hyoscine block completely

cholinergic synaptic transmission in the myenteric plexus (see section
3.7.1.1.).

The results obtained from tissues subjected to these con-

ditions did not differ from tissues incubated in morphine alone.

The

present results therefore indicate that long term changes induced by
morphine in single myenteric neurons are not dependent on ongoing
neuronal activity or synaptic transmission.
The present finding does not support those theories suggesting
changes in synaptic transmission as the underlying mechanism of opiate
toler&~ce

and dependence.

Collier (1968) advanced the idea that super-
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sensitivity of the postsynaptic cell to the presynaptic transmitter
could be induced by morphine if it acted by suppressing synaptic transmission.

This drug-induced supersensitivity could account both for

aspects of opiate tolerance and abstinence.

Release of neurotrans-

mitter would remain depressed throughout the exposure to the morphine
but changes in the postsynaptic cell would compensate for this effect
much like the changes observed with denervation supersensitivity (Thesleff, 1960); as a result, tolerance to morphine deYelops, because, even
in the presence of morphine, a normal response is observed.

If, on with-

drawing the morphine, normal release of transmitter is restored, then a
response which opposes that seen when opiates are giYen acutely should
be observed (abstinence).

However, in the isolated myenteric plexus

there is an absence of any ongoing synaptic actiYity (Nishi and North,
1973a), and it is well established that the action of opiates is directly
on the cell under investigation (Dingledine et al., 1976).

The present

study indicates that opiate tolerance and dependence can be induced at
the cellular leYel without ongoing neuronal actiYity or synaptic transmission, and therefore, argues against the

theo~J

of Collier (1968).

When tissues Nere incubated in solutions containing morphine,
dbc-&~

and IBMX the results obtained were inconclusiYe.

There was no

iifference between sensitiYity of neurons in such tissue to opiates ani
that of neurons incubated in morphine alone; howeYer, less than 50% of
the neurons tested with r.aloxone responded with an excitation and the
degree of excitation was small.

This contrasts with the

~arked

exci-

-::ations produced by naloxone in tissue incubated in solutions lacking
a?;ents ·w-hich

~ay

affect cyclic nucleotide levels.

explanations :f'or this finding exist.

At least tl.;o possible

First, it is possible that in-
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creasing intracellular levels of cyclic nucleotides (cyclic-AMP)

sup~

presses the development of opiate 'dependence' without affecting the
development of opiate tolerance.

Second, altering cyclic nucleotide

levels may affect the development of neither.

The acute action of dbc-

AMP + IBMX on myenteri·c neurons was inhibition of cell firing.
the mean basal firing rate of neurons incubated in

dbc-"~

Indeed,

+ IBMX was

lower than that of control incubated tissue (see section 3.7.3.1. ).
Perhaps the manifestation of 'dependence' (naloxone induced excitation)
was attenuated because of an ongoing depression of neuronal activity
caused by these compounds.

In other words, IBMX and dbc-AMP have no

effect on the underlying mechanism of opiate dependence but exert their
modulatory effects through a physiological antagonism:

IBMX and dbc-

AMP to inhibit these cells and naloxone to excite them.
In any event, further investigation on the effects of the cyclic
nucleotides in the mechanism underlying opiate tolerance and dependence
should be performed prior to the assessment of a role.

Such an investi-

gation should look at the time course of events leading to and the recovery from this state.

4.3.7.

Cellular Mechanism of Opiate 'Dependence"

Speculation -- Enhanced Neuronal Excitability
It has been suggested that the morphine withdrawal

s~1drome

re-

flects a state of rebound hyperexcitability of the CNS (Jaffe and Sharp-
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less, 1968).

This withdrawal syndrome should not be considered a uni-

tary phenomenon but as an ensemble of signs which probably reflect the
intense activation of a number of brain sites.

The neurotransmitter

systems which have been implicated in opiate withdrawal are the cholinergic (Frederickson, 1975), dopaminergic (Lal and Numan, 1976) and nordarenergic (Herz et al., 1974) systems.

Atropine, haloperidol and pro-

panolol have all been shown to alter the severity of the withdrawal
syndrome.

Consistent with this idea of neuronal hyperexcitability is

an increase in activity of myenteric neurons (which have been chronically exposed to morphine) by simply withdrawing the morphine from the
bmidng solution or by administering naloxone.

The underlying mechanism

for this increase in firing is most likely a depolarization of the cell
membrane (Johnson and North, 1980).
The therapeutic implications of this knowledge of hyperexcitability for the management of opiate withdrawal are far
if the directly affected neurons can be identified.

~eaching

especially

Drugs acting to

stabilize the neuronal membrane or to produce CNS depression would most
likely be effective agents in alleviating discomforting signs of abstinence.

Indeed, clonidine, a central noradrenergic agonist with

potent_ inhibitory action in the brain (Svensson, Bunney and Aghajanian,

1975) and guinea-pig ileum (Werner, Starke and Schuman, 1972) have been
used to successfully withdraw subjects from a state of chronic opiate
addiction (Gold, Redmond and Kleber, 1978).

Clonidine has also been

shown to suppress signs of morphine withdrawal in single neurons of
the rat locus coeruleus (Aghajanian, 1978).

Agents which act by stabil-

izing the cell membrane, for example the tricyclic antidepressants, are
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also very effective in suppressing signs of morphine withdrawal in mice
(Contreras, Tamayo and Quijada, 1977).
Clinical manifestations of the withdrawal reaction are in a
direction which opposes that seen when morphine is given acutely to
drug naive individuals.

This finding suggests that Himmelsbach's homeo-

static counteradaptive theory is still operative.

Whatever the under-

lying mechanism,the ultimate withdrawal reaction seems to be the result
of an increased excitability of structure and ?athways mediating specific
physiological effects.

4.3.8.

General Conclusions

Tolerance and 'dependence' can be induced in single mammalian
neurons exposed to morphine in vitro.

This action was mediated through

the opiate receptor since levorphanol but not dextrorphan induced the
response.

The time course of recovery from opiate tolerance and 'depend-

ence was studied,and their pattern of

recove~J

was shown to be multi-

phasic - similar to the pattern observed in human addicts.

~vo

types of

myenteric neurons were observed with respect to recoverJ from opiate
tolerance.

The present findings support the 7alidi ty of the :.'IPLH prep-

aration as a u.seful C!'.Od.el to study the ur.derl:ying changes associated
with opiate tolerance and dependence.

The inability of protein syn-

thesis inhibitors or agents affecting synaptic transmission to modify
the development of opiate tolerance and dependence argues ag<1.inst their
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involvement in the underlying mechanism.

The results with agents affect-

ing cyclic nucleotide metabolism were less clear.

The results obtained

with in vivo exposure to morphine were not different from the results
obtained with in vitro incubations.
The present experiments have helped in understanding the basic
change in the properties of neurons in the tolerant/dependent state.
The fact that naloxone so greatly excited these cells (whereas it normally is without effect) implies that the primarJ change underlying the
withdrawal state is rebound neuronal excitability.

There is recent

evidence suggesting that the mechanism underlying this enhanced excitability is a depolarization of the cell membrane.

It is likely that drugs

affecting membrane properties (e& membrane stabilizing drugs) or drugs
which selectively depress the activity of opiate sensitive cells (eg.
clonidine) will provide a pharmacological means to

detoxi~J

ize drug addicts without themselves producing dependence.

and stabilThe thera-

peutic implications of such drugs are far reaching in light of the fact
that over

500,000 Americans are currently dependent on narcotics.
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4.4.

EXTRACELLULAR RECORDINGS OF MYENTERIC NEURONS -- LIMITATIONS
Extracellular recordings afford one the oprortunity to measure

directly the activity of single neurons and the action of drugs which
may affect this activity (see section 1.).

When applied to the myen-

teric plexus longitudinal muscle preparation this technique suffers from

3 major criticisms.
and sporadic;

One, the firing rate of neurons was often variable

this does not allow for easy interpretation of drug

effects which may be slight.

That is, it was difficult to ascribe a

small effect to a drug because of the variability of neuronal firing.
Two, successful recordings of single myenteric neurons usually lasted
only 1-2 h so drug effects which were slow in onset and offset were
not easily measured; for example, the action of buprenorphine on single
myenteric neurons (see above).

Three, extracellular recording techniques

do not easily lend themselves to quantification of drug effects.
point should be stressed since it is an important one.

This

The large vari-

ability in opiate sensitivity and neuronal firing rate amongst the
myenteric neurons makes statistical comparisons of limited value unless
very large samples are used; on the other hand, effects of drugs on a
given neuron are clear, dose-dependent and readily reproducible when recording conditions permit.
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4.5.

PROPOSALS FOR FUTURE RESEARCH

The present experiments represent

a preliminary approach in the

use of this technique to study the long term effects of opiates.
proposals for future studies are offered.

Three

First, a careful study of

those drugs which may modify the development or expression of opiate
dependence in the whole animal should be performed at the level of
the single mammalian neuron.

In this way it will be possible to deter-

mine whether these drugs are effective directly at the cellular level
or by some indirect mechanism.

Particular attention should be given to

those drugs which are thought to stabilize the cell membrane.

Second,

an in vivo study is required of the long term effects of opiates on
several brain sites.

The action of opiate agonists and antagonists at

these sites should be studied to determine whether these sites demonstrate characteristics of both opiate tolerance and 'dependence'; or,
as suggested by the lesion studies, aspects of only tolerance or of
only dependence.

Third, intracellular recordings of neurons should

be performed so as to help elucidate the mechanisms underlying the
changes

bro,~ht

on by such long term exposures to opiates.
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